Studies on lentivirus infection of macrophages by Lee, Wei-Cheng
| THE UNIVERSITY of EDINBURGH
_ *o




Thesis scanned from best copy available: may contain faint or blurred
text, and/or cropped or missing pages.
Digitisation notes:
• Page 106 skipping in original pagination
Scanned as part of the PhD Thesis Digitisation project
http://libraryblogs.is.ed.ac.uk/phddigitisation
STUDIES ON LENTIVIRUS INFECTION OF MACROPHAGES
WEI-CHENG LEE
This thesis is submitted as part of the course requirements for the degree of
Doctor of Philosophy at the University of Edinburgh
1994
Acknowledgment
I would like to thank my three supervisors, Dr B. A. Blacklaws, Professor
I. McConnell and Dr. D. Sargan, for their help and discussion on my work. In
particular, I am very grateful for Dr. Blacklaws for her constant guidance and
support. I would also very much like to thank Miss D. Allen and Dr. P Bird for
giving me a lot of help, advice and elocution lessons when I worked in the
laboratory. Much of the work was eased by the technical backup of the Department
of Veterinary Pathology, Veterinary Faculty Electron Microscope Service and the
Moredun Research Institute. I would also like to thank the Ministry of Education,
Taipei, Taiwan, R.O.C. for its financial support to do this research.
Finally, I would like to thank my wife and my family for their
encouragement and support.
Declaration
The experiments and composition of this thesis are, unless otherwise state,
my own work. No part of this work has been, or is being submitted for any other
degree, diploma or other qualification.
Wei-Cheng Lee (March, 1994)
ii
UNIVERSITY OF EDINBURGH







Department of Veterinary Pathology,. Univerisity. of Edinburgh^.EHS.lQH.
Ph. D. Date .6.March..19.94
STUDIES ON LENTTVIRUS INFECTION OF MACROPHAGES
Title of Thesis
47,608
No. ofwords in the main text of Thesis.
Several aspects of the interaction of macrophages and maedi visna virus (MVV) were
undertaken: viral replication, phenotype, phagocytosis and antigen presenting function of
macrophages after MVV (EV1) infection.
MVV replication in monocyte-derived-macrophages (MDM) showed viral budding
sites both at cytoplasmic and vesicular membranes. In contrast, viral budding sites
predominantly occurred at the cytoplasmic membrane of skin fibroblasts, whilst vims
accumulated in vesicular lumens of MVV-infected alveolar macrophages (AM). Many
intracytoplasmic type A (ICA) particles accumulated in the cytoplasm of MDM and AM
infected with EV1.
Expression of MHC class II, MHC class I, CD4, CD8, LFA-1 and VPM32 antigen on
MDM infected in vitro was unaltered by 5 days after MVV infection (P>0.05). In vivo MHC
class I, class II (DQ & DR) and LFA-1 expression on AM from MVV infected sheep with
lung lesions was greatly increased compared to uninfected sheep (P<0.05). A significant
decrease in the CD4 : CD8 ratio in bronchoalveolar lymphocytes was also found in the same
group.
The phagocytic activity of macrophages after MVV infection was also studied both in
vivo and in vitro. There was a decrease in the phagocytic activity for RBC (P<0.05) and yeast
by MVV-infected MDM after 5 days post infection, but the FcR expression of MDM assayed
by erythrocyte rosetting (ER) did not show a significant difference between MVV and mock
infected MDM. In vivo, there was no significant difference in ER, phagocytosis of RBC and
P. hemolytica by monocytes between MVV-infected and control sheep. However surface
binding and phagocytosis of opsonized P. hemolytica by AM from MVV infected sheep
without lung lesions was significantly increased compared to uninfected sheep (P<0.05), but
this increase was not seen in ER and phagocytosis of RBC by AM in the same group. In
contrast the ER, phagocytosis of RBC and P. hemolytica by AM from sheep with lung lesions
was slightly lower, but not significantly different from uninfected sheep.
A defect in antigen presenting function of MDM in vitro was also found 3-5 days after
MVV infection by using ovalbumin and PPD specific T cell lines as responding cells.
MVV-specific cytotoxic lymphocytes were activated by autologous MVV-infected
skin fibroblasts, AM and MDM. MVV-infected MDM, AM and skin fibroblasts could be
specifically lysed by MHC-specific and CD8+ cytotoxic lymphocytes (CTL). In addition,
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Maedi visna virus (MVV), the prototype lentivirus, causes progressive
interstitial pneumonia and encephalitis in sheep (Petursson et al., 1976). The
disease was first described as a slow virus disease of sheep in Iceland during the
period 1930-1950 (Sigurdsson, 1957; reviewed in Zink et al., 1987). The name
given to MVV was derived from the syndromes it caused. Maedi, in Iceland, is a
pneumonia of sheep, whilst, visna means wasting, which is due to an encephalitic
lesion (Sigurdsson, 1952 & 1954 & 1957; Sigurdsson & Palsson, 1958). In North
America the disease was described as ovine progressive pneumonia (OPP) and was
first reported in 1915 (reviewed in Zink et al., 1987). Zwoegzerziekte is the name
used to describe the disease in Holland (Narayan & Clements, 1989).
MVV causes a persistent infection and replicates slowly in the host. Most
infections are subclinical with the development of progressive inflammatory lesions
in many organs eventually leading to symptoms. The lesions are characterized by
infiltrations of mononuclear cells (Cutlip et al., 1979; Georgsson et al., 1990).
MVV shares many biological similarities to human immunodeficiency virus (HIV)
and other animal lentiviruses, such as gene structure, development of antigenic
variation, persistent infection in macrophages, evasion of immune surveillance, and
a chronic progressive course of disease (Narayan & Clements, 1989). The
lentiviruses of humans, macaques and cats cause severe immunodeficiency in their
natural hosts. The loss of CD4+ lymphocytes leading to opportunistic infection,
neoplastic changes, and death of the host has been well documented in HIV
infection, but this type of immunodeficiency is not seen with lentiviruses which
infect ungulates (Narayan & Clements, 1989).
Animal models are important for research in AIDS. The simian and feline
infection models most closely resemble HIV. As with other lentiviruses, including
HIV, macrophages are predominant target cells in MVV infection. Lentivirus
replication in macrophages may modify the non-specific cellular defence functions
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of the host which could result in the failure to clear the virus and other infections.
Therefore, studies on MVV/macrophage interaction may help towards a better
understanding of current studies of HIV infection, particularly in viral persistence
and the accessory cell function of virus infected macrophages (Narayan & Clements,
1989).
1.2 Epidemiology
Maedi visna is a common lentiviral disease of sheep in most parts of the
world, except Australia and New Zealand where it has been kept out due to the
restricted importation of sheep (Narayan & Clements, 1989). The disease occurred
in an epidemic form in Iceland following the introduction of subclinically infected
sheep from Europe during the 1930s (Sigurdsson, 1953). It led to the loss of least
150,000 sheep between 1939 and 1952 but was finally eliminated from Iceland by
the slaughter of infected animals and the control of sheep importation (Sigurdsson,
1957). Explosive epizootic infections of the type seen in Iceland are rare. Usually
few animals become overtly ill, and these are adults that were infected 2-3 years
previously (Narayan & Clements, 1990).
The disease has shown two major symptoms: visna, a neurological disorder
which mainly occurs in Icelandic sheep and maedi, a chronic progressive interstitial
pneumonia. Certain breeds, such as Border Leicester sheep in USA, Texel in
Holland and Icelandic sheep are more susceptible to the disease than Columbia
sheep (Narayan & Clements, 1989; Cutlip et al., 1986). This suggests that genetic
factors in the host regulate the extent of viral gene expression in specific cell types
and organs.
The epidemic nature of the outbreak in Iceland is thought to be related to
three main factors ( Narayan & Clements, 1989):
(a) Host: The Icelandic sheep were of a different genotype than the imported
carrier of infection.
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(b) Management: MVV is principally transmitted via the horizontal route
(Pearson et al.,1989). Evidence has shown that the prevalence of maedi-visna
correlates with the length of exposure of lambs to MVV-infected ewes (Houwers et
al., 1983). It has also been shown that transmission of MVV from ewe to lamb
occurs through ingestion of contaminated colostrum or milk (reviewed in Cutlip et
al., 1988). Vertical transmission can occur, but is rare (Cutlip et al., 1981).
However MVV may also spread by exhalation of infected cells which then pass
from one infected animal to another. In Iceland during the winter most sheep are
kept inside in crowded conditions which increases the opportunity of nose-to-nose
contact with easy transmission of virus via nasal exudates.
(c) Coinfection with a secondary agent: During the outbreak of maedi visna
in Iceland, the sheep also developed sheep pulmonary adenomatosis (SPA) which
produces profuse quantities of pulmonary exudate facilitating the transmission of
disease (Narayan & Clements et al., 1989).
1.3 Classification and Morphology of Retroviruses
The family Retroviridae has been divided into 3 subfamilies, Lentivirinae,
Oncovirinae, and Spumavirinae (Dahlberg et al., 1988). The classification is based
on morphological distinctions, the host cell lines in which virus will grow, and
immunological techniques. However, when viral genome and viral gene expression
are used as criteria, the viruses form two categories, simple and complex retrovirus,
which can be further divided into seven subgroups (Coffin, 1990; Cullen, 1992).
The seven subgroups of retroviruses are: C-type retroviruses group A, C-type
retroviruses group B, B-type retroviruses, D-type retroviruses, Lentiviruses, T-cell
leukemia viruses, and Spumaviruses (Coffin, 1990; Cullen, 1992).
MVV is the prototype of the lentiviruses, even though HIV is now the most
studied lentivirus. Besides MVV and HIV, the lentiviruses also include caprine
arthritis encephalitis virus (CAEV), equine infectious anaemia virus (EIAV), feline
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immunodeficiency virus (FIV), simian immunodeficiency virus (SIV), and bovine
immunodeficiency virus (BIV) (Dahlberg, 1988).
Bernhard (1960) first identified and classified retrovirus particles as A, B, C,
and D particles in mouse tumor cells depending on the difference in morphology
shown by electron microscopy. In his classification, type A particles, 60 - 90 nm in
diameter, consisted of 2 forms, intracytoplasmic and intracisternal particles. Both
forms are double-shelled with electron-lucent centers. Originally, it was not known
that type A particles are the core of the type B retroviruses. Type A and type B
particles are 2 different morphological forms associated with the genus Oncovirus
B, generally termed type B viruses. Type B particles such as mouse mammary
tumor viru.-, (MMTV), which bud at the cell membrane with a complete nucleoid to
form extracellular particles, have an eccentric nucleoid and prominent surface spikes
on their outer envelope. Type C viral particles, such as murine leukemia virus
(MuLY), bud at the cytoplasmic membrane with a crescent shape, but with no
intermediate intracytoplasmic form as noted in type B viruses. The extracellular
viruses contain a central nucleoid and lack surface projections and spikes. Type D
viruses, such as Mason-Pfizer monkey virus (MPMV), have a similar morphology to
type B viruses, but the mature virions contain short surface spikes (Fine et al., 1978;
Gelderblom et al., 1991). HIV buds at the cytoplasmic membrane with a crescent
shape and there is no intermediate form in the cytoplasm of virus-infected cells.
The morphology of HIV during budding is similar to type C particles (Palmer et al.,
1985; Munn et al., 1985; Orenstein et al., 1988).
Mature MVV, 70-100 nm in diameter, contains an envelope which is
covered with short spikes and an eccentrically located, cone-shaped nucleoid, 30-
40nm in diameter (Thormar 1961; Coward, et al., 1970), which is composed of viral
gag protein. The spikes are formed by the envelope glycoprotein of MVV (Dubois-
Dalcq et al., 1976). Virus maturation and release from the cytoplasmic membrane
are very similar to type C viral particles. There is no intermediate form in the
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cytoplasm, when MVV is grown in sheep choroid plexus cells (SCP) (Coward et al.,
1970; Macintyre et al., 1973; Weiland et al., 1980). But Filippi et al (1982) report
that infectious intracellular ribonucleoprotein complexes of MVV are found in the
cytoplasm of SCP, which may indicate that intracellular infectious particles may
exist, but do not aggregate in the cytoplasm and therefore are overlooked under
TEM observation. In addition, ICA particles, probably an intermediate form, are
also seen in the cytoplasm of MVV-infected lamb testicular cells (Takemoto et al.,
1971). Furthermore, ICA particles are also reported in CAEV, which is the most
closely related lentivirus to MVV, when it replicates in Himalayan tahr ovary cells
(Dahlberg et al., 1981). Therefore, although MVV like HIV appears to be a type C
retrovirus it may also produce intracytoplasmic intermediates like these seen in type
B viruses.
1.4 Viral Genome and Viral Replication
1.4.1 Entry
Virus binding to the cellular receptor is the first step in infection. The
binding of external gpl20 of HIV virions to CD4 molecules on the T cell or
macrophage membrane is initial phase of the infection for HIV (Earl et al., 1992).
After binding, the viral envelope protein may be cleaved by a cell membrane
associated protease or undergo a conformational change to expose gp41 which leads
to virus membrane fusing with the cell membrane and nucleocapsid entry into the
cytoplasm (reviewed in Levy, 1993). However, the processes between virus binding
to the cell surface and entry into the cell are not clear. The process does not require
high CD4 concentrations on the cell surface as monocytes or cultured macrophages
have a low density of CD4 molecules on their cell membrane (Crowe et al., 1987;
Kazazi et al., 1989; Collman et al., 1990), but are still infected by HIV, in vivo and
in vitro. The virus can be blocked by anti-CD4 antibody (Collman et al., 1990).
Moreover, some CD4~ cells derived from brain or gut can also be infected by HIV
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(reviewed in Levy, 1993). Hence HIV entry into CD4" cells may not be via the
CD4 molecule. In reference to this it has been shown that HIV infection of
macrophages is markedly enhanced by adding sera from certain HIV infected
patients (Takeda et al., 1988). Antibody mediated enhancement of HIV infection of
macrophages was not inhibited by monoclonal anti-CD4 (Dalgleish et al., 1984;
Klatzmann et al., 1984) and was mediated by the FcyRIII, not FcyRI or FcyRII,
expressed on macrophages (Takeda, et al., 1988; reviewed in Meltzer et al., 1990a).
Complement receptors expressed on macrophages have also been implicated in
binding HIV to the cell (Robinson et al., 1990). These phenomena suggest that
immunological responses to HIV may facilitate the infection in the host.
To date the receptor on macrophages for MVV is not clear. MHC class II on
macrophages may act as a component of a cellular receptor for MVV (Dalziel et al.,
1991), although a 50K protein has also been implicated on fibroblast cells (Crane et
al., 1991). MVV has also shown antibody mediated enhancement of infection of
macrophages in a similar way to HIV (Jolly et al., 1989).
1.4.2 Virus genome and gene expression
MVV, like other retroviruses, has a diploid RNA genome about 9,200 bp
(Sonigo et al., 1985; Pyper, et al. 1986; Sargan et al., 1991). It encodes three basic
structural genes, gag, pol, and env (5' to 3') flanked by terminal repeats which
contain promoter and enhancer elements. Thus the overall genomic organization of
MVV RNA is RU5-gag-pol-Q-env-U3R (figure 1.1). In addition, the virus contains
several small ORFs: tat, rev and vif (open reading frame Q) (Sonigo et al., 1985;
Pyper et al., 1986; Sargan et al., 1991), which are thought to code for regulatory
proteins. These small ORFs are located between the pol and env gene and between
env and the 3' terminal (Sargan et al., 1991) (figure 1.1).
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Figure 1.1
Genome organization of EV1 (Sargan et al., 1991). Stop codons in each
reading frame of the EV1 sequence are indicated by vertical lines. Open reading













After the penetration of the virion core into the cytoplasm, viral replication
is initiated. The start of the first strand synthesis occurs just downstream of the 5'
terminal where a t-RNA molecule is bound to the primer binding site. The reverse
transcriptase carried in the virion begins adding deoxynucleotides to the t-RNA
primer. The direction of the nucleotide additions is from 3' to 5' (on genomic RNA)
to form the first strand of DNA(-) using both copies of the genome in the virus. The
original genomic RNA is digested by the RNase activity of RT allowing synthesis of
the second strand of DNA(+) from the DNA(-) template. The use of the two
genome copies allows duplication of the terminal region to give the long terminal
repeat (LTR) found in tne provirus. The genomic sequence of proviral DNA is U3-
R-U5-gag-/?o/-env-U3-R-U5 where U3-R-U5 is a LTR (Clements et al., 1979).
Generally, retroviruses have a strong requirement for dividing cells for
replication. These dividing cells presumably provide optimal conditions for the
synthesis of viral DNA and RNA and integration of proviral DNA. In contrast,
lentiviruses have the ability to replicate in non-dividing cells (Thormar, 1963).
MVV DNA replication predominantly occurs in the nucleus of infected cells (Haase
et al., 1982) rather than in the cytoplasm as occurs in oncogenic retrovirus infection
(Weiss et al., 1982). During replication of oncogenic retroviruses in tissue culture,
the circular form of provirus is predominant (Varmus, 1982). The majority of MVV
DNA in infected tissue culture is as linear duplexes (Harris et al., 1984) with only a
low level of circular forms (Clements & Narayan, 1981., Harris et al., 1984).
Integrated viral DNA is the most efficient template for viral RNA transcription in
the retroviral system (Varmus, 1982). But in MVV the linear non-integrated DNA
may also contribute to the transcription of viral RNA (Somasundaran & Robinson,
1981).
For replication of proviral DNA into genomic RNA and mRNA the
retroviruses use transcription signals present in the proviral LTR (reviewed in
Clements et al., 1990). All messages are initiated at the beginning of the 5' R region
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(the cap site) and transcription proceeds through the viral genome to the poly A
signal in the R region of the 3' LTR (Narayan & Clements, 1989). These processes
are carried out by cellular RNA polymerase (reviewed in Dahlberg, 1988). It is
known that viral gene expression is highly restricted in monocytes where only a low
percentage of cells are expressing viral RNA as detected by in situ hybridization.
Again only a small percentage of these cells express detectable viral protein
(Gendelman et al., 1985). However with monocyte differentiation and maturation
much higher levels of viral RNA as well as viral proteins can be detected
(Gendelman et al., 1985 & 1986), which may indicate that cellular transcription
factors in activated macrophages are necessary for activation of viral transcription.
This may be important in the shift of the viral life cycle from restrictive to
productive infection.
1.4.3 Regulatory genes
Besides gag, /?<?/,and env genes, lentiviruses also contain some small ORFs
which regulate viral replication (Hess et al., 1985 & 1986; Steffy and Wong-Staal,
1991). In early transcription viral regulatory gene products including tat and rev
proteins are expressed in HIV-infected cells (Cullen et al., 1989 & 1992). The tat
protein in HIV-infected cells is essential for viral replication by activating viral
RNA transcription via the viral LTR and also enhancing translation at a
post-transcriptional level (Feinburg et al., 1986; Steffy and Wong-Staal, 1991;
Cullen, 1992). This results in the rapid accumulation of viral RNA in the infected
cells for productive replication. In contrast, MVV tat only modestly enhances MVV
transcription and appears to do so by directly or indirectly interacting with AP-1 and
AP-4 DNA target sites located in the U3 region of the viral LTR (Hess et al., 1989).
The rev gene localized in the nucleoli of infected cells is required for the functional
expression of the unspliced and singly spliced mRNA's encoding gag, pol, and env
gene products and also mediates the establishment of an equilibrium between viral
10
structural and regulatory protein synthesis (Steffy and Wong-staal, 1991; Tiley and
Cullen, 1992). The function of rev regulatory protein is similar between HIV-1 and
MVV (Tilley and Cullen, 1992). MVV Q has some homology to the HIV-1
regulatory gene vt/(Sargan et al., 1991; Audoly et al., 1992) which may play a role
in the maturation of viral particles (Cullen, 1992).
The nef gene of HIV-1 acts as a negative regulatory gene (Guy et al., 1990;
Cullen, 1992) and may play a role in restricted expression from the HIV-1 LTR and
viral replication (Cullen, 1992). Nef appears important in vivo where a deletion in
nef probably leads to decreased virulence (Guy et al., 1990). Vpr, vpu, vpt, and tev
accessory genes have also been defined in HIV (Steffy and Wong-Staal, 1991;
Cullen, 1992), but these genes are not defined in MVV.
1.4.4 Regulation of viral gene expression in infected cells
The balance between latent and productive viral infection is regulated by a
complex interaction between exogenous signals, host transcriptional protein, and
viral regulatory proteins. The lentivirus LTR contains many regulatory elements
including promotor and enhancer sequences (Temin, 1981; Small et al., 1989; Hess
et al., 1986). The induction of HIV LTR activity in T cells can be mediated by
phorbol esters, UV irradiation, antigens, anti-CD3 antibody, mitogens, and
cytokines such as TNF-a, IL-6 and GM-CSF (McCune, 1991). Many of these
factors use signal transduction pathways where the final step is mediated by the
transcriptional activator, NF-^B, (Lenardo and Baltimore, 1989). In vitro, it has
been shown that HIV-infected myeloid cell lines, monocytes or macrophages
cultured with GM-CSF or M-CSF will amplify RT activity and increase the number
of viral particles released into the culture fluid (Folk et al., 1987; Gendelman et al.,
1988; Kalter et al., 1991). This suggests that GM-CSF or M-CSF promotes
monocyte maturation while indirectly affecting virus replication in the cells. TNF-a
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increases expression and replication of HIV in a latently infected T cell line (Clouse
et al., 1989; Matsuyama et al., 1989).
In addition, a number of DNA viruses, such as cytomegalovirus and herpes
simplex virus have been shown to transactivate the HIV LTR when the same cells
are infected (reviewed in McCune, 1991) These viruses are also commonly found
in patients with AIDS or at risk from AIDS. The increase in viral expression due to
these factors may play a role in the onset and progression of clinical disease.
In contrast to HIV, addition of PHA or IL-2 to cultures of infected sheep
PBMC reduces MVV replication (Gorrell et al., 1992). IFN-a has been shown to
suppress HIV replication in human monocytes (Poli et al., 1989; Kornbluth et al.,
1989 & 1990; Gendelman et al., 1990). In MVV-infected sheep, virus replication in
macrophages is markedly reduced by IFN-y released from activated T cells
(Narayan et al., 1985; Kennedy et al., 1985). It has been suggested that its
mechanism of action is to inhibit the development of monocytes into macrophages.
1.4.5 Translation and viral structural proteins
About 20 polypeptides are incorporated into MVV particles (Lin and
Thorman, 1979). The major components of the virion are the envelope glycoprotein
and the gag proteins (Haase et al., 1974; Vigne et al., 1982). In all retroviruses the
gag or gag-pol polyproteins can be thought of as single translation unit (Dahlberg,
1988). The message size of gag-pol is not different from gag messenger RNA and
it is thought that in lentiviruses the gag/pol precusor is made by a frame shift from
gag into the pol gene (Dahlberg, 1988). The levels of gag-pol precursor are much
lower than the precursor levels of gag, in a ratio of around 20 : 1, gag : gag!pol
(reviewed in Coffin, 1990). Both precursors are further digested by proteases which
are of viral origin (Dahlberg, 1986). Pulse-chase experiments have been carried out
to establish how processing occurs (Vigne et al., 1982).
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It has been elucidated that the precursor gag protein, Pr55£flS is further
cleaved into pl6, p25 (p30), and pl4 (Vigne et al., 1982; Houwers et al., 1989).
P16, matrix protein may direct protein to sites of viral budding (Rein et al., 1986).
It is acylated and probably accumulates on the internal face of the cell membrane
and in the virion, it may contact both the viral envelope and p25 core. P25 is the
major core protein of the virus. This protein and the reverse transcriptase of pol are
the most highly conserved of retroviral proteins. P14 is a small basic nucleoprotein
that contains a repeated motif of cysteines which probably bind and protect the RNA
genome (Filippi et al., 1982; Sonigo, 1985).
The pol gene is expressed as a gag-pol polyprotein precursor, Prl508aS-P°l
(Vigne et al., 1982), which is thought to be further cleaved into reverse transcriptase
(RT), integrase/endonuclease, and protease. RT converts the viral genetic
information from the RNA genome to the DNA provirus. Endonuclease/integrase
integrates proviral DNA into cellular DNA. Protease cleaves gag protein as the
virion buds (Vigne et al., 1982; Sonigo et al., 1985).
In contrast, env protein is synthesized from a singly spliced subgenomic
mRNA from which the gag and pol coding regions have been removed (Dahlberg,
1988). In lentiviruses the env gene encodes a single large polypeptide varying from
115K to 160K which is highly glycosylated during synthesis (Sonigo et al., 1985;
Vigne et al., 1982). In MVV the precursor env protein has a molecular weight of
150,000, gPrl50e,!V (Vigne, 1982). The envelope polypeptide contains the basic
amino acid sequence Arg-X-Lys-Arg which is present in all retroviruses (Sonigo, et
al., 1985). The sequence represents the cleavage site of the envelope glycoprotein
into an outer membrane protein, gpl35 (or gpllO), and transmembrane protein,
gp41 (Vigne et al., 1982). The envelope glycoprotein, which is less conserved
among lentiviruses than gag, contains many biologically important determinants,
including the determinants of vims-cell receptor interaction, vims induced cell
fusion (Sargan et al., 1991; Lifson et al., 1986a & b), and the epitopes for vims
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neutralizing antibody (Scott et al., 1979). Antigenic drift of MVV in persistent
infection of sheep is also due to the mutations within the MVV envelope
glycoprotein (Scott et al., 1979; Stanley et al., 1987).
1.4.6 Viral assembly
Transmission electron microscopy (TEM) studies have revealed that
assembling maedi visna virions are first seen as an electron dense, crescent-shaped
patch at the cytoplasmic membrane. Both ends of the crescent meet to form a
complete envelope and core and the virions are released from the cells (Thorman,
1961; Dubois-Dalcq, et al., 1976). The protrusion of the cell membrane appears to
be initiated by attachment of capsid protein to a region of the cell membrane which
is modified by the formation of clusters of globular units (Dubois-Dalcq et al.,
1976). These globular units are most probably local concentrations of envelope
protein in the cellular membrane.
The assembly and budding pattern of HIV virions differs between infected
macrophages and lymphocytes. HIV infected T cells show hundreds of viral
particles associated with the cytoplasmic membrane that indicate HIV assembles and
buds only from the plasma membrane of infected T cells and there is no intracellular
accumulation of mature or immature virus reported (Gendelman et al., 1989).
However, HIV replication in macrophages shows few or no virions at the
cytoplasmic membrane. Virus is localized almost exclusively in intracellular
vacuoles of macrophages (Gendelman et al., 1989; Orenstein et al., 1988; Munn et
al., 1985). HIV not only accumulates within these intracellular vacuoles, but also
assembles and buds from the vacuolar membrane (Orenstein et al., 1988). Evidence
also suggests that these vacuoles are derived from the Golgi complex (Orenstein et
al., 1988). The typical CPE of syncytial formation in HIV infection is mediated by
envelope glycoprotein (Lifson et al., 1986). Finally, these virus-containing vacuoles
are released into extracellular areas by exocytosis or cellular lysis. Ten fold less
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virus is released from HIV-infected macrophages into culture fluid than is released
by an equal number of infected T cells (Meltzer et al., 1990b). This suggests that
the amount of virus released from macrophages is greatly limited, but HIV-infected
macrophages are supposed to represent the major reservoir of persistent infection in
human. Studies of immunoprecipitation patterns show that virions assembled from
macrophages are relatively lacking in gpl20, the outer membrane envelope
glycoprotein, compared to virions released from T-lymphocytes. This may affect
cellular tropism and ability to form syncytia.
MVV assembly in sheep choroid plexus or skin fibroblasts and macrophages
is very similar to HIV with its difference in budding between T-lymphocytes and
macrophages. There are extensive budding sites at cytoplasmic membranes of
MVV-infected sheep choroid plexus cells (Thormar, 1961; Weilland and Bruns,
1980), whereas viral particles accumulate in intracytoplasmic vacuoles of MVV-
infected macrophages (Narayan et al., 1982). Whether there is a relative lack of
gpl35 to gag protein in virions assembled from MVV-infected macrophages, as
noticed in HIV infection in macrophages, is still unclear.
1.5 Immune Response
1.5.1 Humoral immunity
After infection with MVV, sheep develop a virus specific humoral and cell-
mediate immune response (CMI). Precipitating and complement fixing antibodies
can be detected as early as 1 month post infection (Sihvonen et al., 1981), but 2-3
months or longer are usually required to develop neutralizing antibodies (Shivonen
et al., 1981). However, neutralizing antibodies can be detected as early as 2-4
weeks in some experimentally infected sheep (Griffin et al., 1978). These
antibodies are not consistent to any one viral antigen which may be due to variation
in different viral strains (Larsen et al., 1982a), but both precipitating and
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complement fixing antibodies remain at high levels through the course of disease
(Gudnadottir & Kristinsdottir, 1967).
Of the 20 MVV proteins noted by Lin & Thorman (1979), the env and gag
gene products are the major antigenic proteins (Houwers & Scharke, 1987). Agar
gel precipitation methods have also indicated that antibodies to gpl35 are major
components of the antibody response in MVV-infected sheep (Klein et al., 1985).
However only IgM and IgG1? never IgG2 responses, have been detected in the sera
of MVV infected sheep (Reyburn, 1992a). Antibodies to gpl20 from HIV
seropositive individuals have been shown to mediate anti-HIV antibody-dependent
cell-mediated cytotoxicity (ADCC) (Lyeryl et al., 1987; Blumberg et al., 1987).
However, no MVV-specific ADCC activity can be detected in antiserum from MVV
infected sheep. This may be due to the fact that IgG2 is the ADCC antibody in
sheep and there is no detectable IgG2 anti-MVV in sera (Reyburn, 1992a).
The gag proteins of MVV especially p25, which is highly conserved among
virus isolates (Sargan et al., 1991), elicit strong antibody responses during infection
which are often used as an index of infection (Houwers & Nanta, 1989). The role of
this antibody is not clear. However viral core protein (p24) is expressed on the cell
surface of HIV-1-infected cells (Laurent et al., 1989) which would allow antibodies
against gag proteins to be involved in ADCC or antibody-dependent complement
mediated cytotoxic (ACC) activity against infected cells (Rook et al., 1987).
The effectiveness of these antibodies in reducing lentivirus infection is not
clear. It has been shown that non-neutralizing antibodies can aggregate viral
particles on the cell surface (Dubois-Dalcq et al., 1979) which would inhibit their
spread. But antibody and virus may form an immune complex which could enhance
viral infectivity by allowing entry of the monocyte/macrophage via Fc receptors
(Takeda et al., 1988). High concentrations of antibody-positive serum also inhibit
viral replication in tissue culture (Takeda et al., 1988). However it has been shown
that the affinity of neutralizing antibody for MVV is lower than that of virus for
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cells (Kennedy-Stoskopf & Narayan, 1986) which suggests a possible mechanism of
how virus escapes from neutralizing antibodies and spreads in vivo. Furthermore,
MVV is able to escape neutralizing antibodies via another mechanism, antigenic
drift of the env proteins. Here new variants cannot be recognized by antibodies
induced to the original MVV isolate (Clements et al., 1980; Narayan et al., 1978).
Neutralizing antibodies and ADCC also play an important role in the control
of HIV infection (Merigan et al., 1991). In HIV, low or absent serum neutralizing
antibodies correlate with a poor prognosis of disease (Scheppler et al., 1988).
Moreover, evidence shows that sera from healthy HIV seropositive individuals has a
significantly higher level of ADCC activity compared to sera from patients with
AIDS (Rook et al., 1987). The HIV envelope is the major target for humoral
antibody responses. Several conserved domains localized on the envelope gpl20
and the external portion of gp41 are primarily involved in antibody neutralization of
virus (Matthews et al., 1986; Ho et al., 1987). However, persistent infected
macrophages have a relative lack of expression of the viral envelope glycoprotein,
gpl20, on their surface (Meltzer et al., 1990b) which may assist in evasion of
ADCC by infected cells. Anti-viral antibody may contribute to depletion of CD4+
lymphocytes as gpl20 bound to the surface of lymphocytes via CD4 can cause lysis
of the lymphocytes via ADCC but not ACC (Lyerly et al., 1987).
1.5.2 Cell-mediated immunity
The CMI response to MVV appears earlier than the humoral immune
response. Lymphoproliferative responses can be detected as early as 1 to 7 weeks
after sheep have been experimentally inoculated with MVV, but these reactions are
then lost (Griffin et al., 1978; Larsen et al., 1982a; Sihvonen, 1981). The decrease
in CMI responses sometime after MVV infection is very similar to other viral
infections and is generally associated with clearance of virus. After acute MVV
infection, there are some cells (macrophages) which contain proviral DNA and viral
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RNA, but few cells express viral antigen (Gendelman et al., 1985). Perhaps not
enough antigen is expressed to maintain detectable levels of sensitized cells in the
blood. However, when followed for three years after infection, sheep showed a
transient and irregular CMI response in the blood (Larsen et al., 1982b). A more
recent report indicates that CMI can be persistently detected in the blood of
experimentally and naturally infected sheep using purified viral or gag antigen. The
major proliferative response is mediated by CD4+ lymphocytes (Reyburn et al.,
1992b).
CMI responses are well known in HIV infection. Specific HIV antigen
induced lymphoproliferative responses can be detected in HIV patients without
symptoms (Reddy et al., 1987), but lymphoproliferative responses to mitogens or
specific recall antigens are greatly decreased in patients with generalized
lymphadenopathy or AIDS (Pinching et al., 1991). The suppression of
lymphoproliferative responses correlates to the depletion of CD4+ lymphocytes,
decreases in CD4+ lymphocyte function, and progressive destruction of dendritic
cells (DC) (Pinching et al., 1991). DC and Langerhan's cells have a major antigen
presenting function, particularly in primary responses (Harding et al., 1988).
Decreased MHC class II expression on these antigen presenting cells (APC) has
been noted in HIV infected patients and is associated with a severe impairment of
antigen presenting function (Eales et al., 1988; Macatonia et al., 1989 & 1990;
Meyaard et al., 1993). In contrast, CD4+ lymphocytes are not target cells of MVV
and the lymphoproliferative response to mitogens, BCG or OVA are not
significantly suppressed in MVV-infected sheep in vitro, when compared to normal
control animals (Larsen et al., 1982a; Dr. P. Bird, personal communication). There
is also no significant change in the CD4/CD8 lymphocyte ratio in peripheral blood
mononuclear cells (PBMC) of MVV-infected sheep (Dr. P. Bird; personal
communication). Mild immune suppression of MVV-infected sheep has also been
reported (Myer et al., 1988), but most studies have no evidence for gross
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immunosuppression associated with MVV infection. In vivo, it has been shown that
MVV-infected sheep have a decreased delayed-type hypersensitivity response to
PPD and primary antibody response to OVA (Dr P. Bird, personal communication).
These results suggest that, in vivo, an immune defect is at the macrophage level.
However, concurrent infection with the virus causing sheep pulmonary
adenomatosis or pasteurellosis is often reported in research and field cases (Cutlip et
al., 1979; Markson et al., 1983). This suggests that immunosuppression may occur
in some MVV-infected sheep, particularly in lungs with pulmonary lesions.
Development of the humoral immune response and CMI response,
particularly in the generation of specific cytotoxic lymphocytes (CTL) is very
important in the hosts recovery from various viral infections. Precursors of MVV-
specific MHC class I restricted CD8+ CTL which can be activated by culturing with
IL2 and virus, show specific cytotoxic activity on autologous MVV-infected skin
fibroblasts (Blackaws et al., 1994). However, in vivo, macrophages are the major
target cells of MVV. The MVV-specific, MHC class-I restricted recognition of
autologous infected macrophages has only been reported once (Kennedy-
Stopskopfs, 1989a).
In contrast, HIV-specific MHC class I restricted CTL are directed against
various HIV-infected targets which express viral antigens including proteins coded
by the env, gag, and poi genes (Langlade-Demeyen et al., 1988; Riviere et al., 1989;
Nixon et al., 1988) and other regulatory genes (Walker et al., 1989; Riviere et al.,
1989). Moreover, MHC class II restricted, gag or env specific CD4+ cytotoxic
lymphocytes have been reported in HIV infected patients or healthy HIV
seronegative volunteers who were primed with recombinant env protein (Littaua et
al., 1992; Orentas et al., 1990., Curiel et al., 1993). There have also been reports of
HIV envelope specific cytotoxicity, which is not restricted by MHC antigens and
may not be mediated by T cells (Riviere et al., 1989).
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1.5.3 Innate immunity
Besides humoral and cell-mediated immune responses, both of which play a
major role in acquired host defense, the body also requires a variety of cells and
factors to deal with immediate antigenic insult. Monocytes and natural killer cells
are armed to perform these non-specific activities (Taylor and Cohen, 1992).
Both clinical and experimental data suggest that NK cells mediate defence
against viral infection and malignancies, including HIV infection (Bandyopadhyay
et al., 1990; Merigan et al., 1991). NK cells constitute a small population of
lymphocytes in blood that display a large, granular morphology. These cells are
CD3", CD2+ and CD16+ (Taylor and Cohen, 1992). The number of circulating NK
cells is not significantly decreased in HIV-infected patients, including patients with
AIDS (Katzman and Lederman, 1986). However, a decreased NK activity has been
documented in HIV infection, especial those patients with AIDS-related complex
(ARC) or AIDS when compared to levels in normal individuals (Rook et al., 1985;
Katzman and Lederman, 1986; Poli et al., 1985b; Ljunggren et al., 1989; Scott-
Algara et al., 1992). But, culture in vitro of NK cells from HIV infected individuals
with IL-2 can restore cytotoxic activity (Rook et al., 1985). Hence, the decrease in
NK activity is thought to be related to the depletion of CD4 cells in HIV-infected
patients with AIDS or ARC. NK cells show significant cytotoxic activity against
HIV-infected lymphoid cells (Ruscetti et al., 1986). There is no data documenting
the role of NK cells in MVV infection.
Activated macrophages have been found to play an important role in
resistance to some viral infections (Sissons and Oldstone, 1980; Kohl, 1991).
However, in lentivirus infections, monocytes play a dual role as they not only act as
a reservoir of virus, but also as effector cells and antigen presenting cells for the
host. Hence, there is the interesting situation of whether monocyte/macrophages
can lyse lentivirus-infected monocyte/macrophages. However, there is no evidence
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documented that lentivirus-infected monocyte/macrophages are lysed by other
macrophages using their inherent cytotoxic function or by ADCC mechanisms.
1.5.4 Evasion of the immune surveillance
After viral infection, both the host's nonspecific (NK, macrophages, IFN)
and specific immune response are induced to eliminate the invading virus and
destroy virus infected cells to allow the host to recover from infection (Rouse and
Babiuk, 1979). However, lentiviruses can evade immune surveillance and persist in
host cells. A number of mechanisms allow this immune evasion: proviral DNA
integration and latency, restricted replication states in different maturation stages of
macrophages, low affinity of neutralizing antibodies, cell to cell spread of virus, and
antigenic variation (Narayan and Clements, 1989).
Integration of a viral genome into the host cell genome is an effective way to
establish persistence in the host and when the DNA is truly latent, avoid immune
recognition. It is thought that circular DNA is the precursor for integration into host
DNA, however most MVV proviral DNA exists as a linear duplexes, with only low
levels of the circular form (Harris et al., 1984). Hence integration of MVV into the
host cell genome appears to be limited. In vivo, proviral DNA has been detected in
low levels in promonocytes of the bone marrow and monocytes in blood
(Gendelman et al., 1985). A regulatory protein encoded by the nef gene of HIV,
which can inhibit HIV-1 LTR-specific gene expression and viral replication (Cullen,
1992), is thought to be involved in the initiation of latency. There is no nef gene in
MVV but there may be a nef-like domain in the rev gene (Sargan et al., 1991).
Antigenic variation of MVV in persistently infected sheep is another feature
of lentivirus infection (Narayan et al., 1978). Over a long time virus undergoes
progressive antigenic variation, mainly within the env gene. In one infected animal
serologically distinct virus could be isolated late in the course of the disease which
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was not efficiently neutralized by sera obtained shortly after infection (Narayan et
al., 1978). The infected animal subsequently developed neutralizing antibodies
against these variants. The mutations in these isolates were located within 2
kilobases of the 3' terminus of the genome, which is within the env gene giving rise
to amino acid substitutions within the glycoprotein (Clements et al., 1980).
Other factors including viral infection of macrophages, low affinity of
neutralizing antibody (section 1.7.1), and LV-IFN (section 1.7.3) which also limit
viral replication. These factors directly or indirectly inhibit viral protein expression
on the cell surface which allows evasion of the host immune response.
1.6 Pathology
The onset of MVV disease is insidious. After infection virus persists for
several months or years in the host with increasing symptoms resulting in
progressive deterioration in health and finally death (Cutlip et al., 1988). There are
two major clinical signs and pathological lesions in MVV-infected sheep. The first
is a chronic interstitial pneumonia where clinically the sheep show shortness of
breath and later dyspnea, especially after exercise. Affected lungs become heavy,
enlarged and firm with multiple grey areas (Cutlip et al., 1979; Oliver et al.,
1981a & b; Lairmore et al., 1988b). Some of them may show a concurrent infection
with other pulmonary diseases (Cutlip et al., 1979; Markson et al., 1983; Myer et
al., 1988) or adenomatosis (Markson et al., 1983; Myer et al., 1988).
Histopathologically, classical maedi is characterized by marked thickening of
interalveolar septa with smooth muscle hyperplasia and accumulations of lymphoid
cells into follicular-like structures, particularly in peribronchial areas (Cutlip et al.,
1979; Oliver, et al., 1981a&b). The histopathology of sheep lungs infected with
both bacteria and MVV consists of a combination of lymphoproliferative interstitial
pneumonia and bronchopneumonia (Lairmore et al., 1988b). The complexity of
lesions resembles that found in pediatric and adult AIDS with opportunistic
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pulmonary infections which are a major cause of death in humans with HIV
infection (Joshi et al., 1986; Marcheusky, et al., 1985).
MVV causes neurological symptoms which are characterized by posterior
ataxia. The symptoms may persist and progress over several weeks to months
leading to hind limb paralysis (Cutlip et al., 1988; Georgsson et al., 1990).
Pathological lesions are distributed throughout the brain and spinal cord,
particularly in white matter. The major early lesion of the spinal cord is
inflammation around the central canal, whereas the most prominent changes in later
stages are randomly scattered demyelinated lesions in the white matter (Petursson et
al., 1976; Georgsson et al., 1989). The choroid plexus is frequently inflamed with
the formation of lymphoid nodules (Petursson et al., 1976). Histopathological
lesions include perivascular cuffs with mononuclear cells, predominantly
lymphocytes and plasma cells (Oliver et al., 1981a). In severe cases, demyelination,
microglial nodules and multinucleated giant cells are present, especially in white
matter (Petursson et al., 1976). In contrast to the pulmonary lesions, only a small
proportion of MVV infected sheep develop clinical neurological lesions (Oliver et
al., 1981a).
Neurological abnormalities are very common in HIV patients with AIDS
(Wigdahl et al., 1990). The predominant cell type in the brain infected with HIV is
the monocyte/macrophage. It is thought that the virus enters the brain through
infected monocytes which release monokines, enzymes and chemotactic factors,
which may be toxic to neurons and leads to infiltration with inflammatory cells.
Another mechanism may involve direct virus infection of nerve cells that results in
either direct cell killing or alteration in cellular metabolic function (Wigdahl et al.,
1990).
MVV causes inflammation in the mammary glands with diffuse infiltration
of mononuclear cells in the interstitial tissue of the glandular parenchyma and
nodules of lymphocytes around glandular ducts (Cutlip et al., 1985; Lujan et al.,
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1991; Watt et al., 1992a). MVV also induces arthritis, predominantly in carpal or
tarsal joints which are thickened by an accumulation of mononuclear cells and
villous proliferation of the synovial membrane (Cutlip et al., 1985 ; Oliver et al.,
1981a; Lairmore et al. 1988b; Watt et al., 1992a). Studies on the mediastinal lymph
node of MVV infected sheep show marked B lymphocyte proliferation, with mild
proliferation occurring in T lymphocyte areas (Ellis et al., 1985c).
1.7 Pathogenesis
1.7.1 Cell tropism
MVV is highly tropic for the monocyte/macrophage lineage, such as
macrophages in lung, brain, lymph nodes, bone marrow and spleen, but not in liver
or connective tissue (Kennedy et al., 1985; Gendelman et al., 1985). The sheep
lentivirus is thought not to be lymphotropic (Gorrell et al., 1992), however there is
one report of rare cells in the CNS which are positively stained for MVV gag
antigen which have the morphology of lymphocytes (Georgsson et al., 1989). It can
not be excluded that these cells were MVV specific B cells with antigen attached to
their immunoglobulin or perhaps monocytes which had similar morphology to
lymphocytes in these tissue sections. All other reports have failed to find MVV
proteins or RNA in lymphocytes. There has been one recent report that MVV may
also infect dendritic cells in the blood at a higher frequency than monocytes (Gorrell
et al.. 1992). However, in this study the dendritic cells are recognized as non-B,
non-T, non-adherent, and MHC class II positive cells. The depletion of adherent
cells from PBMC by incubation of these cells in plastic flasks is not enough to
completely remove monocytes (author's data) which are also MHC class II positive.
Furthermore, dendritic cells do not survive in culture as well as monocytes,
therefore more definitive proof is needed before it can be said conclusively that
blood DC are infected by MVV.
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Both CD4+ lymphocytes and macrophages are targets for HIV. Langerhan's
and dendritic cells and some CD4~ cells are also infected by HIV (reviewed in Levy
1993). HIV isolates have shown different tropisms for lymphocytes or monocytes
(Evans et al., 1987). Lymphotropic HIV strains do not infect monocytes, whereas,
monocyte-tropic strains infect both lymphocytes and monocyte/macrophages
(Collman et al., 1989). For SIV both lymphocytes and monocyte/macrophages are
infected (McEntee et al., 1991; Banapour et al., 1991).
1.7.2 Lentivirus replication in macrophages
In situ hybridization for MVV indicates that infected cells are predominantly
macrophages in different affected tissues, including lung, spleen, lymph node, and
brain (Kennedy et al., 1985). However, only low levels of viral DNA or RNA
(under 200 copies per cell) can be detected in monocytes/macrophages in these
tissues. Moreover, only a few of these cells with viral RNA (about 1%) produce
virus (Haase et al., 1976; Gendelman et al., 1985). Hence, the lesions caused
directly by viral infection may be very limited. So why do the lesions persistently
grow? A constant recruitment of latently infected promonocytes and monocytes
from bone marrow into tissues (the Trojan Horse mechanism) which then
differentiate and activate in the tissues, may allow constant low levels of viral
antigen expression and so chronic active inflammation to persist (Gendelman et al.
1985; Peluso et al., 1985).
In vivo viral antigen or RNA expression in monocytes is very low, however,
they become readily detectable after cultivation of monocytes or by co-cultivation
of PBMC with sheep choroid plexus cells (Gendelman et al., 1986). This suggests
that the very low frequency of infected monocytes may be an underestimate of the
actual, in vivo, viral infection. In contrast, mature macrophages in target organs of
the infectious animals have much higher levels of viral RNA and many of these
have viral proteins (Gendelman et al., 1986; Narayan et al., 1983).
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HIV can be successfully recovered from monocytes (adherent cells from
blood) of HIV infected patients by coculture on activated lymphocytes during all
stages of the disease, but recovery of virus from nonadherent cells (lymphocytes)
has not been consistendy successful from subclinically infected patients (Ho et al.
1989). Detection of proviral DNA in PBMC by polymerase chain amplification of
DNA was at a frequency of 0.0025% (Ho et al., 1989). However, this frequency
increases about 100-1,000 fold in patients with symptomatic disease (Ho et al.,
1989; Schuitemaker et al., 1992b). These results suggest that during subclinical
infection virus is predominantly associated with the monocyte/macrophage lineage.
But, in later stages of HIV infection this switch to a lymphocyte infection with
about 1 in 400 CD4+ T cells harboring virus (Ho et al., 1989). However,
productively infected cells in early or late stages of disease do not exceed 0.001%
(Harper et al., 1986).
In vitro, HTV-associated cytopathic changes in a monocyte monolayer are
characterized by cell fusion and lysis of 20-40% of the cell population after 2 weeks
in culture (Gendelman et al., 1988 & 1990). Furthermore, cultured monocytes from
HIV-infected patients show a markedly lower ability to survive after 10 days of
culture, when compared to monocytes cultured from a normal control (Muller et al.,
1990) which may be due to HIV replication.
During HIV infection, the cells producing virus in tissues are not CD4+
lymphocytes but macrophages (Meltzer et al., 1990a; Gendelman et al., 1989).
Langerhan's cells (LC) and dendritic cells (DC) play important roles in initiation
and regulation of the immune response. Langerhan's cells found in the mucosa of
the rectum and vagina may act as early target cells for HIV and vehicles to
disseminate virus to the regional lymph nodes (reviewed in Gendelman et al., 1989)
which leads to progressive follicular destruction (Armstrong and Home, 1984;
Cameron et al., 1992). DC function is also impaired in HIV infection (Macatonia et
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al., 1990 & 1992). The destruction and impairment of LC and DC also causes
immunodeficiency.
In vitro, MVV causes lytic infection of macrophages and sheep choroid
plexus cells (SCP). The cytopathic effect (CPE) of MVV in SCP or sheep synovial
cells is characterized by the rapid formation of syncytial cells and cellular lysis
(Lairmore et al., 1987). More time is needed to produce these cytopathic changes in
vims-infected macrophages and multinucleated giant cells are not as evident in
vims-infected macrophages as in vims-infected fibroblasts. It is also known that
MVV protein, including gpl35 and gp41 are involved in cell fusion (Crane et al.,
1988; 1991). CPE in vims-infected monocytes or macrophages are dependent on
the virus strain (Lairmore et al., 1987) as well as the stage of maturation of the
monocytes (Gendelman et al., 1986; Narayan et al., 1983). Three different CPE
have been defined by MVV on fibroblasts and macrophages (Lairmore et al., 1987).
Type 1 isolates produce a high vims titer and lysis of synovial cells, but replicate
slowly and cause no fusion of AM. Type 2 isolates produce a low vims titer and
less syncytia or no cell lysis in both synovial cells and AM. Type 3 isolates produce
a high vims titer, cellular fusion and lysis in both synovial cells and AM.
Furthermore, the pathogenicity of these different strain isolates correlates to the in
vivo vimlence in lambs (Lairmore et al., 1987).
1.7.3 LV-IFN
In MVV infection macrophages not only act as target cells for vims , but
also process viral antigens and present them with MHC-class II molecules on the
cell surface to initiate immune responses. The interaction of macrophages,
lymphocytes and vims in culture results in the production of lentivirus-interferon
(LV-IFN) (Narayan et al., 1985; Zink and Narayan. 1989). LV-IFN production can
be blocked by monoclonal antibody to MHC class II (Narayan et al., 1985).
27
However the interaction of fibroblasts, virus and lymphocytes does not result in the
production of LV-IFN (Narayan et al., 1985).
LV-IFN is a nongylcosylated protein of molecular weight 54-64 KD and is
heat and acid stable (Lairmore et al., 1988a; Narayan et al., 1985). It has similar
biological activities to IFN-a and IFN-y. It inhibits the maturation of monocytes to
macrophages in vitro, and also stops virus replication in monocyte/macrophages at
the transcriptional level (Zink & Narayan, 1989). However, viral replication is not
restricted in SCP cells in the presence of LV-IFN (Lairmore et al., 1988a).
Macrophages treated with LV-IFN secrete relatively high levels of prostaglandin E2
(Narayan et al., 1988), which is potentially important in suppressing the functions of
macrophages.
In vivo the high levels of MHC class II antigen expression seen on
macrophages of lymph nodes, spleen, AM and macrophages isolated from
inflammatory synovitis in MVV-infected sheep (Kennedy et al., 1985; Kennedy-
Stoskopf et al., 1989b: Cordier et al., 1990; Harkiss et al., 1991) may be induced by
LV-IFN activity. Infection of macrophages with MVV does not result in increased
MHC class II expression, thus the virus does not appear to have any direct effect on
expression of MHC class II molecules (Narayan and Zink, 1988). The increase in
MHC class II expression on tissue macrophages may potentially increase the antigen
presenting capacity of these cells (Kennedy et al., 1985) and so lead to the chronic
stimulation of the immune response giving the inflammatory lesion seen in MVV
infection. However, research has documented the suppressive effect on
lymphoproliferative responses of activated AM due to secretion of nitric oxide
(Stuehr and Marietta, 1987; Holt et al., 1985). Hence, AM, at least in mice, are
recognized as suppressor cells, rather than cells which stimulate immune responses.
Whether this is also the case with LV-IFN activated AM is unknown.
Epidemiological evidence often shows concurrent infection of the lung with other
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bacterial pathogens (Markson et al., 1983), which suggests that pulmonary immune
function is suppressed in sheep with maedi.
Persistent LV-EFN activity may be the reason why AM in MVV infected
sheep appear to be activated to spontaneously release flbronectin and increase their
neutrophil chemotactic factor secretion (Cordier et al., 1990). This could accelerate
the entrance of leukocytes into local tissues and enhance cell-mediated tissue
damage. Other functions of AM may also be enhanced by IFN-y activity: for
example phagocytosis and their intracellular killing ability (Murray et al., 1987b).
Local IFN production in infected target organs may be responsible for inhibition of
viral replication and the chronic nature of the disease.
1.7.4 Immune mediated pathology
After MVV infection, sheep develop chronic active inflammation in many
organs over a long latent period (Gendelman et al., 1985). With disease progression
these inflammatory infiltrates destroy normal tissue architecture leading to
impairment of normal function. However, the cause of lesions in MVV infection is
very complex and may involve on immunopathological mechanism (either viral
specific or autoimmune) and/or abnormal cytokine release from infected cells.
A major component of the pathology is immune mediated as it has been
shown that treatment of sheep with cyclophosphamide or antiserum developed in the
horse against sheep thymocytes suppresses the cell mediated immune response and
reduces the development of the CNS lesions compared to untreated controls after
MVV infection (Nathanson et al., 1976). Autoimmunity mediating lesion formation
in MVV infection has not been reported, but the arthritis seen in MVV infection has
similar lesions to rheumatoid arthritis and may be induced by heat shock proteins
(Dr. G. Harkiss, personal communication).
Evidence drawn from studies on mediators released from AM indicates AM
from MVV-infected sheep spontaneously release neutrophil chemotactic factor and
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fibronectin which may induce pulmonary lesions including cellular infiltration and
proliferation of fibrous tissue (Cordier et al., 1990). The AM from MVV infected
lungs are therefore activated and so may release high levels of cytokines, eg IL-1
and TNF-a. There is also a massive increase in the number of AM in affected lungs
which may amplify the lesion. In vitro, It has been suggested that ovine lentiviruses
do not induce TNF-a secretions in AM culture (Ellis et al., 1991), although this
work was poorly controlled. The local production of TNF-a stimulated by bacteria
during dual pulmonary infection may be central to the pathogenesis of chronic ovine
lung disease and lead to the cachectic state. Lentivirus-infected sheep with
pulmonary lesions have significantly elevated levels of LV-IFN (see section 1.7.3)
which activates AM and may also serve to amplify the local inflammatory response
to promote tissue damage. In HIV infection it has been shown that inappropriate
secretion of monokines (IL-1, IL-6 or TNF-a) by HIV-infected macrophages in the
brain and lung (reviewed in Narayan & Zink, 1988; Fauci, 1988; Steffen et al.,
1993; Breen et al., 1990) mav induce both neurologic syndromes and tissue injury.
1.8 Functional Capacity of the Lentivirus-infected Monocytes
Monocyte/macrophages secrete some 100 products categorized as enzymes,
complement components, enzyme inhibitors, reactive oxygen intermediates,
cytokines, hormones and coagulative factors (Nathan, 1986). These secreted
products are involved in a wide range of biological functions including
phagocytosis, intracellular killing and antigen presentation; all very important in
host defense mechanisms.
Macrophages are now recognized as important cells in HIV infection. Data
including membrane phenotype, chemotaxis, antimicrobicidal activity, phagocytosis
and antigen-presenting functions have been reported in monocyte/macrophages from
HIV-infected patients. However there is limited documentation of these areas in
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MVV-infected sheep, even though the monocyte/macrophage lineage is recognized
as the predominant target cells for MVV infection.
Most research shows that monocytes do not significantly change in number
in HIV-infected patients (Smith et al., 1984), but there may be a decrease in
monocyte numbers in the blood in late stages eg. AIDS. There are no reports of
decreasing monocyte numbers in MVV-infected sheep. Surface molecules,
including CD4, CD8 and FcR expressed on monocytes in HIV seropositive patients
are not different from seronegative controls (Davidson et al., 1988). However MHC
class II expression on monocytes from HIV-infected patients with AIDS is
decreased when compared to seronegative controls, but a significant difference is
not found in HIV patients without AIDS (Davidson et al., 1988; Heagy et al., 1984).
A similar phenomenon is also found in AM from HIV patients with AIDS (Roy et
al., 1987). The decreased MHC class II expression on monocytes or macrophages
may be related to the severe depletion of CD4 lymphocytes in patients with AIDS.
Expression of MHC class II molecules on antigen presenting cells is related to their
function. Some groups have reported that the antigen presenting function of
monocytes infected with HIV, in vitro, is decreased (Petit et al., 1988; Macatonia et
al., 1989; Ennen et al., 1990), whereas, others showed no effect (Mann et al.,
1990b). Defects in accessory cell function of PBMC were not observed in HIV
infected people (Clerici et al.,1990). This is probably a reflection of tne very low
frequency of circulating monocytes which are infected. However, an increase in
MHC class II expression has been found in AM from sheep with maedi (Cordier et
al., 1990; Lujan et al., 1993) and macrophages isolated from carpal joints of MVV-
infected sheep with inflammatory synovitis (Harkiss et al., 1991). The up-
regulation of MHC class II expression on these macrophages may be mediated by
LV-IFN activity (Narayan et al., 1985).
Monocyte chemotaxis in response to stimulation by N-formylmethionyl-
leucyl-phenylalanine (f-met-leu-phe), C5a, endotoxin, Giardia lamblia and casein is
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depressed below normal levels in HIV-infected patients with AIDS, particular in
those patients with Kaposi's sarcoma or opportunistic infections, when compared to
healthy control patients (Poli et al., 1985a; Smith et al., 1984). Evidence also
indicates that serum taken from asymptomatic seropositive individuals may reduce
chemotaxis by monocytes from normal individuals. These results suggest that the
reduction in chemotactic activity seen in HIV infected patients was due to an
inhibitory factor present in the serum. In contrast, there is an increase of neutrophil
chemotactic attractant and fibronectin from AM in MVV-infected sheep (Cordier et
al., 1990). These factors are closely related to the pathogenesis of pulmonary
lesions. There are no significant differences in the levels of IL-2 and prostaglandin
E2 (PGE2) production from pulmonary lymph node leukocytes from MVV-infected
sheep or uninfected controls (Lairmore et al., 1988a).
Functional analysis of macrophages has been approached both in vivo and in
vitro in HIV infection. Phagocytosis in monocyte/macrophages is of major
importance and functions to remove and destroy invading pathogens. Fc and C3b
receptors on the monocyte surface mediate these activities (Fanger et al., 1989).
Non-specific phagocytosis of latex beads or infectious agents such as Candida or
Toxoplasma gondii by monocytes from HIV-infected patients with AIDS is normal
(Bender et al., 1988). However, receptor-mediated (Fc and C3 receptors)
phagocytosis is impaired in HIV patients with AIDS, but not in those patients
without the AIDS syndrome (Bender et al., 1988). Intracellular killing assays
determine the ability of monocytes and macrophages to kill intracellular pathogens.
This function of macrophages can be enhanced by treating cells with EFN-y or TNF
(Murray et al., 1987b; Bermudez and Young, 1988). Studies of the intracellular
killing activity of monocytes both in steady state or after further in vitro exposure to
IFN-y from HIV patients have shown normal results (Murray et al., 1987b).
Some secretory products, which are related to the effector function of
monocyte/macrophages, including H^CH and TNF, show normal secretion levels or
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appropriately increased levels after in vitro treatment of the cells with IFN-y or
lipopolysaccharide (LPS) (Murray et al., 1987a; Capsoni et al., 1992). TNF-a
released in the supernatant of cultured peripheral blood monocytes from
symptomatic HIV-1 infected patients is significantly higher than normal controls.
IL-1 also shows a similar elevation in the symptomatic HIV-1 infected group, but
does not reach statistical significance (Roux-Lombard et al., 1989). Both cytokines
act as effector molecules to stimulate collagenase and collagen synthesis, and trigger
IL-2 and IL-6 secretion (Dinarello, 1991). These factors may be involved in the
pathogenesis of HIV infection.
Analysis of tissue macrophages in HIV-infected patients shows a very
different picture to that of the relatively normal blood monocyte population (Smith
et al., 1984; Poli et al., 1985a). It has been shown that skin Langerhan's cells and
dendritic cells are severely affected in HIV infection (Armstrong et al., 1984).
Changes are characterized by condensation of nuclear chromatin and vacuole
formation in the cytoplasm. HLA-DR and CD1 expression on these cells is
markedly decreased by at least 50% (Belsito et al., 1984). These cellular changes
increase in parallel with disease progression (Armstrong et al., 1984). Indeed, in
late-stage disease there can be a complete loss of dendritic cells which are important
for antigen presentation in lymph nodes (Cameron et al., 1987).
The results of phenotype and effector function of macrophages are often
controversial and not well defined during HIV infection (reviewed in Gendelman et
al., 1989). The variation in results may indicate that low numbers of circulating
monocytes are infected and so there is no great alteration in monocyte function. In
addition, monocytes which will eventually migrate into other tissues have a
relatively short circulating half-life in blood (Beelen et al., 1989). Most
importantly, perhaps, the long incubation times seen with HIV infection may
introduce many confounding factors including drug therapy, secondary infections,
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and of greatest effect, the depletion of CD4 lymphocytes, which will affect the
results obtained in functional assays of monocyte/macrophages
AM play an important role in response to pulmonary disease.
Immunosuppression is not a recognized feature of MVV infection. However, most
research into the problem of immunosuppression is limited to the field of
lymphoproliferative responses to mitogens or antigens which may not be the correct
area for study. Perhaps what should be studied in MVV infection is the accessory
cell functions of macrophages. Also the tissue from which the macrophages is
derived (whether affected by MVV infection or not) could have an strong effect on
the types of changes seen.
1.9 Aims of Project
Macrophages are predominant targets and reservoirs of lentiviruses,
particularly for MVV and CAEV. Macrophages have a broad range of biological
activities which are important in host defense mechanisms, particularly in
phagocytic and antigen presenting functions. Study of the interaction of
macrophages and virus (MVV) can be used not only for the pathogenesis of MVV
infection, but also as a model of HIV/macrophage interaction.
The project presented here has looked at several aspects of the interaction of
macrophages and MVV (EV1, British strain). These studies include firstly, the
characteristics of MVV replication in macrophages (where viral assembly occurs in
cell, at what stage in in vitro differentiation of macrophages is virus produced);
secondly, whether MVV infection alters macrophage phenotype and effector
functions (using erythrocyte rosetting and phagocytosis); and thirdly whether the
antigen presenting function of macrophages for soluble antigen is changed after
MVV infection. Finally, the ability of MVV infected macrophages to act as targets






All chemicals were supplied by SIGMA Chemical Co., Poole, Dorset,
England or BDH Chemical Ltd., Poole, England unless otherwise stated.
Radiolabelled compounds were supplied by Amersham International pic.,
Amersham, Bucks, England. Tissue culture plasticware was supplied by GIBCO-
BRL, Paisley, Scotland. Universals and centrifuge tubes were supplied by Bibby
Sterlin Ltd.
2.2 Cell Lines and Cell Culture
2.2.1 Culture of skin fibroblasts
Sheep skin fibroblasts derived from biopsies as detailed in Bird et al.,
(1993) were cultured in Dulbecco's modified Eagle's medium (Gibco, BRL Paisley
Scotland) containing 2mM L-glutamine, 100U penicillin per ml, 100 pg
streptomycin per ml and 10% FCS (DME / 10%FCS) at 37°C, 5% CCb.
Cell lines were detached using 0.05% (w/v) trypsin in 0.02% (w/v) EDTA in
PBS and passed to other tissue culture flasks at 1:3.
2.2.2 Freezing and thawing of cells
1-2 x 106 cells per ml, in an ice-cold mixture of 90% FCS and 10% DMSO,
were frozen slowly by placing the ceils in a polystyrene box filled with cotton wool
at -70°C overnight and then the vials were transferred to liquid nitrogen. To
resuscitate frozen cell lines, an aliquot was warmed quickly at 37°C, gradually
diluted with warm DME / 10%FCS, and then centrifuge at 350 xg for 5 minutes.
The cell pellet was suspended in DME / 10%FCS, incubated for 5 minutes at 37°C.
and then pelleted again. Finally, the cells were resuspended in DME / 10%FCS and
transferred into 25 cm2 tissue culture flasks.
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2.2.3 Monocyte/Macrophage Culture
2.2.3.1 Gelatin-plasma-coated flasks or plates
Gelatin-coated flasks or plates were prepared according to the method
described by Jones et al., (1989). 2.5 ml or 0.5 ml of 2% sterile gelatin was added
to each 25 cm- tissue culture flask or well of 24-well plates. After 1 hour
incubation at 37°C, the gelatin was removed and the plates dried in a 37°C
incubator. The dried flasks and plates could be stored at room temperature until
use. Immediately before use, they were incubated with autologous plasma for 30
minutes at 37°C. Plasma was removed and the flasks or plates washed twice with
PBS. These pretreated flasks or plates were then ready for the culture of
monocytes.
2.2.3.2 Monocyte isolation and culture
Blood was collected in heparin-containing tubes (10 units for 1 ml blood).
Buffy coat cells were obtained by centrifugation of the heparinized blood at
1,250 xg for 15-20 minutes at room temperature. Autologous plasma was collected
and used for the gelatin-coated flasks or plates. The buffy coat was diluted in sterile
phosphate buffered saline (PBS) (0.85% NaCl, 0.02% KC1, 27 mM Na2HP04,
1.5 mM KH2PO4, pH 7.2), overlaid on Lymphoprep (Nyegaard, Oslo, Normay) and
then centrifuged at 1,250 xg for 20 minutes at room temperature. Peripheral blood
mononuclear cells (PBMC) were harvested at the interface and then washed three
times (500 xg, 5 minutes) with PBS. The PBMC were finally suspended in RPMI-
1640 medium containing 2mM L-glutamine, 20mM Hepes, 100 U penicillin per ml,
100 (ig streptomycin per ml, and 5 x 10~5M 2-mercaptoethanol (2-ME) (RPMI) with
10% fetal calf serum (FCS) and 10% lamb serum (LS) (Gibco)
(RPMI / 10%FCS/10%LS). The PBMC were counted and the concentration
adjusted to 5 x 10^ cells per ml. Normally, 0.5 ml, 5 ml or 15 ml of this cell
suspension was plated into each well of a 24-well plate, 25 cm2 or 75 cm2 flasks,
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respectively. The cells were left for 1 hour or overnight at 37°C, 5% C02,
depending on the experiment and the non-adherent cells were then washed off with
warm RPMI/2%FCS. Fresh RPMI/ 10%FCS/ 10%LS was added for continuous
culture The cultural medium was replaced every 5 days. After 5-7 days culture,
most non-adherent lymphocytes could be removed as above and the cultured
adherent macrophages (monocyte-derived-macrophages; MDM) were usually nearly
confluent. Over 95% of these adherent cells were non-specific esterase (NSE)
positive.
After 7 days in culture, normal cultured MDM showed proliferation and
some detached to become suspended in the supernatant. The suspended cells could
be passaged to other flasks where they became adherent and could be used in further
experiments.
2.2.4 Alveolar macrophage (AM) isolation and culture
AM were collected by bronchoalveolar lavage (BAL) with cold Hank's
Balanced Salt Solution (HBSS). The cells were pelleted by centrifugation at 700 xg
at 4°C for 10-20 minutes, depending on the volume of BAL fluid. Cell pellets were
washed with RPMI / 2%FCS three times. The cell number was counted and
adjusted to 5 x 1(T> cells per ml in RPMI / 20%FCS. Specimens contaminated with
blood or parasites were not used. Five ml of cell suspension were seeded into
25cm- flasks and then incubated at 37°C, 5% C02. Non-adherent cells were
removed 2 hours later and the flasks re-fed with fresh medium. The purity of AM
was over 95% as determined by NSE staining. AM were cultured in a similar
manner to monocytes but with RPMI / 20%FCS
To harvest adherent MDM or AM, cultures were washed with PBS once and
2.5 ml of 5 mM EDTA in PBS was added to 25 cm2 flasks. After 2-5 minutes
incubation, the flasks were knocked to dislodge the cells and a rubber policeman
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used to scrape off any adherent cells remaining. The cells were washed once with
warm RPMI / 2%FCS and then used.
2.2.5 Non-specific esterase (NSE) staining (Hudson and Hay, 1989)
Cytospins or cells cultured on glass coverslips were fixed in cold 45% (v/v)
formaldehyde, 25% (v/v) acetone in 0.1M phosphate buffer (pH 6.6) for 40 seconds.
The fixed cells were washed with water and incubated with the substrate, 0.025%
a-naphthyl butyrate developed in 0.067 M phosphate buffer, pH 5.8, which
contained 0.12% (w/v) sodium nitrate and 0.12% (w/v) pararosaniline, for 40
minutes at 37°C. The cells were washed in running water and then counterstained
with 0.4% methylene green for 5 minutes. Cells were classified as positive by the
appearance of a brown color.
2.2.6 Giemsa Staining
Fibroblasts were fixed in cold methanol/acetone mixture (1:1) for 5 minutes
and then treated with 1 % potassium dichromate for another 30 minutes. The treated
cells were further fixed by cold methanol/acetone mixture for 5 minutes. The cells
were stained with Giemsa's solution (2 fold dilution made fresh) for 5 minutes. The
stained cells were washed in running water, dried in air, and then mounted in DPX.
Macrophages were stained as above but after washing in water they were incubated
in Giemsa' buffer (0.1 M citric acid, 0.2 M disodium hydrogen phosphate pH 5.75)
for 5 minutes, rewashed and mounted as above.
2.3 Virus
2.3.1 Virus isolates
Maedi visna virus (MVV), strain EV1, was isolated on skin fibroblasts from
PBMC of a sheep with an acute maedi-like disease and has a limited passage history
in vitro (Sargan et al., 1991). The Icelandic strain of MVV, 1514, was obtained
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from J.E. Clements, The John Hopkins University School of Medicine, Baltimore,
Maryland and has a long passage history in tissue culture. Skin fibroblasts were
grown to 90% confluence in 175 cm2 or 225 cm2 flasks and then infected with EV1
at a low multiplicity of infection (0.1 TCID50 per cell) in DME / 2%FCS. When
cultures showed extensive cytopathic effects (5-7 days), the virus-containing
supernatant was harvested, cellular debris removed by centrifugation at 1,500 xg at
4°C and stored, in aliquots, at -70°C. MVV was titrated on skin fibroblasts as
described below.
2.3.2 Experimental infection and titration of MVV
For experimental infections, skin fibroblasts were infected with 0.5 TCID5q
per cell in DME / 2%FCS for 2 hours at 37°C and virus inoculum removed and
replaced with DME / 2%FCS. Macrophages were infected with 1-2 TCID50 MVV
per cell in RPMI / 2%FCS for 2 hours, 37°C and the virus inoculum replaced with
RPMI / 10%FCS.
Virus titer was measured by limiting dilution and detection of cytopathic
effects on skin cells. Virus-containing supernatants were serially diluted in
DME / 2%FCS and 50fil added to 2 x 10^ skin fibroblasts also in 50 (ll
DME / 2%FCS per well of 96-well flat bottom microtiter plates. Six replicates of
each diluted supernatant were set up and plates incubated for 3-4 days at 37°C, 5%
CO2 then 100 p.1 of DME / 2%FCS was added to each well with a further culture for
3-4 days. On day 7 the cells were fixed in cold acetone : methanol (1:1) and then
stained with Giemsa's solution (see above). CPE were determined by syncytial cell
formation. The virus titers were expressed as the 50% end point of the tissue
culture infective dose (TCID5q) as calculated by the Reed & Meunch method
(1938).
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2.3.3 Viral antigen preparation (for lymphoproliferation assay and Western
blotting)
Skin fibroblasts were infected with MVV at 0.1 TCID5o/cell or AM at 1
TCID5o/cell and maintained in DME / 2%FCS or RPMI / 10%FCS until extensive
cytopathic effects were observed. The culture supernatant and infected cells (cells
removed by a rubber policeman) were collected and cells pelleted by centrifugation
(10,000 xg) for 20 minutes at 4°C. The cell pellet was suspended in a minimum
amount of PBS (equivalent to approximately 4x 10^ cell per ml) and stored, in
aliquots, at -70°C to be used in immunoblotting experiments. Viral particles were
pelleted from the clarified supernatant by further centrifugation 100,000 xg, 2 hours
or 10,000 xg for 16 - 18 hours at 4°C. The virus pellet was suspended in a small
volume of PBS and stored, in aliquots, at -70°C to be used for immunoblotting
experiments and lymphoproliferative assays.
2.4 Detection of Viral Antigens
2.4.1 Immunofluorescent antibody staining (biotin-streptavidin method)
Cultured MDM, AM or skin fibroblasts infected with MVV, either grown on
glass-coverslips or cytospins prepared from cell suspensions, were fixed in 80%
methanol in saline. Fixed cells were washed in PBS containing 0.1% bovine serum
albumin (BSA) and 0.01% sodium azide (PBA) and then blocked with PBA
containing 2% normal rabbit serum and 2% normal sheep serum
(PBA/2%NRS/2%NSS) for 30 minutes. The blocked cells were stained with the
monoclonal antibody (Mab), anti-gag p 15 (1:5,000 of ascites), 415 (gift from Dr. D.
Houwers), or anti-p25, ID-10 (VPM70) saturated supernatant (Reyburn et al,
1992c) for 1 hour at room temperature. The cells were washed 5 times in PBS with
0.01% Tween-80 (PBST) and then stained with sheep anti-mouse Ig-biotin
conjugate (1:400) in PBA for 1 hour. The cells were washed 5 times with PBST
and then stained with streptavidin-FITC conjugate (1:2500) in PBA (Serotec) for
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another 1 hour. After 5 washes with PBST, the stained cells were mounted with
citifluor (Citifluor Ltd., London, UK) and examined under a UV microscope (Leitz
Ortholux II). MVV-infected cells stained with a nonspecific mouse IgG2a or
uninfected cells stained with specific monoclonal antibody were included in the
experiments as the negative controls.
2.4.2 Detection of viral antigen expressed on the cell surface and in the
cytoplasm by flow cytometry (McSharry et al., 1990)
The presence of MVV antigen on the surface of infected cells was detected
by indirect immunofluorescence antibody (IFA) staining carried out in Rhesus
tubes. Infected and uninfected cells were cultured and harvested as described before
then blocked with PBA/2% NRS/2% NRS for 30 minutes at 0°C. The cells were
further incubated with a monoclonal antibody (anti-pl5 or anti-p25) at 0°C for forty
minutes, washed three times with PBA and then incubated with FITC-conjugated,
anti-mouse IgG F(ab')2 (1:50 in PBA, Dakopatts Ltd) at 0°C for another twenty
minutes. After three washes with PBA, cells were fixed with 1% paraformaldehyde
in PBS and analyzed by flow cytometry.
To detect internal viral antigen, the infected and uninfected cells were fixed
in 80% methanol in PBS followed by three washes with PBA before blocking and
incubation with monoclonal antibody as previously described.
2.4.3 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) of protein
Resolving gels were prepared as 7.5%, 10% or 5%-20% linear gradient
acrylamide gels (Acrylamide : N,N'-methylenebisacrylamide, 37:1) in 375 mM
Tris HC1 pH 8.7 and 0.1% SDS. Stacking gels were 3% acrylamide, 0.15% N,N'-
methylenebisacrylamide with 125mM Tris HC1 pH 6.8 and 0.1% SDS. The samples
were mixed with sample buffer (0.1% bromophenol blue in 125 mM Tris HC1
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pH 6.8 containing 20% (v/v) glycerol, 10% 2-ME (v/v), and 10% SDS (w/v) and
then boiled for five minutes before electrophoresis. Five |ig of protein as
determined by Bio-Rad microtitre assay or 2x10^ AM in 5 pi sample buffer were
loaded in each track of a vertical slab gel (Bio-Rad Mini-protein II Slab cells) and
then electrophoresed with running buffer (0.025 M Tris, 0.19 M glycine, 2mM
EDTA(Na2), 0.1% SDS) at 180V for forty to sixty minutes.
After electrophoresis, the separated polypeptides in the PAGE gel were
transferred to nitrocellulose membrane (Hybond C, Amersham) using a semi-dry
electroblotter (Ancos, Denmark) in blotting buffer (0.192 M glycine, 25 mM Tris in
20% methanol) for two hours at 120mA according to Kyhse-Andersen (1984).
After blotting, the nitrocellulose membranes were blocked with 5% low-fat dried
milk in PBS for thirty minutes, replaced with primary antiserum which was also
diluted in 5% milk/PBS, and then left overnight at 4°C with shaking. The blots
were washed with 6 changes of borate buffered saline (BBS) (0.1 M boric acid,
0.034 M sodium tetraborate, 0.075 M sodium chloride) / 0.05% Tween-80 and then
incubated for 1 hour in an alkaline phosphatase conjugated secondary antibody
(1:1,000) in 5% milk/PBS. The blots were washed with shaking in BBS/0.05%
Tween-80 again and then developed with 0.02% nitro-blue tetrazolium and 0.01%
5-bromo-4-chloro-3-indolyl phosphate, 0.02 M MgCb in 0.1 M Tris HC1 pH 9.5
(Pluzek & Ramlau, 1988) for 15 to 30 minutes. The reaction was stopped by
washing in water. Marker was separated before blocking and stained for 5 minutes
in 0.5% Amido black and destained in 50% methanol, 5% acetic acid.
Gels were stained with Coomassie Blue (0.025% Coomassie Brillant Blue G-
250 dissolved in 20% methanol, 5% acetic acid and then filtered through Whatman
No. 1 filter paper) for 15-20 minutes at room temperature and then destained with
several changes of 20% methanol, 5% acetic acid in water.
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2.5 T ransmission Electron Microscopy (TEM)
Cultured MDM, AM, and skin fibroblast cells in 75 cm2 flasks were infected
with MVV at 1 TCID50 (macrophages) or 0.5 TCID50 (skin fibroblasts) per cell,
respectively. On day 4, 6-7, or 9, depending on the morphological changes and
CPE in the culture, infected and mock infected cells were gently scraped off the
flask surface with a rubber policeman. The cells were washed once with PBS and
then immediately fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3), at
4°C for two hours. The fixed cells were washed with cacodylate buffer and then
post-fixed in 1% osmium tetroxide for one hour at 4°C. The fixed cells were
further dehydrated through a gradient of acetone, and then embedded in Araldite.
Ultrathin sections (60 nm) were cut and stained with uranyl acetate and lead citrate.
These stained sections were examined under a transmission electron microscope
(Philips 400 Electron Microscope).
2.6 Scanning Electron Microscopy (SEM) Observation
For SEM examination, cells were cultured on glass coverslips in 24-well
plates. Cells were infected with MVV (1 TCID50 per macrophage or 0.5 TCID50
per skin fibroblast) as described previously. Depending on the designated time and
CPE formation in the cultures, coverslips were washed with PBS 5 times to remove
non-adherent cells and cellular debris and then fixed in 3% glutaraldehyde in 0.1M
cacodylate buffer at 4°C overnight. After three washes with cacodylate buffer, the
cells were post-fixed in 1% osmium tetroxide for one hour at 4°C. The cells were
rinsed in the same buffer, dehydrated in a gradient of acetone, and subsequently
dried in a critical point dryer. The dried cells on the coverslips were mounted onto
SEM stubs and then coated with evaporated gold palladium. The specimens were
examined under a scanning electron microscope (Philips SEM 505).
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2.7 Phenotypic Analysis of Cultured MDM, AM and PBMC
2.7.1 Cells and viral infection
MDM were cultured in 25 cm2 flasks and infected with virus, 1 TCID50 per
cell on day 7, 9, 10 and 11 as previously described. AM were cultured for 1-3 days
and then infected with MVV, 1 TCID50 per cell. The cells were harvested by
treatment with 5 mM EDTA in PBS as described in section 2.2.3 and MDM
phenotype was analyzed on the same day.
2.7.2 Indirect immunofluorescent staining for flow cytometry
Cultured macrophages, AM or freshly prepared PBMC (section 2.2.3.2)
were washed twice with PBA and then aliquoted into Rhesus tubes, 1x10^
macrophages or 1 x 10^ PBMC per tube. Cells were pelleted by centrifugation at
250 xg for 3 minutes, 0°C and then resuspended in monoclonal antibody for 40
minutes, 0°C. The panel of monoclonal antibodies used is shown in table 2.1.
Indirect immunofluorescent antibody staining used in flow cytometry was
performed as follows: cells were pelleted and incubated in 25 (il of monoclonal
antibody (saturated supernatant or ascites diluted in PBA) for 40 minutes at 0°C.
The cells were washed three times with cold PBA and then stained with 25 (il anti-
mouse IgG, F(ab')2-FITC conjugate (1:50) (Dakopatts Ltd), for 20 minutes at 0°C.
After three washes in cold PBA, 5,000 or 10,000 cells gated using FSC and SSC on
macrophage or lymphocyte areas respectively were analyzed by flow cytometry
using a Becton-Dickinson FACScan with Consort 30 version F software. Normal
mouse serum (NMS, 1:500) stained cells were set up as background staining
controls. The percentage of positive cells and mean fluorescence intensity (MF)
were determined by using Lysys Version 1.62 and Consort 30 Version F.
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SBU-T4(1) lSG2a CD4 MHC class II restricted T cells
SBU-T8(1) I§G2a CD8 MHC class I restricted T cells
VPM8 (2) IgGt Ig light chain B cells
VPM19(3) IgGi MHC class I nucleated cells
VPM32(4) !gG2a not defined macrophages
VPM33(4) IgM not defined B & T cells,
monocyte/macrophages
VPM36(5) IgGi MHC class II
DQ- a chain
B & activated T cells, DC,
monocyte/macrophages
VPM38(5) IgG! MHC class II
DR- a chain
B & activated T cells, DC,
monocyte/macrophages
VPM65(6) IgGi CD14 monocyte/macrophages, DC,
neutrophils
ST197(7) Ig°2b T19 y8 T cells
F10-150-39 (8) IgGi
LI 80-1 (9) lgGl
LFA-1 B & T cells, monocyte/macrophages
LFA-3 B & T cells, monocyte/macrophages
1. Maddox et al., 1985
2. Bird et al., in preparation
3. Hopkins & Dutia,1990
4. Gonzalez, 1988
5. Dutia et al., 1990
6. Gupta et al., in preparation
7. Mackay et al., 1989
8. Mackay et al., 1990
9. Hunig et al., 1985
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2.7.3 Generation of concanavalin A (Con A) supernatant
Single cell suspensions were prepared from the mesenteric lymph node of
sheep. The lymph node was teased apart with sterile forceps and then put through a
stainless steel mesh. Single cell suspensions were collected and washed twice in
RPMI / 2%FCS. Concanavalin (Con) A-supernatant was prepared by culturing of
mesenteric lymphocytes, 1 x lO^/ml, with 5 |ig Con A per ml in RPMI / 10%FCS
for 2 days at 37°C, 5% C02. After centrifugation to remove cells, the supernatant
was collected and stored, in aliquots, at -20°C.
In this study 50% Con A-supernatant in RPMI / 10%FCS was normally used
to activate cultured MDM for 2-3 days.
2.8 Phagocytosis
2.8.1 Cells and virus infection
MDM were cultured in 24-well plates as described in section 2.2. The
cultured MDM were infected with MVV, 1 TCID50 per cell on day of 5, 7, 9 or 11
of culture. The phagocytic assay was performed on day 12 or 13 of culture.
2.8.2 FITC-labelled particles
The method described by Tuijnman et al (1990) was used to FITC conjugate
particles. To label sheep RBC, a 5% suspension of sheep RBC in microtube was
washed three times with PBS using a microfuge (Sanyo) at 3,000 rpm, 2 minutes to
pellet the RBC and incubated with FITC at a final concentration of 100 qg/ml in
PBS for 30 minutes at 37°C The FITC labelled SRBC were washed twice in PBS
and then opsonized with a pooled antiserum.
To label yeast (Candida utilis) (Buschmann et al., 1989), yeast were cultured
in nutrient broth supplemented with 2% glucose in an incubated shaker at 30°C
overnight. The cell suspension was washed three times with PBS by centrifugation
(500 xg, 10 minutes at 4°C) and the pellet resuspended in PBS at a concentration of
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4 x 108 yeast/ml and FITC stock solution (1 mg/ml) was added to a final
concentration of 100 jig/ml. The suspension was stirred at ambient temperature for
30 minutes and then washed in PBS three times. The pellet was finally suspended
in PBS at 1 x 108 yeast/ml and then used in the phagocytic assay.
To label Pasteurella hemolytica (serotype A6) (kindly given by Dr J. E.
Phillips), P. hemolytica was cultured on blood agar plates at 37°C overnight.
Bacterial colonies were harvested by washing the plate with PBS and scraping off
the bacteria with a rubber policeman. The bacterial suspension was washed once
with PBS using a bench centrifuge (Beckman, Microfuge E) at 12,000 rpm for 30
seconds. The bacterial concentration, as determined by spectrophotometry (LKB,
ULTROSPEC 4050), was adjusted to OD55o=0.5 which was the equivalent of
3-4 x 108 CFU per ml when checked by colony formation. Bacteria were labelled
with FITC at a final concentration of 100 }lg/ml at 0°C for 30 minutes with mild
mixing. The bacterial suspension was washed with PBS twice and resuspended to
the original concentration for opsonization.
2.8.3 Opsonization
FITC-labelled sheep RBC were opsonized by a subhemagglutinating dilution
(1:40 in PBS) of anti-SRBC antiserum developed in rabbits (kindly given by Dr. J.
Hopkins) for 30 minutes at 37°C. The opsonized RBC were washed twice with
PBS and then resuspended to 1% in RPMI / 2% FCS.
FITC-labelled P. hemolytica was opsonized with a rabbit antiserum to P.
hemolytica (A6) (kindly given by Dr. W. Donachie; Moredun Research Institute,
Edinburgh) The serum was titrated for optimum phagocytosis by macrophages and
a 1:10 dilution of serum was used for further experiments. The FITC-labelled P.
hemolytica was incubated with antiserum at 37°C for 30 minutes. The bacterial
suspension was then washed twice with PBS and resuspended in RPMI/2%FCS
without antibiotics to the original concentration. A stock of FITC-labelled,
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opsonized bacteria in 15% glycerol, RPMI with no antibiotics (OD55o=0.5), was
stored at -70°C and used in phagocytic assays of fresh monocytes and AM from
normal control and MVV-infected sheep.
2.8.4 Phagocytosis by cultured MDM
MDM were cultured and infected with MVV in 24-well plates as described
before. The cultured MDM were washed with RPMI / 2%FCS to remove non¬
adherent cells. Assays were then undertaken on adherent cells. The cells were fed
with 250 pi RPMI / 2% FCS containing 50 pi of FITC-particles and incubated for
1 hour at 37°C.
Non-ingested RBC were removed with PBS and any remaining on the
outside of MDM hypotonically lysed with distilled water for 30 seconds, and
immediately neutralized with 2x PBS. The cells were treated with 5 mM EDTA in
PBS for five minutes and then gently scraped off with a rubber policeman. The
cells were transferred into Rhesus tubes, washed with PBA and immediately
analyzed by flow cytometry. MDM which had not been fed with FITC-targets were
used as background controls.
In assays using bacteria and yeast, cells were washed with PBS 3 times and
then harvested as described above. After being transferred into Rhesus tubes, cells
were pelleted, suspended in 1% cold paraformaldehyde in PBS for 1 hour and
analyzed by flow cytometry.
2.8.5 Erythrocyte rosette assay
Fresh AM or MDM (harvested with 5mM EDTA in PBS) were washed in
cold PBA in Rhesus tubes as described before. The cell pellets were suspended in
50 pi of 1% FITC-labelled opsonized SRBC and then incubated at 0°C for 30
minutes. The samples were resuspended in PBA and immediately analyzed by flow
cytometry.
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2.8.6 Phagocytosis by fresh AM from MVV-infected and control sheep
AM were collected as previously described, but these cells were washed in
RPMI / 2%FCS. One x 10^ AM were pelleted in Rhesus tubes and then suspended
in 50 pi of FITC-labelled particles. After 1 hour incubation at 37°C, non-ingested
RBC were hypotonically lysed with distilled water for 30 seconds and neutralized
with 2x PBS. After another 3 washes with PBA, the cells were analyzed by flow
cytometry. The phagocytosis of P. hemolytica by AM was performed as previously
described, but with frozen stocks of FITC-labelled, opsonized P. hemolytica. After
3 washes with PBS, the cells were fixed in 1% paraformaldehyde in PBS for an
hour and then analyzed by flow cytometry.
2.8.7 Phagocytic and erythrocyte rosetting activity of monocytes
FITC-labelled, opsonized RBC and P. hemolytica (frozen stocks used) have
been described earlier (section 2.8.2). A modified double-staining flow cytometry
method was used to study phagocytosis by monocytes. Briefly, 1 x 10^ PBMC in
RPMI / 2%FCS pelleted in Rhesus tubes were fed with 50pl FITC labelled particles
and then incubated for 1 hour at 37°C. The external RBC were hypotonically lysed
by distilled water for 30 seconds and neutralized with 2x PBS. The cells were
washed with cold PBA three times and then stained with the monoclonal antibody
VPM65 (anti-CD 14) followed by F(ab')2 rabbit anti-mouse IgG R-phycoerythrin
conjugate (1:50 Serotec) as described before (section 2.7.2).
For the erythrocyte rosetting assay PBMC were washed in PBA and then
stained with the monoclonal antibody, VPM65, followed by the phycoerythrin
conjugate. After 3 washes with cold PBA, the cells were incubated with opsonized
RBC at 0°C for 30 minutes, resuspended in cold PBA, and then analyzed by flow
cytometry. PBMC alone, PBMC fed with FITC-labelled particles, and PBMC
stained with monoclonal antibody without FITC-labelled particles were used as
background controls. Ten thousand cells were gated from the monocyte-enriched
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area as determined by the FSC and SSC profile. Each treatment was performed in
duplicate in an experiment.
2.9 Generation of Antigen-Specific T cell lines
2.9.1 Primed sheep
All sheep were adult Finnish Landrace crosses obtained from the Moredun
Research Institute, Edinburgh, and were used to generate ovalbumin (OVA) and
PPD-specific T cell lines. Sheep (1203T and 1275T) were primed with OVA, 1 mg
in complete Freund's adjuvant (CFA), and boosted 3 weeks later with OVA, 1 mg in
incomplete Freund's adjuvant (IFA). One week to 10 days after being boosted with
antigen, the sheep were bled to obtain PBMC for generating OVA-specific T cell
lines. These sheep were boosted with antigen once more in order to repeat this
experiment.
Sheep 1275T after being primed with OVA in CFA also responded to
purified protein derivative (PPD) (MAFF, Weybridge), probably due to the heat
killed, dried Mycobacterium tuberculosis in CFA. It and sheep 1216V which had
been primed with Bacille Calmette-Guerin (BCG), 5 human doses, 6 months
previously, were boosted with 50 Ug PPD in 1ml PBS, intradermally at 4 separate
sites. The lymphoproliferative response to PPD was tested 7 days after boosting and
PBMC in both sheep were then used to generate PPD-specific T cell lines.
2.9.2 Generation of antigen-specific T cell lines
PBMC were purified as previously described. Three x 10^ PBMC per well
in RPMI / 10%FCS were stimulated with either 100 |Ug of OVA or 12.5 |ag of PPD
per ml in 24-well plates for 6-7 days at 37°C, 5% CO2. This was the first antigen
stimulation cycle. The cells were harvested, overlaid on Lymphoprep and
centrifuged (750 xg, 10 minutes) to remove dead cells. Interface cells were washed
two times in RPMI / 2%FCS before going on to IL-2 expansion cycle. For this
2 x lO^/ml viable lymphocytes in RPMI/10%FCS medium supplemented with
10 U recombinant human IL-2 (from recombinant E. coli, N.I.B.S.C., Potter Bar)
per ml were cultured for another 6-7 days. This cycle was sometimes prolonged to
9-14 days, depending on the lymphocytes appearance. Fresh rhIL-2 was added
every 3-4 days. Viable cells were harvested over Lymphoprep as above. These two
cycles were repeated 1-4 times more to obtained antigen specific T cell lines. For
subsequent antigen stimulation cycles, 2 x 106 irradiated, autologous PBMC
(3,000 Rad 137Cs) per well were used as antigen presenting cells. Lines were
harvested over Lymphoprep and 5 x 106 viable cells per aliquot were stored under
liquid nitrogen as described in section 2.3.2. Some cell lines were cultured for 3-4
cycles before use.
Autologous MDM were often used as antigen presenting cells to stimulate
the T cell lines instead of irradiated PBMC. Adherent cells in 24-well plates from
which lymphocytes had been removed at the end of the first antigen stimulating
cycle were used as a source of macrophages or MDM. The MDM were cultured in
RPMI /10%FCS/10% LS containing 50% Con A-supernatant (V/V) for 2-3 days at
37°C, 5% CO? and then used as antigen presenting cells in secondary antigen
stimulating cycles with antigen and lymphocytes.
2.9.3 Lymphoproliferative assays
Freshly isolated PBMC (section 2.2.3.2) were cultured in RPMI / 10%FCS.
OnexlO5 PBMC in 100 pi RPMI/10%FCS with 100 pi antigen in
RPMI / 10%FCS were cultured in 96-well flat-bottomed plates at 37°C, 5% CO?.
After 5 days, the cultures were pulsed with 1 pCi of tritiated methyl thymidine
(^H-TdR) for 5 hours, 37°C and then harvested onto glass filter paper using a semi¬
automatic cell harvester (Titertek cell harvester, Flow Laboratory) or a automatic
cell harvester (TOMTEC, HARVESTER 96). 3H-TdR incorporation was measured
by a liquid scintillation counter (LKB-Wallac 1218 Rackbeta or Wallac 1450
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Microbeta). The cultures were set up in triplicate for each antigen concentration and
the data has been expressed as the mean (CPM) ± standard deviation. Medium
alone or final 5 fig Con A/ml were used as negative and positive controls.
For antigen-specific T cell lines, 3-5 x 104 antigen-specific T cells were
mixed with 2x 105 irradiated autologous PBMC in 100|il RPMI/10%FCS and
antigen (100 |il) and then cultured as previously described. Antigen-specific T-
cells, or irradiated PBMC alone, antigen-specific T cells with antigen, or antigen-
specific T cells with irradiated PBMC were set up as background controls with final
5 jig Con A/ml as positive controls.
2,9.4 Antigen presenting ability of cultured MDM and AM
MDM were cultured, infected with MVV (1-2 TCID50 per cell in 25 cm2
flasks) and harvested as previously described. 1- 2 x 10^ viable MDM per well
were plated into 96-well flat-bottom microtiter plates. Antigen-specific T cells
(3-5 x 104 cells per well) and antigen were added to a total volume of 200|Ltl in
RPMI / 10%FCS. The cells were cultured for 5 days at 37°C, 5% CO2 and then
3H-TdR incorporation over the last 5 hours measured as section 2.9.3.
Sheep 1203T developed serious arthritis and was humanely euthanized
during the course of these experiments. AM were collected from its lungs and used
to test the antigen presenting ability of AM using cell concentrations as for MDM.
2.10 Cytotoxic Assays
2.10.1 Generation of virus-specific, cytotoxic T lymphocytes (CTL)
PBMC were obtained from MVV-infected sheep and placed into gelatin-
plasma coated 75 cm2 flasks. After 1 hour at 37°C incubation, non-adherent cells
were collected as peripheral blood lymphocytes (PBL) which were then used to
generate MVV-specific, cytotoxic T lymphocytes. The adherent cells were cultured
as MDM and used as target cells in the cytotoxic assay. Two x 106 PBL/ml of
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complete RPMI/10%FCS with 5U rhIL-2 per ml were cultured with 105
autologous skin fibroblasts which had been infected with MVV, 0.5 TCID50 per cell
in DME / 2%FCS, for 1.5-2 hours. Cells were cultured in 1 ml per well of 24-well
plates at 37°C, 5% CO9 for 3-4 days and then fed with 0.5ml RPMI / 10%FCS with
5 U rhIL-2 per ml. After 7 days culture, the non-adherent cells were harvested and
viable cells counted using trypan blue exclusion. One x 10^ viable cells per ml in
RPMI / 10%FCS with 5 U rhIL-2 were seeded onto newly cultured, MVV-infected
skin fibroblasts for 7 days as described above. After the end of the second cycle,
cells were harvested, overlaid onto Lymphoprep, and centrifuged (750 xg, 10
minutes). Viable cells were harvested at the interface and washed twice with warm
RPMI/2%FCS. Cells were counted in 1% trypan blue and made to the required
concentration in RPMI / 10%FCS for use as effectors in CTL assays.
Alveolar lymphocytes in BAL fluid were purified by depletion of adherent
AM (2 x 10? BAL cells were incubated in 175 cm2 flasks for 1 hour at 37°C).
After two rounds of adherence, non-adherent cells contained around 80%
lymphocytes and 20% AM. These cells were cultured in the same manner as PBL
on autologous, MVV-infected skin fibroblasts with IL-2 and used as effectors in
assays. The ability of AM to activate CTL in vitro was assessed by using AM to
present live viral antigen to autologous PBL from MVV infected sheep. Two x 105
AM per well were infected with MVV 1 TCID5q per cell for 2 hours, 37°C. 2xl06
PBL were added in RPMI / 10%FCS with IL-2 as above and incubated for 7 days,
37°C, 5% CO9. Viable lymphocytes were transferred to AM which had been
cultured for 7 days then infected as above, and the lymphocytes cultured for a
further 7 days before harvesting as before.
2.10.2 Preparation of target cells
Both MDM (see section 2.12.1) and skin fibroblasts, either autologous or
heterologous, were used as target cells. 1-2 x 104 MDM in complete
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RPMI / 10%FCS or 1 x 104 skin fibroblasts in DME / 10%FCS per well were plated
into 96-well flat-bottomed microtiter plates and incubated overnight at 37°C, 5%
COo. Cells were either mock infected or infected with MVV, using 0.5 (skin
fibroblasts) or 1-2 TCID50 (MDM or AM) per cell, and incubated for 24 hours (skin
fibroblasts) or 48 hours (MDM). Each well was labelled with 1.5 pCi (for Wallac
micro-p counter) or 2.5 pCi (for LKB Wallac RIA Gamma counter) Na251Cr04 in
50 pi medium (DME/2%FCS or RPMI/10%FCS, respectively) and incubated
overnight at 37°C, 5% CCK The cultures were washed four times with
RPMI / 2%FCS and then used as target cells.
AM were cultured in 25 cm2 flasks and then mock-infected or infected with
MVV, 1 TCID50 per cell. AM in flasks were labelled overnight with 100 pCi
Na251CrC>4 in 2 ml medium at 37°C, 5% CO2. AM were harvested and washed
four times with RPMI / 2%FCS and then used as target cells.
2.10.3 CTL-mediated cytotoxicity
Effector cells were made to the required cell concentration in
RPMI / 10%FCS, usually 3 dilutions, eg 6x10^, 1.2x10^, 2.5x10^ cells per ml to
give effector : target ratios of 12:1, 25:1 and 50:1. 200 pi of the effector cells
(CTL) were added to each well of washed targets. The plates were centrifuged
(200xg, 1 minute) and incubated at 37°C, 5% CCD- After 6 or 16 hours incubation,
either lOOpl of the supernatant was taken and counted in a gamma counter (LKB-
Wallac 1274 Riagamma), or 40pl of the supernatant was mixed with 120pl
Optiphase "Hisafe 3" (Wallac) in a 96-well Falcon flexible ELISA plate and
counted by scintillation counting (Wallac 1450 Microbeta) for one minute. Assays
were performed in triplicate for each dilution of effector cells. The minimum
release was taken from wells without added effectors and maximum release was
measured by addition of 1% Triton X-100 to the targets. Results were expressed as
the percentage specific lysis, calculated as below:
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specific lysis (%) = (mean cpm test - mean cpm minimum) / (mean cpm maximum -
mean cpm minimum) x 100 ± (standard derivation of cpm test/ mean cpm
maximum-mean cpm minimum) x 100.
2.10.4 Depletion of lymphocytes with monoclonal antibody plus complement
Lymphocytes (1 x 107) were incubated for 40 minutes 0°C in 500 |il of
SBU-T4 (l(ig/ml), or SBU-T8 (l|ig/ml) in RPMI / 2%FCS. The cells were washed
twice in RPMI /2%FCS and then suspended in 500 |il newborn rabbit serum (1:5
dilution in RPMI / 2%FCS) for 30 minutes at 37°C. After one wash with
RPMI / 2%FCS, the complement depletion was repeated once more. The cells were
washed twice with RPMI / 2%FCS and then suspended in RPMI / 10%FCS. Viable
cells were counted in 1% trypan blue and diluted to the required cell concentration
for effectors in CTL assays.
Depletions were checked by antibody staining and analysis on the FACS
using FACSCAN software. Dead cells were gated out by staining with 20 fig/ml
propidium iodide in RPMI / 2%FCS after monoclonal antibody staining.
2.10.5 Cytotoxic activity of lymphokine-activated killer cells (LAK)
PBMC were prepared as described in section 2.2. The adherent cells
(monocyte-enriched cells) were depleted and cultured as target cells (section
2.10.2). The PBL (non-adherent cells) were cultured in 25cm2 flasks at a
concentration of 3 x 10^ cells/ml RPMI / 10%FCS in the presence of 10U rhIL-2/ml
for 5 days or 13 days. More rhIL-2 (10U) was added on culture day 3. The effector
cells were overlaid onto Lymphoprep and viable cells harvested from the interface
(500 xg, 10 minutes). After 2 washes with RPMI/2%FCS, the viable cells were
counted and diluted to the required concentration in RPMI / 10%FCS.
To separate FcR+ and FcR" cell populations, 2 x 10^ PBL/ml were mixed
with 50 p.1 1% opsonized sheep RBC (section 2.8.3) and incubated at 37°C for 10-
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15 minutes. The cell mixture was centrifuged (200 xg for 3 minutes), resuspended
in PBS and incubated for another 30 minutes at 37°C, 5% CO2. The cell mixture
was diluted and overlaid onto Lymphoprep. After centrifugation (500 xg, 10
minutes), erythrocyte rosette positive (ER+) cells were at the bottom of the tube,
and erythrocyte rosette negative (ER~) cells were at the interface. Both populations
were collected separately, diluted in RPMI / 2%FCS and washed twice. ER+
population were lysed with buffer (10 mM potassium bicarbonate containing
0.155 M ammonium chloride and 0.1 mM EDTA) and washed twice in
RPMI / 2%FCS. Both ER+ and ER" population were cultured in 25 cm2 flasks as
described above. These lymphokine activated killer cells were then used as
effectors in cytotoxicity assays as described in section 2.10.3.
The target cells, MDM and skin fibroblasts, either autologous or
heterologous, were prepared as previously described (section 2.10.2 ).
2.11 Experimental Sheep
Finnish Landrace crossed sheep (1-4 years old), were purchased from the
Moredun Research Institute, Edinburgh. Uninfected sheep used for the generation
of antigen-specific T cell lines were kept at the Moredun Research Institute. MVV-
infected sheep were kept at the Bush Field Station, Easter Bush Estate, Edinburgh.
In addition, lungs for normal BAL were taken from abattoir material or
experimentally culled sheep at the Moredun Research Institute. They were of mixed
breed and age (adult).
Sheep naturally-infected sheep with MVV from a contaminated flock




ULTRASTRUCTURAL OBSERVATION OF MAEDI VISNA VIRUS
REPLICATION IN MACROPHAGES AND SKIN FIBROBLASTS
58
3.1 Introduction
In vivo, MVV replication in monocytes and macrophages is restricted so that
only small amounts of viral protein are detected, although many copies of viral
RNA may be seen in target cells (Gendelman et al., 1985). There is also no
evidence of cell free viremia (Petursson et al., 1976; Bird et al., 1993), therefore it is
unlikely that large numbers of virions are produced in vitro. The restriction of virus
replication may be due to the infected cell type (macrophages), maturation stage of
monocyte/macrophages, LV-IFN as well as other cytokines and host immune
surveillance (Narayan and Clements, 1989). In vitro MVV replication is productive
in both macrophages and fibroblasts. MVV replication in sheep choroid plexus
(SCP), or skin fibroblast cells induces cytopathic effects (CPE) which are
characterized by the formation of syncytia and cellular lysis which coincides with
the period of peak virus production (Thormar, 1961; Macintyre et al., 1973).
However, the CPE seen in MVV-infected cultures is viral isolate and cell type
dependent (Narayan et al., 1982; Lairmore et al., 1987).
Virus isolates have been divided into three different groups by their
replication patterns in sheep fibroblasts and macrophages (Lairmore et al., 1987).
Group replication patterns are (1): growth to high virus titer and many syncytia, (2)
high titer but few syncytia, or (3) low titer and no syncytia in both macrophages and
synovial cells. These different groupings correspond to pathogenicity when isolates
are used to experimentally infect lambs (Lairmore et al., 1987). In addition,
phenotypically distinct MVV isolates induce different immune responses to env
proteins compared to gag proteins (Kajikawa et al., 1990). The rapid/high virus-
infected group developed a five-fold higher geometric mean titer of anti-env
antibody than did the slow/low virus infected group in vivo (Kajikawa et al., 1990).
To date sheep choroid plexus (SCP) culture has been widely used in the
study of MVV. Using transmission electron microscopy (TEM) many viral budding
sites have been found at the cytoplasmic membrane of SCP (Thormar, 1961;
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Macintyre et al., 1973; Narayan, et al., 1982) as is the case for CD44" T cells in HIV
replication (Palmer et al., 1985; Meltzer, et al., 1990). In contrast, only a few viral
budding sites are present at cytoplasmic membranes of HIV infected macrophages
(Orenstein et al., 1988) or MVV-infected macrophages (Narayan et al., 1982).
Most HIV and MVV virions in macrophages accumulate in vacuoles. In vitro,
MVV replication in skin fibroblasts or choroid plexus cells has been extensively
studied, but MVV replication in macrophages, especially by electron microscopy, is
still limited.
HIV replication has been compared in lymphocytes and macrophages. More
than 35% of total viral proteins synthesized are env gene products in HIV-infected
lymphocytes. In contrast, a relative lack of env protein, not more than 10% of total
viral protein, was seen in HIV-infected macrophages (reviewed in Meltzer et al.,
1990). This data suggests that HIV derived from macrophages is relatively deficient
in env protein and so may be less infectious than HIV derived from lymphocytes
through CD4 entry or may use other virus receptor molecules. Whether MVV
synthesis and assembly in macrophages is similar to that seen in HIV infected
macrophages is not documented.
A British isolate of MVV (strain EV1) was isolated by cocultivation of
peripheral blood mononuclear cells of a sheep with an acute maedi-like disease with
ovine skin fibroblasts (Sargan et al., 1991). This strain shows typical CPE (syncytia
and lytic infection in skin fibroblasts). However, EV1 replication in monocytes and
macrophages has not been studied. Therefore, the characteristics of EV1 replication
and viral protein synthesis in monocytes and macrophages were studied and
compared to those in skin fibroblasts.
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3.2 Results
3.2.1 Maedi-visna virus (strain EV1) replication in monocytes and AM
During EV1 replication in MDM (infection on day 7), there were no
remarkable morphological changes in the first 4 days post infection under light
microscopic examination, compared with uninfected controls. But 5 days post
infection some infected cells became small and refractive and gradually lysed in the
culture. Compared to uninfected monocytes or macrophages, about 30-40% of cells
were lost within the first 6 days. By day 9, about 60% to 80% of cells were
detached from the well.
The time course of MVV replication in monocytes and macrophages is
shown in figure 3.1. No virus was detected in the supernatant of fresh monocytes
infected with virus by day 3 post infection. However, virus production was seen by
day 4 which peaked at day 7 post infection. In contrast to fresh monocytes, 7 day-
cultured MDM infected with MVV showed 104 - 10^ TCID5o/ml in the supernatant
by day 2 post infection with peak titers at day 4-8 post infection. Three-day
cultured monocytes infected with MVV showed intermediate viral production in the
supernatant compared to fresh monocytes and day 7 cultured monocytes. In
contrast, MVV replication in AM showed a steady increase in the virus titer in the
supernatant with time. At the peak of virus production, viral infected monocytes,
MDM and AM had degenerated and eventually lysed in the culture. The typical
fibroblast CPE, syncytia, were not evident in infected fresh and 3-day cultured
monocytes. Syncytia were seen in 7-day cultured MDM infected with MVV. These
syncytia (often 4-8 nuclei) were not as large as those seen in skin fibroblasts (often
more than 8 nuclei) infected with MVV. For the remaining experiments (TEM and
SEM observation) 7 day cultured MDM were always used for infection.
Fluorescence antibody (FA) staining of virus-infected MDM for gag protein,
pi5, also showed increasing amounts of this protein with time. On day 2 post
infection, 20 to 30% of MDM showed a weak positive specific fluorescence for p 15
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Figure 3.1 Maedi-visna virus (EV1) replication in monocytes, MDM and AM
2.5 x 1()6 PBMC (for MDM) or 2.5 x 10^ AM were seeded in 24-well plates
and nonadherent cells were removed as described in materials and methods (section
2.2.3 & 2.2.4). Monocyte/MDM were infected with EV1 at 1 TCID50 per cell on
day 0, 3 or 7 and AM were infected on culture day 1. After 2 hours incubation,
non-absorbed viruses were removed and cultures were re-fed with fresh medium.
Supernatant was collected every two days and virus titers were assessed on skin
fibroblasts as described in section 2.3.2.
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FIGURE 3.1
0 2 4 6 8
DAYS POST INFECTION
■Q Monocyte (day 0)
-• Monocyte (day 3)
-n Monocyte (day 7)
-© AM (day 1)
Figure 3.2 Antibody staining of MDM after infection with MVV
MVV-infected and mock-infected MDM (infection on day 7) were fixed in
methanol. Cells were stained with 415 monoclonal antibody to viral gag protein,
pi5, followed by anti-mouse IgG-biotin and streptavidin as described in section
2.4.1. Mock-infected MDM stained with 415 monoclonal antibody were used as
negative controls.
A. Mock infected MDM.
Magnification: x 1,000




antigen in their cytoplasm, but after 4 days post infection, over 80-90 % of MDM
were strongly positive for p 15 antigen (figure 3.2.B).
3.2.2 Culture of monocytes from MVV-infected sheep
Monocytes cultured from MVV-infected sheep often gave poor cell
recoveries when compared to those from uninfected sheep. Therefore, cultured
monocytes from normal or MVV-infected sheep, and detection of viral antigen by
FA staining on cultured MDM were investigated and compared. Monocytes from
normal sheep gradually increased their size and cytoplasm : nucleus ratio in the first
7-10 days and cultures became nearly confluent (figure 3.3.A). Thereafter,
macrophage proliferation in the culture could be found. Monocytes from MVV-
infected sheep, especially naturally or long-term experimentally infected sheep, had
apparently normal monocytes for the first three days in culture but the cell density
was less than that from normal sheep. More cells became detached from the plastic
during culture, especially macrophages from naturally infected sheep. There was
also great variation in the CPE seen in monocytes between MVV-infected sheep.
Syncytia (figure 3.3.B) could be found in cultured monocytes from some sheep (4
out of 7 naturally infected-sheep) after 7 days culture, but were not noticeable in
monocytes from experimentally infected sheep. Cultures containing syncytia were
also positive (low frequency) for viral p 15 gag antigen (data not shown).
Furthermore, cultured MDM from one naturally infected sheep which showed
syncytia formation were processed for TEM observation and MVV particles could
be seen in the cytoplasm of the cells (data not shown).
3.2.3 TEM observation of MVV (EV1) infected MDM
By day 4 post infection with MVV, MDM showed no gross changes in
cellular microorganelles, except for an increase in the amount of endoplasmic
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Figure 3.3 Cultured MDM from MVV-infected sheep
MDM from uninfected and MVV-infected sheep were cultured in gelatin-
coated 24-well plates as described in section 2.2.3. After 7 days culture, MDM
were fixed in methanol and then stained with Giemsa's stain.
A. MDM cultured from an uninfected control sheep.
Magnification: x200
B. MDM cultured from a naturally MVV-infected sheep which had pulmonary
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reticulum and number of ribosomes. The morphological changes seen in infected
MDM by 6 to 9 days post infection were variable in each cell, including profound
vacuolation of the cytoplasm and swelling of mitochondria and the nuclei contained
dispersed heterochromatin margins (figure 3.4 b & c). Some MVV-infected MDM
lost their surface processes. However, there were no obvious syncytia found in
these sections. Virus budding was seen from both the cytoplasmic and vesicular
membranes of the cells and virions were seen accumulating both in cytoplasmic
vacuoles and in intercellular spaces.
There were two types of viral particles seen in MVV-infected MDM. The
first form was intracytoplasmic particles (figure 3.4.f), which had a similar
morphology to intracytoplasmic type A (ICA) particles of the type B and D
retroviruses (Fine and Schochetman; 1978). The ICA panicles were about 80-
lOOnm in diameter, round in shape with one electron dense incomplete or complete
ring, and electron-lucent centers. A ring of ribosome-like substance surrounded the
panicle surface. Sometimes, the abenant forms with 2 or 3 electron-dense rings
were seen. The ICA particles were easily seen in the cytoplasmic matrix, some of
them being closely associated with the endoplastic reticulum. No ICA panicles
were found within vesicles although they were often seen around the vesicles (figure
3.4 e). Moreover, no ICA panicles were seen budding from the cytoplasmic
membrane in these specimens.
The second type of viral panicle was mature or immature virions which had
electron-dense, round or bar-like nucleoids and were about 70-120nm in diameter
(figure 3.5 c). The shape and size depended on the plane of section and the maturity
of the virion. Mature viral particles were smaller than ICA particles and were about
70 to 90 nm in diameter. Most mature virions had a round to bar-like nucleoid
(occasional coffin shaped nucleoids were seen) which was centrally placed in the
virion, but sometimes, two or more round nucleoids were observed. In contrast,
immature virions which had just been released from the cytoplasmic membrane
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were bigger in size, 90 - 120nm, and had a circular electron-dense nucleoid (figure
3.5.c). Mature viral particles predominantly accumulated in vesicular lumens
(figure3.5.b) and extracellular areas (figure 3.5.a).
During viral budding, an electron-dense nucleoid formed with a crescent
shape which fused with the vesicular (figure 3.4.f) or cytoplasmic membrane (figure
3.5.a). Both ends of the crescent eventually met and then formed a ring-like
nucleoid with an electron translucent center. After that, virions were released from
the membrane as immature virions. These immature virions had a ring shaped
nucleoid and very short, faint spikes (figure 3.5 a). The ring-like nucleoid gradually
condensed and became centrally located as in the mature virions. Between 5 and
7% of viral containing MDM on day 8 and 9 post infection showed viral budding
sites on their cytoplasmic membrane. Compared to the number of ICA and mature
particles which had accumulated, there were only a few viral budding sites present
at the vesicular and cytoplasmic membranes (TEM only sees a small percentage of
membrane surface area). However, a lot of viral buds were found at the
cytoplasmic membrane in a few MDM, especially smaller MDM (figure 3.4.c & d).
Clustered viral particles found in the extracellular spaces (figure 3.4.d) might have
been released from cells by exocytosis or cellular lysis.
3.2.4 TEM observation of MVV (EV1) infection in AM
EV1 replication in AM was very similar to that found in MDM. There were
more ICA particles (figure 3.5.e&f) found in the cytoplasmic matrix and fewer
mature viral panicles accumulated in vesicles (figure 3.5.d). It was very difficult to
find viral budding at the cytoplasmic membrane, and there were only a few viral
buds found on vesicular membranes in these specimens. In a time course of
infection, only a few virions could be found in AM by day 4 post infection,
whereas, nearly 70% of AM on 9 days post infection contained ICA or mature viral
particles (data not shown).
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Figure 3.4 Transmission electron micrographs of MVV-infected MDM
MDM were cultured in 75cm2 flasks (day 7) and then infected with EV1, 1
TCID50 per cell. After 6-7 days incubation, MDM were pelleted and fixed in 3%
glutaraldehyde in cacodylate buffer and then post-fixed in osmium tetroxide.
Ultrathin sections were made and double stained with uranyl acetate and lead citrate
and then observed under a Philips 300 TEM.
a. Uninfected MDM showed intact processes, microorganelles and nucleus.
Magnification: x7,000
b. MVV-infected MDM 6 days post infection. Both virus-infected cells had
become very vacuolated. Magnification: x3,750.
c. MVV-infected MDM 6 days post infection. A lot of viruses were budding from
the cytoplasmic membrane (j*-). Magnification: x7,700.
d. MVV-infected MDM 7 days post infection. The small MDM in the right hand
corner showed a few viral budding sites ( ) at its cytoplasmic membrane. In
contrast, well differentiated MDM became very vacuolated (upper right). Clumps
of viral particles (—►) accumulated in intercellular spaces. Magnification: x7,700.
e. MVV-infected MDM 7 days post infection. A few viral particles were present
in the vesicular lumen and intracytoplasmic matrix. Viral budding sites were also
present at the vesicular membrane ( ). High magnification of vacuole (V) is
shown in photograph (f). Magnification: x 10,000.
f. Viral buds on a vesicular membrane ( >-) and intracytoplasmic type A (ICA)
particles (—►). Magnification: x35,000.
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Figure 3.5 Transmission electron micrographs of MVV-infected MDM (a- c)
and AM (d-f)
The MDM and AM specimens were processed as prescribed in section 2.5.
a. High magnification of figure 3.4d. Viral budding sites at the cytoplasmic
membrane ( ^-) and virions in the intercellular space (—►).
Magnification: x46,000.
b. MVV-infected MDM 7 days post infection. A large number of viral particles
accumulated in the vesicular lumen and viral budding was present at the vesicular
membrane ( *-). Magnification:x37,500.
c. MVV-infected MDM 7 days post infection. Mature virions (—►) contain a bar¬
like nucleoid and have a size of 70-90 nm in diameter. In contrast, immature
virions ( *"■) have a denser central nucleoid and are larger than mature virions.
Space bar = lOOnm. Magnification: x60,000.
d. MVV-infected AM 8 days post infection. A clump of viral particles
accumulated in a vacuole. Magnification: x35,500.
e. MVV-infected AM 8 days post infection. Viral particles (ICA) scattered in the
cytoplasmic matrix. Magnification: x 12,500.
f. MVV-infected AM 8 days post infection. Typical ICA particles in the
cytoplasm. Space bar = lOOnm. Magnification: x46,000.
69
 
3.2.5 TEM observation of MVV (EV1) infection in skin fibroblast cells
In contrast to MVV replication in MDM, there were a lot of viral budding
sites present at the cytoplasmic membrane of MVV-infected skin fibroblasts (figure
3.6.b) and numerous free viral particles were scattered in extracellular areas (figure
3.6.c). But only a few ICA viral particles were found in the cytoplasm of some
infected skin fibroblasts at 8-9 days post infection (data not shown). Viral particles
which had accumulated in the vesicles of MVV-infected skin cells were rare. Other
morphological changes of MVV-infected skin fibroblasts included multiple nuclei
(syncytia) (figure 3.6.a) and degeneration of mitochondria and nuclei.
3.2.6 Comparison of strain EV1 and 1514 replication in MDM
ICA particle formation is characteristic of type B murine and type D
retroviruses (Spumavirus) (Fine and Schochetman, 1978) but not lentiviruses. The
detection of ICA particles in MDM and AM could therefore be due to endogenous
virus in these cell types which are activated by MVV infection. To address this
question the Icelandic MVV strain, 1514, was used to compare with EV1. A single
source of MDM was infected with EV1 and 1514 virus at the same time, cultured
under the same conditions, and then processed for EM examination. MDM infected
with EV1 contained ICA particles, mature and immature virions and viral budding
sites similar to previous observations (figure 3.7. a, c, e). In contrast, 1514 virus-
infected MDM did not contained ICA particles. Interestingly, 1514 viral budding
sites found at the cytoplasmic membrane showed crescent nucleoids which
invaginated and apparently released virions into the cytoplasm (figure 3.7. b, d, f).
This phenomenon was different to EV1 which budded and released into the
extracellular area (figure 3.7.c). Other ultrastructural changes in MDM infected
with 1514 virus included serious hydropic degenerative changes in the cytoplasm,
swelling of nuclei and dilation of vesicles.
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Figure 3.6 Transmission electron micrographs of MVV-infected skin
Fibroblasts
Skin fibroblasts were cultured in T-75 flasks and then infected with MVV,
0.5 TCID50 Per ce^- Depending on CPE formation, skin fibroblasts were harvested
and processed as described in section 2.5.
a. MVV-infected skin fibroblasts 6 days post infection. The skin cell showed 3
nuclei and is probably a syncytium.
Magnification: x4,600.
b. MVV-infected skin fibroblasts 6 days post infection. A large number of viral
buds were present at the cytoplasmic membrane.
Magnification: x 16,500
c. High magnification of viral budding sites ( >■), immature viral particles and




Figure 3.7 Comparison of strain EV1 (a, c, and e) and 1514 (b, d, and f)
infected MDM.
MDM from the same source were infected with EV1 (a, c, e) or 1514
(b, d, f) virus , 1 TCID50 per cell , respectively, and cultured under similar
conditions. On 6 days post infection, cells were processed for TEM observation as
previously described in section 2.5.
Both viral budding at the cytoplasmic membrane ( ^-) (box 1) and ICA particles
in the cytoplasmic matrix (box 2) were found in the same cell infected with EV1.
A higher magnification of viral budding sites and ICA particles in boxes in (a) are




Viral budding sites which appeared to invaginate into the cytoplasm ( ) were
found in MDM infected with 1514 virus. An immature virion (—►) is shown in the







3.2.7 Surface changes of MVV-infected skin fibroblasts and macrophages
Scanning electron micrographs of MVV-infected MDM were prepared 2, 4,
6, and 8 days post infection. The morphology of adherent MDM observed under
SEM could be classified as three types. The first category was healthy or normal
MDM which were well spread on the coverslips, with an abundance of membrane
ruffles (figure 3.8.c). The second type of MDM had degenerated which was
characterized by atrophy or partial loss of the membrane ruffles (figure 3.8.d) and
decreased extension on the coverslip (figure 3.8.b). Moreover, these cells had
surface globular structures which varied in size (0.5-lpm) and shape. These may be
derived from the degenerating membrane ruffles or be viral budding sites. The third
category of infected MDM had uniform and tiny globular structures (200-250nm)
on their surface (figure 3.8.e, f). The severely degenerated MDM, predominantly
found in the late phase of viral infection, had completely lost their membrane ruffles
and pseudopods (data not shown).
In non-infected MDM, about 90% of cells were healthy with less than 10%
having degenerated. By 2 days post infection, most MVV-infected MDM had
similar morphology to non-infected MDM, but a few MDM (about 8%) showed a
few globular structures on their surface. By 4 days post infection, the healthy,
degenerate and severely degenerate cells were 80%, 15%, and 5%, respectively.
Moreover, 36% of MDM exhibited globular structures on their surface membrane.
By 6 days post infection , 35% of adherent MDM had degenerated and over 50% of
them exhibited globular structures. After 8 days post infection, 70-80% of MDM
were detached from the coverslip (figure3.8.b) and over 90% of the remaining
adherent MDM were degenerative or severely degenerative and showed variable
globular structures on their surface. These results are summarized in table 3.1.
The surface changes on MVV-infected AM were different to those seen on
MDM. It was difficult to find virion-like particles on the cell surface like those
found on MDM. But in the early phase of viral infection, localized areas of surface
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ruffles were lost and replaced by a bulge containing some small globular structures
(figure3.9.a, b), similar to those found on MDM. This phenomenon may be
exocytosis of a virion-containing vesicle into the extracellular space. With
increasing time post infection, surface ruffles were gradually lost and replaced by
many such bulges and volcano-like structures (data not shown).
The change in surface morphology of skin fibroblasts infected with MVV
was more easily observed than changes of MDM. Normal uninfected skin
fibroblasts were very flat and well attached to the coverslip by extended filaments
(figure3.10.a). Their surfaces were very smooth and had a low contrast under SEM
observation, but sometimes, a few globular structures varying in size and shape
could be found on cells, which might be cell debris. However, with time after MVV
infection, the number of degenerative cells increased in culture. They were
characterized by shrinking of cellular filaments, and appeared to have a rough cell
surface (figure 3.10.b). There were many uniform globular structures on the cell
surface (figure 3.10.c). The globular structures were 200-250nm in diameter (figure
3.10.d). Some semi-globular structures with a similar size were seen to be just
budding from the cell membrane and were probably sites of viral budding
(figure3.10.d). The proportion of cells positive for globular units on days 0, 2, 4,
and 6 days post infection were 6%, 38%, 82% and 93%, respectively.
3.2.8 Detection of viral proteins synthesized in AM and skin fibroblasts
The difference in viral replication and assembly patterns found in AM and
skin fibroblasts was very similar to that reported for HIV replication in macrophages
and lymphocytes (Orenstein, et al., 1988; Folks et al., 1988; Gendelman et al.,
1989), respectively. As there is a known difference in the amount of gag : env
synthesized in macrophages and lymphocytes in HIV, the synthesis of gag and env
was studied in MVV infected macrophages and skin fibroblasts.
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Figure 3.8 Scanning electron micrographs of MVV-infected MDM
MDM were cultured on coverslips in 24-well plates. On day 7 MDM were
infected with MVV, 1 TCID50 per cell. At designated times cells were washed
with PBS 5-6 times, then fixed in 3% glutaraldehyde in cacodylate buffer at 4°C
overnight and post-fixed in osmium tetraoxide for 1 hour. The cells on coverslips
were dehydrated in graded acetone and then dried in a CO2 critical point dryer.
Cell surfaces were coated with evaporated gold and observed under SEM.
a. Uninfected MDM were confluent in culture. Magnification: xl20.
b. MVV-infected MDM 8 days post infection. Most virus infected cells had lysed
and were detached from the coverslip. Magnification: x625
c. Uninfected MDM had intact membrane ruffles and was evenly spread on the
coverslip. Magnification: x3,100
d. MVV-infected MDM 6 days post infection. The degenerative MDM showed
partial loss of membrane ruffles and there were a lot of globular structures of
various sizes on its surface. Magnification: x5,000
e. MVV-infected MDM 6 days post infection. Similar to (d), but the cell surface
was covered by more uniform globular structures which may be viral particles.
Magnification: x2,500















control 91.7 6.0 2.3 <3
2 days 92.7 5.5 1.8 7.7
4 days 80.1 14.9 5.0 36.4
6 days 65.1 21.5 13.4 51.1
8 days 7.5 17.9 74.6 90.1
* Cellular condition was classified by the appearance of surface ruffles, pseudopods and globular
structures on MDM surfaces. Values are taken from observations of 200-300 cells.
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Figure 3.9 Scanning electron micrographs of MVV-infected AM
Fresh AM were cultured on coverslips in 24-well plates for 1 day and then
infected with MVV, 1 TCrD50 per cell. Two days postinfection cells on coverslips
were processed as described in section 2.6.
a & b. MVV-infected AM had lost their surface ruffles in specific areas and
showed instead a clump of globular structures. In contrast, the surface ruffles
surrounding these areas were still intact.
Magnification: x5,000.
c. High magnification of globular structures of (b) which were of 200-250 nm




Figure 3.10 Scanning electron micrographs of MVV-infected skin fibroblasts
Skin fibroblasts were cultured on coverslips in 24-well plates and then
infected with MVV, 0.5 TCID50 per cell. At designated times, cells on coverslips
were processed as described in section 2.6.
a. Uninfected skin fibroblast. Cell surface was flat with little contrast to the
coverslip and attached well to the coverslip. The cellular surface was very smooth
but with occasional debris.
Magnification: x5,000
b. MVV-infected skin fibroblast 2 days post infection. The cellular surface was
very rough, containing a large number of small globular structures and cell debris
of irregular size.
Magnification: x5,000.
c & d. MVV-infected skin fibroblast 4 days post infection. A large number of
viral particles with similar size and shape had accumulated on the skin cell surface.
Viral particles were 200-250 nm in diameter. It also shows viruses just budding
( *-)from the cytoplasmic membrane (d). Space bar = 1p.m.




SDS-polyacrylamide gel electrophoresis patterns of the MVV viral proteins
were stained using serum from a MVV infected sheep (848A) or control normal
sheep serum. The normal sheep serum stained bands at around 60-70KD in both
uninfected and infected skin cells (figure 3.1 l.c). A clear band at about 16 KD was
detected with MVV sheep serum in the lysates of uninfected and viral infected AM
and as such is unlikely to be virus specific. However, the development of viral
specific protein bands could be seen with increasing time post infection (figure
3.11.A) especially the p25 gag band (from day 4 post infection) and env gpllO
smear (from day 6 post infection).
Both lysates of MVV-infected skin cells and AM, and their released virions
showed a predominant p25 gag band and an env smear (from 110KD-135KD)
(figure 3.1 lb).
It was very difficult to compare the gag (p25) : env protein (gpllO) ratio
present in the lysates of MVV infected cells and the assembled virions released in
the supernatant. However there did not appear to be a specific lack of env compared
to gag.
In addition, other viral specific proteins, 14KD, 17KD, 35KD, 41KD could
be detected in the lysates of MVV-infected cells (14KD and 17KD in virion as
well). These proteins might include gag precursor proteins and processing
intermediates and pol gene products.
3.3 Discussion
EV1 replication in skin fibroblasts and mature macrophages in vitro is rapid
and lytic. Therefore EV1 is like the rapid/high MVV isolates reported previously
(Lairmore et al., 1987), although EV1 causes less syncytial formation than others.
The maturation state of monocytes (time in culture) affected MVV replication with
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Figure 3.11 Comparison of viral peptides synthesized in AM and skin
fibroblasts
AM (dayl) and skin fibroblasts were cultured in T-175 flasks and infected
with EV1 at 0.5 and 0.1 TCID50 per cell, respectively. Cells (AM on 2-9 days post
infection; skin fibroblasts on 7 days post infection) were harvested, counted and
pelleted by centrifugation at 10,000xg for 15 minutes. Virions were further
pelleted from clarified supernatant by centrifugation at 100,0()0xg for 2 hours.
Cellular and viral pellets were suspended in a small amount of PBS (4xl0^cell/ml).
Protein concentration was determined by the Bio-Rad protein microassay.
Samples and sample buffer were mixed and boiled for 5 minutes. Five jil of
specimen containing 1x10^ AM (A) or 5|J.g protein (B and C) were loaded in each
track of 5-20% polyacrylamide gradient gels.
Separated peptides were transferred to nitrocellulose filters and then stained
with serum taken from a MVV-infected sheep (848A, panel A & B) or control
normal sheep serum (panel C), followed by rabbit anti-sheep IgG-alkaline
phosphatase conjugate. The bands were developed in alkaline phosphatase
substrate, 5-bromo-4-choloro-3-indoyl-phosphate as described in section 2.4.3.
A. Uninfected AM lysate (lane 1) and EVl-infected AM lysate (lane 2: 2 day pi;
lane 3: 4 day pi; lane 4: 6 day pi and lane 5: 8 day pi) were loaded in each track.
Molecular weight markers (lane M) and p25 and gpllO positions (*-) are
indicated.
B. Comparison of viral proteins expressed in MVV-infected AM lysates and skin
fibroblast lysates and found in supernatant virions. Lane 1: Uninfected AM lysate,
Lane 2: MVV-infected AM lysate (9 days pi); Lane 3: viral pellet from AM; Lane
4: Uninfected skin fibroblast lysate; Lane 5: MVV-infected skin fibroblast lysate 6
days pi, and Lane 6: viral pellet from skin fibroblasts. Molecular weight markers
and p25 and gpl 10 positions (j*-) are indicated.
























































virus being produced earlier and to high levels in mature macrophages (7 days
cultured before infection). This has been previously shown for MVY (Gendelman
et al., 1986) and CAEV (Narayan et al., 1983). A similar phenomenon has also
been reported for HIV replication in fresh and mature monocytes (Potts et al.,
1990). This suggests that fresh monocytes do not support productive lentivirus
replication. How the monocyte stops replication is unknown. HIV replication in
macrophages apparently causes a more chronic infection than EV1 with more
syncytial formation (Perno et al., 1989; Collman et al., 1989: Schmidtmayerova et
al., 1992). However, these results are variable depending on the viral isolates and
macrophages used.
Ultrastructural observation of MVV grown in tissue culture, in particular
sheep choroid plexus cells (SCP), has been widely studied (Thorman, 1961;
Coward, 1970; Takemoto, 1971; Macintyre, 1973; Weiland, 1980). Strain EV1 has
a similar size, shows bar shaped nucleoids and crescent budding forms at
cytoplasmic or vesicular membranes as previously observed in other lentiviruses
(Munn et al., 1985; Orenstein, et al., 1988; Weiland et al., 1977; Dahlberg et al.,
1981; Gelderblom et al., 1991). However, ICA particles were evident in EV1-
infected MDM and AM which have not been mentioned in previous observations of
MVV-infected macrophages (Lairmore et al., 1987; Narayan et al., 1982).
ICA particles have been reported in MVV infected sheep testicle cells
(Takemoto et al., 1971, Coward et al., 1972), but not found in SCP (Thorman et al.,
1961; Macintype et al., 1973: Weiland et al., 1985 ) or sheep kidney and liver cells
(Thormar et al., 1961). There have also been aberrant ICA-like particles described
budding from the endoplasmic reticulum in caprine arthritis encephalitis virus
(CAEV)-infected tahr cells (Dahlberg et al., 1981). In addition, ICA particles were
found in cultures infected with EIAV (Weiland et al., 1977; Gonda et al., 1978) and
SIV (Munn et al., 1985), but not HIV. This suggests that ICA particles may be an
assembly form in some lentiviruses. However there is always the danger that
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endogenous retroviruses or retroviral genes may be activated by infection with
another virus (especially as little is known about endogenous sheep retroviral
sequences) (Barban et al., 1984; Herr and Spell, 1985). To address this problem
MDM from the same source were infected with 2 different MVV isolates and viral
assembly studied by electron microscopy. EV1 showed the accumulation of ICA
particles whilst none were seen with 1514. This suggests that MVV infection itself
has not activated endogenous retroviral sequences. To prove that the ICA particles
were MVV gag protein immunogold staining with mouse monoclonal anti-pl5 was
attempted. Although some gold particles could be seen on ICA particles, staining
was weak (data not shown) and so it was not definitively shown that MVV gag was
in these ICA particles. Therefore it would appear that EV1 has a propensity to form
ICA like particles in macrophages rather than skin cells. Why different cell types
should cause aberrant virion formation or why two highly conserved gag antigens
(EV1 and 1514 gag 90% homologous; Sargan et al., 1991) should act differently in
macrophages is unknown.
ICA particles in retroviruses contain a high molecular weight polyadenylated
genomic RNA (Pattersson et al., 1978), but little reverse transcriptase (Wong-Staal
et al., 1975). These particles also have defects in their envelope gene, do not
appear in extracellular spaces and are not pathogenic (Minna et al., 1974). ICA
particles budding into the vesicular lumen or being released from the cytoplasmic
membrane of macrophages have not been found, which suggests that ICA particles
are aberrant forms of virion in MVV. Whether these particles are infectious is
unknown.
ICA particles have been documented as precursors of simian
immunodeficiency virus (SIV), but these particles clearly bud at the cytoplasmic
membrane with both ring or crescent shaped nucleoids and have clearly seen spikes
(Munn et al., 1985). Therefore, SIV is morphologically more closely related to
type D rather than type C viruses. In contrast, HIV in lymphocytes and monocytes
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does not produce ICA particles and buds only with crescent shaped nucleoids
(Palmer et al., 1985; Orenstein et al., 1988). This gives HIV a morphological
classification with murine type C retroviruses. In contrast, EV1 in MDM and AM
produces ICA particles, but they do not bud at the cytoplasmic membrane and they
do not appear to mature in vesicular lumens. There are no ring-shaped buds at
cytoplasmic or vesicular membranes and the clear spikes on the viral surface like
those found on type D retroviruses (Fine et al., 1978) are not seen. From the
morphological observations found here, MVV EV1 has features of type B, C and D
retroviruses by both viral budding form and ICA particle formation.
In contrast to MVV which has viral budding from the cytoplasmic
membrane, HIV virions locate almost exclusively in intracellular vesicles of
monocytes or macrophages (Meltzer et al., 1990; Orenstein et al., 1988). These
vesicles are morphologically similar to Golgi apparatus-derived and dilated vesicles
(Orestein et al., 1988). Here the origin of dilated vesicles which accumulated viral
particles in MVV infected macrophages could not be identified. Clustered viral
particles were observed in the extracellular spaces between infected macrophages
which suggests that most viral particles which accumulated in vesicles of AM are
released into the extracellular space by exocytosis or cell lysis. This was supported
by SEM observation (figure 3.9.a & b).
The surface changes seen in MDM or macrophages infected with MVV were
linked to the level of cell degeneration and the amount of viral budding from the
surface. Two types of globular structures were found on the surface of MVV
infected macrophages. Large globular structures, with varying size (>500nm) and
shape, may have been degenerative or rounded surface ruffles. Similar changes in
surface ruffles have been found by other investigations, including cytomegalovirus-
infected (Bruggen et al., 1989), and lipopolysaccharide-treated macrophages (Kang
et al.,1992). These changes may be caused by cell depolarization or changes in
plasma membrane fluidity and the microfilament cytoskeleton (Jones, 1986). Other
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small uniform globular structures measuring 200-250nm which were present on the
surface of MVV-infected skin fibroblasts and MDM and are thought to be virions or
sites of viral budding similar to those seen in a previous report (Dubois-Dalcq et al.,
1976). In this report viral buds are covered by subglobular units which are thought
to be viral env proteins gradually being added to the viral surface (Sheffield, 1974;
Dubois-Dalcq et al., 1976), but these were not seen here. Viewing may be limited
by the resolution of the machine.
The size of viral particles measured by SEM is different to TEM. This may
be caused by differences in treatment of specimens, the angle of observation under
SEM or error in machine measurements. Different sizes from different methods of
viewing have been mentioned before (Dubois-Dalcq et al., 1976). Under TEM
observation there was only a small proportion of infected MDM showing sites of
viral budding at the cytoplasmic membrane (figure 3.8), however, about 50% of
MDM (6 days post infection) observed under SEM showed virions on their surface.
The difference may arise from the limited observation of cell numbers and cell
surface under TEM compared to greater numbers of cells and more cell surface
screened under SEM.
MVV infected cells fall into three groups by their patterns of viral budding.
These are viral budding from (i) cytoplasmic, (ii) cytoplasmic and vesicular and (iii)
vesicular membranes shown here by skin cells, MDM and AM respectively. The
pattern of viral budding of MVV in MDM (above) is somewhat different from
previous reports of HIV and other MVV isolates which accumulated in vesicles
(Narayan et al., 1982; Gendelman et al., 1988; Lairmore et al., 1987;
Schmidtmayerova et al., 1992). Research using CD4-bearing cells shows fusion of
HIV-infected MDM therefore viral env must be expressed at the cell surface (Crowe
et al., 1992), which suggests that HIV viral budding could be from the cytoplasmic
membrane of macrophages. Therefore, it is possible that budding from the
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cytoplasmic membrane by HIV may not be efficiently detected under TEM
observation.
The inverted form of viral buds at the cytoplasmic membrane of MDM
infected with strain 1514 has not been reported before. Whether a similar
phenomenon would also be found in other cultures such as skin fibroblasts and AM
infected with 1514 is not clear, but a normal budding form as seen here with EV1
has been reported in 1514 infected sheep choroid plexus cells (Dubois-Dalcq et al.,
1976, 1979). In comparison to EV1, strain 1514 has been highly passaged in tissue
culture which may have allowed mutation of the virus until these altered assembly
forms are seen. Mutant HIV strains which replicate in MDM generating various
aberrant viral budding structures and viral particles have also been reported
(Klimkait et al., 1990; Peng et al., 1989).
HIV replication and assembly in macrophages is different to that found in T
lymphocytes (Munn et al., 1985; Palmer et al., 1985; Orenstein et al., 1988).
Immunoprecipitation analysis of HIV proteins shows that in macrophages env
glycoprotein synthesis is greatly decreased compared to lymphocytes and that
virions released from macrophages have a relative lack of env compared to gag
(reviewed in Meltzer et al., 1990). Although MVV has a similar pattern of viral
replication and assembly in AM and skin fibroblasts as HIV has in macrophages and
T-lymphocytes, the results shown here suggest that env protein synthesis is not
affected by the host cell type in MVV. The proportion of env protein, gpllO,
assembled in virons or produced in cells was not accurately evaluated, but the clear
env viral protein band seen in AM lysates or supernatant virus is in direct contrast to
immunoprecipitation results from HIV infected macrophages. By electron
microscope study mature MVV virions released from both skin fibroblasts and AM
showed very short, faint spikes (figure 3.5.d & 3.6.c) on their surface which is
probably viral env protein.
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3.4 Summary
MDM, AM and skin fibroblasts were all permissive for infection by the
British isolate of MVV, EV1. Virus grew rapidly and produced high titers of virus
in skin fibroblasts and mature MDM. However replication was slower in less
mature MDM or AM.
TEM and SEM observation showed that EV1 not only buds at vesicular
membranes, but also at the cytoplasmic membrane of MDM. This is different to
MVV replication in AM which did not show budding at the cytoplasmic membrane.
ICA particles are evident in the cytoplasm of AM and MDM infected with strain
EV1, but not MDM infected with strain 1514. The morphological classification of
MVV as a type C or B or D of retrovirus, by ICA particle formation, budding form
and mature virion structure is therefore complicated by differences in viral strain or
infection of different cell types.
There were no gross defects in env protein synthesis in MVV-infected AM




PHENOTYPE OF OVINE MONOCYTE-DERIVED-
MACROPHAGES INFECTED WITH MAEDI VISNA VIRUS
PART B:
PHENOTYPIC CHANGES ON ALVEOLAR MACROPHAGES
IN SHEEP WITH MAEDI VISNA VIRUS INFECTION
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4.1 Introduction
The monocyte/macrophage lineage originates from haemopoietic stem cells
which subsequently develop into monoblasts or promonocytes in bone marrow. By
complex cytokine stimulation and regulation, these cells differentiate into
monocytes and are released into blood. Monocytes may remain in the blood for
36-104 hours and then emigrate into tissues. Subsequently, monocytes differentiate
and mature as resident macrophages (Beelen et al., 1989). These resident
macrophages have similar morphology and basic phenotype, but still display
considerable functional heterogeneity in response to the resident environment
(Beelen et al., 1989). Interleukin 3 (IL-3) and granulocyte-macrophage-CSF (GM-
CSF) have a broad specific activity on pluripotent stem cells leading to their
differentiation and proliferation (Schrader, 1986). For macrophages, IL-3 acts on
early progenitors which develop into mature cells of multiple lineages (granulocyte,
erythrocyte, monocyte and megakarocyte). Macrophage-CSF (M-CSF) and GM-
CSF act at a late stage to stimulate progenitors to develop into monocytes and
macrophages (Geissler et al., 1989; Eischen et al., 1991; Haig et al., 1990).
Over 90% of circulating human monocytes express HLA-DR, whereas, only
25-60% express HLA-DQ and DP (Gonwa et al., 1986). MHC class II on
monocytes is closely linked to antigen presentation (Unanue and Cerottini, 1991).
The leukocyte integrin family including LFA-1 (CDlla), CR3 (CDllb), P150/95
(CD 11c) and fibronectin receptor are major cell surface molecules on
monocyte/macrophages (Ross et al., 1989). Intercellular adhesion molecule-1,
ICAM-1, serves as the ligand for LFA-1 (Mackay and Imhof, 1993). Both
molecules are involved in stabilizing cell contact between macrophages and immune
effector cells to allow antigen presentation to lymphocytes (Mackay and Imhof,
1993). Both CD1 lb and CD1 lc molecules are specific for complement component,
C3b, and are involved in phagocytosis (Myones et al., 1988; Owen et al., 1992).
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Immunoglobulin Fc receptors (FcR's) are involved in phagocytosis and
endocvtosis (Fanger et al., 1989; Sarmay, 1992). FcyRI (CD64), FcyRII (CDw32)
and FcyRIII (CD 16) have been identified on monocytes and macrophages
(Anderson, 1989). Expression of these molecules on macrophages is enhanced by
IFN-yand IL-2 (Fanger et al., 1989; Fieagy et al., 1984; Gonwa et al., 1986; Nash et
al., 1992). CD14 is an important surface molecule of human monocytes and serves
as a receptor for LPS (Ziegler-Heitbrock and Ulevitch, 1993). This molecule on
human monocytes is down-regulated by IFN-y (Ziegler-Heitbrock, et al., 1992).
Monocyte/macrophages play a central role in viral persistence in both HIV
and MVV infection, but many functional studies of monocyte/macrophages in HIV
infection do not show conclusive results (Gendelman et al., 1989). Not only are
results controversial but many functional defects of monocytes during HIV infection
could be associated with the defect in T lymphocytes such that the generation of
cytokines, in particular, IL-2 and IFN-y is defective (Murray et al., 1984). There is
often variation in monocyte/macrophage phenotype amongst individuals as well as
in macrophages derived from different tissues. These differences may be related to
differences in function. Therefore the study of changes in monocyte phenotype
during culture may help to explain functional changes.
It has been reported that there is a decrease in HLA-DR expression in
monocytes from HIV-infected patients with AIDS (Heagy et al., 1984; Roy et al.,
1987). In addition, AM from ARC and AIDS patients did not express the normal
amount of class II and LFA-1 antigen on their surface when compared to the normal
controls (Roy er al., 1987; Bray et al., 1993). Documentation shows that there is a
great reduction in MHC class II expression and function of dendritic cells and
Langerhan's cells in HIV-infected patients with ARC and AIDS (Eales et al., 1988;
Belsito et al., 1984). In vitro, studies using the human promonocytic cell line U937
as a monocyte model have shown an increase in the expression of mature monocyte
surface markers, except for HLA class II antigens, after infection with HIV (Petit et
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al., 1987). It is thought that this has contributed to the immunosuppression of HIV
infection.
Although there are many biological similarities between HIV and MVV
infections, particularly in viral persistence (Narayan and Clements, 1989), the fate
of the surface molecules expressed on macrophages, in vivo, is different. It has been
shown that MHC class II expressed on the surface of AM from MVV-infected sheep
is significantly increased compared to uninfected sheep (Lujan et al., 1993; Cordier
et al., 1990). Similarly, an increase has been reported in macrophages in synovial
fluid from MVV-infected sheep (Kennedy-Stoskopf et al., 1989b; Harkiss et al.,
1991). Furthermore, a significant increase in spontaneous fibronectin released by
AM from maedi has also been described (Cordier et al., 1990). This suggests that
macrophages from MVV affected sites are activated rather than being decreased
functionally as in HIV. These differences are thought to be an indirect effect caused
by LV-IFN which is generated during MVV infections (Narayan et al., 1985; Zink
et al., 1989). However, the direct effect on surface molecules of macrophages after
infection with MVV in vitro is not clear. Therefore, a study of the changes in
surface molecule expression on cultured MDM infected with MVV and the
comparison with changes in AM from MVV-infected sheep was undertaken.
Surface molecule expression on cultured monocytes during maturation will also be




Part A: Phenotvpic Study of Monocyte-derived Macrophages
4.2.1 General observation of cultured monocytes during maturation in vitro
Gelatin-coated flasks or plates were used to culture monocytes from PBMC
as previously described in section 2.2.3. The numbers of monocytes recovered by
different culture methods were compared. Monocytes recovered from the flasks in
which non-adherent cells had been washed off after 1 or 2 hours incubation showed
high purity (70-80%) based on non-specific esterase staining, but low absolute
numbers after 3 to 5 days in the culture. In contrast, higher numbers but lower
purity monocytes were recovered in adherent cells from flasks in which PBMC had
been left overnight and then the non-adherent cells were removed. Many of the
contaminating PBMC were trapped on the flasks by fibrinous strands. After 5 to 7
days of culture, these fibrinous strands with the contaminating cells and other debris
could be easily removed from the flasks. The purity of monocytes recovered from
these cultures was near or over 95%, confirmed by Giemsa and nonspecific esterase
staining (figure 4.1). Monocytes cultured for 5-7 days markedly increased their size
and cytoplasm/nucleus ratio and also showed very strong nonspecific esterase (NSE)
activity compared to fresh monocytes. Mild to moderate proliferation of MDM
could be found in cultures, but it was very variable from culture to culture. If
present, this proliferation persist for 2-3 weeks and their cellular density in long
term cultures gradually decreased. Most macrophages from proliferating cultures
which had fallen off the flask could be passaged to another flask where they became
adherent. Using these methods, MDM could be continuously cultured for at least 3
months. However, fibroblast, epitheloid and syncytial cell contamination also
appeared in long term cultures which could interfere with experiments.
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Figure 4.1 Monocyte differentiation and maturation in culture
Monocytes were cultured in gelatin-coated flasks or 24-well plates in RPMI-
1640/10% FCS/10% LS as described in materials and methods (section 2.2.3).
A. Seven day cultured MDM, which looked confluent, were fixed in methanol
and stained with Giemsa's stain. The differentiated macrophages had a round or
spindle shape and a high cytoplasm/nucleus ratio. The spindle shaped macrophages
would become round in prolonged culture.
Magnification: x200
B. Seven day cultured MDM were non-specific esterase (NSE) positive using
a-naphthyl acetate (section 2.2.5). The NSE staining intensity was dependent on
the maturity of the macrophages. The maturity of the macrophages was also




4.2.2 Kinetics of surface molecule expression on cultured monocytes of sheep
Since the cultured MDM were variable in size, MDM were gated on a large
FSC and SSC area excluding lymphocytes and cell debris. Analysis of cell staining
from the FACS often uses a 1% gate set on negatively stained cells to calculate the
percentage of cells above this as positively stained cells with the antibody of
interest. Using the percentage positive cells to express the phenotype of MDM may
not reflect the actual situation, as with monocyte maturation there is an increase not
only in size, but also autofluorescence of the cells (Pankow et al., 1990). Due to
these factors, it was very difficult to separate positive and negative populations of
MDM, particularly where molecules were weakly expressed. Hence, the mean
fluorescence intensity (MF) of specific molecules with negatively stained
fluorescence (normal mouse serum, NMS) subtracted was used to express the
following data.
VPM32 is a monoclonal antibody which detects tissue macrophages, but not
monocytes or T and B lymphocytes (Gonzalez, 1988). The antibody is thought to
be specific for Fc-yRIII of macrophages (Gonzalez, 1988). With monocyte
maturation in vitro, the expression of VPM32 antigen were greatly increased from
day 3 (MF=34.8) until day 9 (MF=43.2) and decreased slightly on day 13
(MF=28.4) (Figure 4.2). Setting a 1% gate on NMS staining, the average number of
positive cells on day 9 were between 60% and 80% of cultured macrophages.
VPM19 is a monoclonal antibody specific for a monomorphic region of
MHC class I molecules which is expressed on most nucleated cells (Hopkins and
Dutia, 1990). Monocytes express class I throughout differentiation in vitro to
macrophages (figure 4.2) although the fluorescence intensity of staining and
therefore possible density of MHC class I on the surface appeared to decrease within
the first 3 days of culture to steady levels thereafter. VPM36 and VPM38 are
monoclonal antibodies specific for MHC class II DQ and DR a chains, respectively
(Dutia et al., 1990). The expression of MHC class II antigen was moderately high
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(MF=85.6; 60-80%) on fresh monocytes, but after 3 to 5 days in culture, the MHC
class II molecules were dramatically reduced such that less than 5% cells (MF=6.4)
were positively stained. Monocytes from sheep which had been primed with
antigen in complete Freund's adjuvant or monocytes cultured without removing the
lymphocytes (nonadherent cells) maintained a low to moderate density of MHC
class II expressing positive cells (10-30%) (data not shown). MHC class II DQ was
expressed in a similar manner and intensity as MHC class II DR on fresh and
cultured monocytes.
Fresh monocytes did not express either CD4 or CD8. After culture, they
gradually began to express both molecules on their surface (figure 4.2) with
maximal levels around day 7 in culture (MF: CD4=25.1; CD8=35.6) which began to
decrease after day 9. Apparently, more CD8 was expressed than CD4.
F10-150-39 (anti-LFA-1) and L180-1 (anti-LFA-3) monoclonal antibodies
stain lymphocytes, monocytes and macrophages. It was, therefore, difficult to
differentiate lymphocytes and monocytes in fresh PBMC using these monoclonal
antibodies. However, with the increased size and purity of cultured monocytes,
these monoclonal antibodies could be used to analyze the surface molecules on
MDM. The percentage of mature MDM positive for LFA-1 and LFA-3 on day 7-12
of culture was maintained between 50-60% (MF=46.2-54.4) and 70-80%
(MF=50.3-63.5), respectively (data not show). VPM 8 is a monoclonal antibody
specific for Ig L-chain (Dr. P. Bird; personal communication). The number of
VPM8 positive cells decreased during monocyte maturation, but at the end of the
culture on day 13, 15% (low intensity) of cultured MDM were still positive for
VPM8 antigen. However, the intensity varied greatly between cultures (data not
shown). Another monoclonal antibody, VPM65, has been newly developed in the
Department and reacts to the CD 14 molecule, the LPS receptor, on
monocyte/macrophages (Gupta et al., 1993). Both fresh monocytes and cultured
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Figure 4.2 Phenotype of cultured monocytes
Monocytes from uninfected sheep were cultured in gelatin-coated flasks as
previously described (section 2.2.3). Non-adherent cells were removed after 2
hours (for day 0 assay) or overnight. Adherent cells (monocytes) were harvested on
designated days by treating cells with 5mM EDTA in PBS. Cells were counted and
stained with monoclonal antibody (as indicated) and then rabbit anti-mouse IgG,
F(ab)2 fragment-FITC conjugate. Cells were analyzed immediately by flow
cytometry.
The results have been expressed as mean fluorescence intensity (MF) which





































































































MDM showed a moderately high intensity (MF=51.4 on day 7) of staining for the
LPS receptor without much change during culture (data not shown).
4.2.3 Regulation of the MHC class II phenotype of cultured macrophages
We were interested in using MDM in antigen presentation assays and so the
loss of MHC class II expression during culture was unfortunate. It was therefore
decided to see if MHC class II expression could be induced easily on cultured
MDM. A crude Con A-supernatant generated from cultured lymphocytes from the
mesenteric lymph node (section 2.7.3) was used to activate cultured MDM. In this
experiment MDM were cultured as previously described and then different
concentrations of Con A-supernatant (10%, 25%, 50%, and 75% v/v) were added to
the MDM culture for 1 to 3 days and cells harvested for phenotypic analysis. A
representative profile is shown in figure 4.3. Results show that the crude Con A-
supernatant (50% v/v) greatly enhanced MHC class II expression (MF: DQ=38.41;
DR=44.63) after 2 days treatment, compared to untreated MDM (MF: DQ=5.5;
DR=13.8). Treatment of the cells with Con A-supernatant for 1 day only slightly
enhanced MHC class II density on MDM. Treatment for 3 days did not greatly
improve class II expression over 2 days treatment (data not shown). In addition,
MDM treated with phytohemagglutinin (PHA; 10p.g/ml) or Con A (5|ug/ml) alone
for 2 days did not enhance MHC class II expression (data not shown). Con A-
supernatant slightly enhanced MHC class I expression on MDM, but the intensity of
CD8 molecules expressed on cultured MDM was slightly decreased. Other
molecules including LFA-1 and LFA-3 were not affected (Figure 4.3).
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Figure 4.3 Regulation of surface molecule expression on cultured MDM by
Con A-supernatant
Con A-supernatant was prepared from the culture supernatant of mesenteric
lymph node stimulated with 5(lg Con A/ml for 2 days as described in section 2.7.3.
Twelve-day cultured MDM were fed with 50% Con A-supernatant (v/v) for 2 days.
Cells were harvested and stained with monoclonal antibodies as previously
described (section 2.7.2). A: NMS; B: VPM19 (anti-MHC class I); C: SBU-T8
(anti-CD8); D: VPM36 (anti-MHC class II DQ); E: F10-150-39 (anti-LFA-1); F:
VPM38 (anti-MHC class II DR).
The unshaded area ( □ ) shows cultured MDM and the shaded area ( ■ )




4.2.4 Affect of MVV infection on MDM phenotype
Two methods were used to look at the effect of MVV infection on MDM
phenotype. In the first experiment, MDM were infected with MVV, 1 TCID50 per
cell, on day 3 of culture, then virus-infected and mock-infected MDM were
harvested for phenotypic analysis every 2 days (data not shown). There was often
variation in the expression of CD4, CD8, MHC class I and VPM32 antigen at 2 days
postinfection, but this included both increased and decreased levels of expression.
After 4 days postinfection, the fluorescence intensity of most surface molecules on
MVV-infected MDM was similar to those found on mock-infected MDM. More
than 4 days post infection, most surface molecules, especially MHC class I, CD8
and anti-VPM32 antigen were greatly decreased, this could be by up to 30-40% on
7-8 days MVV-infected MDM compared to the uninfected control. However,
owing to the great variation in surface molecule staining in different cultures, these
results did not show statistically significant differences between virus-infected and
mock infected MDM (data not show). Both MVV and mock infected MDM were
negative for MHC class II expression unless given prior treatment with Con A-
supernatant.
Previous observations of MDM-infected with MVV (chapter 3) have shown
that after 6 days there is a lytic infection of MDM such that most cultured MDM are
gradually lost. In the above experiment, it was difficult to get enough cells for flow
cytometric analysis in late MVV-infected cultures. Moreover, the decreased
expression of surface molecules 7-8 days postinfection was probably due to cell
death caused bv productive replication of virus within cells. Therefore, a second
experiment was designed to address the early phenotypic changes on MDM infected
with MVV. In this experiment monocytes were cultured then infected with MVV
on day 7, 9, 10, and 11 individually. Some cultures were also infected with MVV
as early as 5 days. Antigen expression on MVV and mock infected MDM was then
analyzed on the same day, day 12. The results are shown in table 4.1 and figure 4.4.
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Expression of most surface molecules including CD4, CD8, VPM32, MHC
class I and MHC class II on infected MDM was not significantly altered up to 5
days post infection (table 4.1). However, some experiments showed a tendency for
surface molecule expression to increase slightly at early times after infection (up to
3 days post infection). After 7 days postinfection, some surface molecules,
especially VPM19 and VPM33 which were highly expressed on cultured MDM,
were greatly decreased at the cell membrane about 30-40% of values of mock-
infected MDM (data not shown).
4.2.5 Detection of virai antigens expressed on the cell surface and in the
cytoplasm by flow cytometry
In order to study the relationship between phenotype alterations and viral
antigen expression on MDM, viral antigen (gag pl5) expressed on the cell surface
or within the cytoplasm accumulated intracytoplasmically was assayed using flow
cytometry. Viral antigen (pi5) expressed on the cell surface was detected on
unfixed cells as previously described (section 2.7.2). Detection of internal viral
antigen was performed by fixing cells in 80% methanol. MVV-infected MDM did
not express gag antigen on the cell surface up to 4 days postinfection (figure 4.5 E).
However, at 6 days postinfection, a small population (14%) of MDM express gag
antigen on their surface (figure 4.5.F). In contrast, internal viral antigen (p 15) could
be detected as early as 3 days postinfection (6.7%, data not shown). By 6 days
postinfection. 65% of MDM were positive for p 15. Interestingly, MVV-infected
AM did not express gag antigen (pi5) on their surface after 7 days postinfection,
but more than 60% AM showed internal antigen (pi5) (data not shown). In
contrast, skin cells express viral antigen (pi5) weakly on their surface by 4 days
post infection (figure 4.5 B), but cytoplasmic gag antigen was strongly expressed as
early as 2 days postinfection (figure 4.5 C).
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Figure 4.4 Affect of MVV infection on MDM phenotype
MDM were cultured in gelatin-coated T-25 flasks and then infected with
MVV, 1 TCID50 per cell on day 7, 9, 10, and 11, respectively. On day 12 MDM
were harvested and stained with a panel of monoclonal antibodies: SBU-T8 (anti-
CD8), VPM19 (anti-MHC class I); VPM38 (anti-iMHC class II DR), VPM32,
VPM33, and F10-150-39 (anti-LFA-1) as indicated and subsequendy with rabbit
anti-mouse IgG, F(ab)2 fragment-FITC conjugate as described in materials and
methods (section 2.7.2).
This is a representative profile of 5 separate experiments. Negative control
staining was uninfected MDM stained with NMS (dense dotted line; ) and
has been shown with MVV-infected (solid line; ) and uninfected (loose
dotted line; ) MDM stained with specific monoclonal antibodies.
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FREQUENCY





1 day 2 days 3 days 5 days
CD4 10.9 ±3.1* 12.0 ± 1.2 17.4 ±4.9 14.2 ±5.5 7.3 ±6.0
CD8 29.7 ± 6.9 32.4 ±6.1 38.7 ±7.9 40.0 ± 8.0 23.4 ±4.3
MHC classl 70.8 ±7.3 73.0 ±8.2 80.9 ±9.8 74.0 ± 11.7 63.7 ±8.5
MHC classll
(DR)
10.4 ±14.4 13.1 ±6.0 5.2 ±7.0 5.9 ±4.3 1.2 ± 10.2
LFA-1 47.4 ± 10.3 52.0 ±6.9 50.9 ± 6.72 51.9 ±6.9 46.2 ± 13.9
LFA-3 51.4 ±6.0 54.5 ± 8.6 55.5 ±5.14 51.3 ±7.1 45.8 ± 14.9
VPM32 antigen 39.4 ±5.0 41.9 ±6.9 44.5 ± 13.9 46.4 ±8.4 37.6 ±7.9
VPM33 antigen 72.5 ± 2.6 77.2 ± 15.9 78.5 ± 18.1 68.2 ±9.2 52.2 ±9.6
* Data (mean + sd) are expressed as mean fluorescence intensity (MF) where
negative control fluorescence (NMS control) has been subtracted. Data were collected from
5 separate experiments.
** Cultured MDM on day 7, 9, 10, and 11 were infected with MVV, 1 TCID5Q per cell,
and analyzed on day 12.
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Figure 4.5 Expression of viral antigen (gag pl5) on the cell surface or in the
cytoplasm of MDM and skin fibroblasts
Cell surface (external) gag antigen was detected on skin fibroblasts and
MDM blocked with 2% normal rabbit serum and normal sheep serum in PBSA and
then stained with monoclonal antibody, 415, followed by rabbit anti-mouse IgG,
F(ab')2 conjugate as described in section 2.4.2. In contrast, cells initially fixed in
80% methanol, blocked with 2% normal rabbit serum and 2% normal sheep serum
in PBSA and then stained with monoclonal antibody, 415, followed by FITC
conjugate, were used to detect viral antigen in the cytoplasm (internal). Both
groups of stained cells were analyzed by flow cytometry.
The upper panel shows skin fibroblasts (A-D) infected with MVV, 0.5
TCID50 per cell and the lower panel shows MDM (E-F) cultured for 7 days,
infected with MVV, 1 TCID50 per cell. Infection times are indicated on the figure.
Negative staining with an irrelevant mouse IgG2a monoclonal antibody is
shown by the unshaded area (□) with staining for gag p 15 shown by the shaded
area (■). A 1% gate was set on the negatively stained cells and the percentage cells
staining positive for gag above this is shown in each panel.
A & B: skin fibroblasts with external gag antigen.
C & D: skin fibroblasts with internal gag antigen.
E & F: MDM with external gag antigen.
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4.2.6 Comparison of the alveolar macrophage (AM) phenotype from MVV-
infected and uninfected sheep
In this study lungs from the majority of experimentally infected sheep
(13/16) did not show gross pulmonary lesions, whilst those from naturally infected
sheep (5/5) showed mild to marked interstitial pneumonia. The lungs with lesions
were larger, firmer and heavier than normal lungs. They had a reddish-pink hue
with multiple gray foci or were a diffuse gray in color. Control sheep were
experimentally culled sheep without infection and showed no gross pulmonary
lesions. MVV infected and control sheep were not age and breed matched.
AM from MVV infected sheep, either with or without pulmonary lesions,
showed significant increases in the surface expression of MHC class II, DQ and DR,
compared to uninfected control sheep (table 4.2 and figure 4.6). AM from lungs
showing lesions also had a significantly increased MHC class I expression.
However this difference was not seen on AM from lungs without gross lesions
(table 4.2, figure 4.6).
AM also expressed LFA-1 and LFA-3. LFA-1 expression significantly
increased on AM from lungs with lesions but not on those from lungs without
lesions (table 4.2, figure 4.6). LFA-3 expression was unaltered by MVV infection
(data not shown). VPM32 staining on AM was very low and showed no change in
MVV infected sheep. AM were negative for CD4, CD8 and T19 molecules (data
not shown).
4.2.7 Changes in the CD4/CD8 lymphocyte ratio in bronchoalveolar lavages
from MVV-infected sheep
Using FSC and SSC parameters to gate on small lymphocytes, the CD4 and
CD8 T lymphocyte population was also studied in BAL's. By using the percentage
positive lymphocytes to calculate the CD4/CD8 ratio it was shown that there was a
statistically significant decrease in the CD4 : CD8 ratio in MVV-infected sheep with
lung lesions compared to uninfected sheep (table 4.2). Most MVV-infected sheep
with pulmonary lesions showed a decrease in the CD4 : CD8 ratio (< 1), but the
ratio in MVV-infected sheep without pulmonary lesions was variable (ranged from
0.4 - 5.4). In contrast, the CD4 : CD8 ratio of lymphocytes from normal lungs were
consistently higher than 3.
4.3 DISCUSSION
4.3.1 Phenotypic expression of cultured MDM
In vivo the migration of monocytes into tissues results in the generation of
organ-specific populations of resident macrophages which show different
phenotypes and functions (Andreesen et al., 1990). For example AM express high
MHC class II levels, but low levels of CD 14, whilst peritoneal macrophages show
low MHC class II levels but have high CD14 expression (Andreesen et al., 1990).
The factors attributing to these differences in vivo may be intrinsic differentiation
pathways of monocytes influenced by organ specific microenvironments. In vitro, it
is possible to alter culture conditions (by the addition or absence of serum, growth
factors or cytokines) to grow monocytes in different differentiation states and
showing different levels of surface antigen expression and function (Geissler et al.,
1989; Eischen et al., 1991: Kreutz et al., 1992). The in vitro states are therefore
comparable to different organ specific macrophages seen in vivo.
Serum contains many factors important for monocyte differentiation in vitro.
In fact monocytes cultured in the absence of serum cannot mature and die in culture.
They can, however, be rescued by the addition of growth factors (Geissler et al.,
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Figure 4.6 Phenotype of AM from MVV-infected sheep
lxlCP AM were stained with monoclonal antibodies followed by anti-
mouse IgG, F(ab)2 conjugate as previously described in section 2.7.2.
This is a representative profile of surface molecule expression of AM from
MVV-infected sheep with pulmonary lesions compared to uninfected controls. The
unshaded area (□) indicates AM stained with normal mouse serum, whilst, the
shaded area (■) shows AM stained with specific monoclonal antibodies. VPM36,
anti-MHC class II DQ (A & E); VPM38, anti-MHC class IIDR (B & F); VPM19,








































































































































































1989; Eischen et al., 1991; Kreutz et al., 1992). Indeed, GM-CSF will increase
surface antigen expression of CR3 and FcyllR, phagocytic ability, cytotoxicity and
TNF secretion of macrophages (Eischen et al., 1991). GM-CSF treated human
MDM exhibit low grade proliferation (Elliott et al., 1989), but GM-CSF stimulates
mouse MDM proliferation (Chen et al., 1988).
Other factors which are also present in serum are cytokines. IFN-y is a very
important cytokine which can activate macrophages and increase MHC class II DR,
MHC class I and FFA-1 surface expression (Gonwa et al., 1986; Watanabe et al.,
1991; Nash et al., 1992), but it restricts monocyte maturation (Andreesen et al.,
1990) Another cytokine, TNF-a, acts as a potent stimulator of monocyte
differentiation in myeloid leukemia cell lines, but TNF-a acts as an antagonist to
IFN-y to decrease MHC class II expression on mature monocytes (Watanabe et al.,
1991, Gonwa et al., 1986).
In the experiments shown, monocytes were grown in high serum
concentrations (10% FCS and 10% FS) to allow growth and differentiation of the
monocytes in vitro. However, these serum concentrations were not enough to
overcome the loss of MHC class II expression in vitro. A similar result in cultured
human monocytes has been reported (Szteinet et al, 1984). However, cultured
human monocytes in teflon bags (suspension), in the presence of GM-CSF
persistently express MHC class II DR for 2 weeks (Eischen et al., 1991) suggesting
that adherence to plastic may down-regulate MHC class II expression. In vivo,
activated T-helper cells secrete IF-2 which has been thought to be the primary
stimulus causing IFN-y release from immune T cells (Torres et al., 1982) which
could then act on monocytes to allow MHC class II expression. In vitro, cultured
MDM do not come into contact with activated lymphocytes. Con A-supernatant
from activated lymphocytes used in this experiment may very well have contained
IFN-y which would explain the enhanced expression of MHC class II (both DR and
DQ) molecules. But the Con A supernatant did not greatly increase MHC class I
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and LFA-1 expression as is seen with human monocytes stimulated by recombinant
IFN-y (which causes an induction of specific mRNA) (Nash et al., 1992). The
difference may be due to the presence of other factors within the Con A-supernatant
acting against monocyte activation (in a similar manner to TNF-a) or the fact that
the cultured ovine monocytes showed high levels of expression of MHC class I and
LFA-1 which may be maximal without further stimulation.
Low levels of expression of CD4 molecules have been reported on human
monocytes and cultured MDM (Collman et al., 1990) and support for its expression
comes from the fact that CD4 acts as a receptor for HIV infection allowing infection
of macrophage. (Kazazi et al., 1989; Collman et al., 1990; Crowe et al., 1992).
However, expression of CD4 on sheep monocytes and cultured MDM has not been
studied in depth. The experiments reported here show that fresh sheep monocytes
and AM did not express CD4 molecules on their surface, but low intensity staining
for CD4 molecules was seen after short term culture. The difference between CD4
expression on human and sheep monocytes is not understood, but may be a lower
intensity of staining in the ovine system. However, internal and surface CD4
expressed on 7 day cultured MDM have been reported in humans (Collman et al.,
1990). Perhaps, ovine monocytes contain internal CD4 and it and/or newly
synthesized CD4 is expressed on the surface after culture. Moderate intensity
staining for CDS molecules was seen on MDM with similar kinetics of expression
as CD4, but the biological significance of CD8 expression on MDM is not clear. A
low percentage (10%) of fresh human monocytes expressing CD8 has been reported
(Moebius, 1989). In addition, here, CDS and MHC class II were inversely
expressed on cultured MDM and Con A-supernatant activated MDM, but the reason
for this is unknown. However, a similar inverse expression of MHC class II and
CD 14 on AM and peritoneal macrophages has been reported (Andreesen et al.,
1990). Some molecules such as FcyRIII (CD16), a-chain of vitronectin (CD51),
Maxl and Max3 are not expressed on fresh human monocytes, but are gradually
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expressed on mature macrophages (Eischen et al., 1991) which is similar to the
pattern of expression of VPM32 antigen and CD8 expression on cultured monocyte
here.
4.3.2 Expression of surface antigens on MVV-infected MDM in vitro
Immature monocytes limit MVV replication (Narayan et al., 1983) and so
monocyte cultures were not productively infected with MVV until they had
differentiated. Three day cultured monocytes underwent phenotypic changes but
did express VPM32 antigen, CD4 and CD8 and stable levels of MHC class I
although MHC class II was still detectable. They were therefore considered to be
macrophages and were used for infection with MVV. However, changes seen after
infection were variable and so it was difficult to say whether they were caused by
MVV infection, restriction of MVV infection or further differentiation of the cells
with time in culture.
Seven-day cultured MDM have completely differentiated into macrophages
(as defined by morphology, non-specific esterase staining and stable surface antigen
expression). There was no significant difference in surface molecule expression on
MVV infected and mock infected MDM up to 5 days post infection. However in
some cultures there was enhanced expression of surface antigen early after viral
infection. MDM may therefore increase their functional and biological activities in
response to viral stimuli early in infection, but these changes were not further
amplified by a cascade reaction due to the lack of lymphocytes in the cultures. The
interaction of infected macrophages and lymphocytes may produce LV-IFN and
enhance surface antigen expression as seen in vivo (Lairmore et al., 1988a; Kennedy
et al., 1985). A similar phenomenon of enhanced antigen expression has been seen
in AM infected with parainfluenza virus type 3 (Gonzalez, personal
communication). There was no loss of surface antigen from MDM up to 5 days
post infection with MVV (table 4.1), but by 7-8 days post infection degenerative
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changes including a decrease in surface antigen expression was seen. This is
probably due to productive replication of the virus as this is supported by the
detection of viral antigen in the cytoplasm (figure 4.5). The kinetics of the changes
also coincide with surface changes seen in MVV-infected MDM observed under
transmission and scanning electron microscopy (chapter 3).
Fc receptors are important surface molecules for monocytes and
macrophages. These receptors participate in phagocytosis, antibody-dependent cell-
mediated cytotoxicity (ADCC) and superoxide production (Anderson, 1989; Jungi
et al., 1990; Sarmay,1992 ). VPM32 is thought to be specific for FcyRIII
(Gonzalez, 1988). MVV-infected MDM showed no decrease in the surface
expression of VPM32 antigen 5 days postinfection.
In contrast, the HIV-infected (chronic) monocyte-like cell line (U937) shows
decreased expression of CD4 (Mann et al., 1990a) and MHC class II, but increased
expression of LFA-la (CDlla) and (3 (CD18) on the surface (Petit et al., 1987;
Mann et al., 1990a). In HIV-infected MDM, HLA-DR increased, HLA-DQ
decreased, and HLA-DP was unchanged (Mann et al., 1990a). A different study has
shown that H9 cells after infection with simian immunodeficiency virus (SIV) in
vitro (chronic infection) increase MHC class II antigen expression on their cell
surface. This was caused directly by viral infection, not mediated by IFN-y activity
(Kannnagi et al., 1987). The difference between results seen here and those with
HIV and SIV may be due to the chronic (non lytic) infection seen with these two
viruses, whilst MVV causes a lytic infection of MDM. Comparison to human T
cells productively infected with HIV may be more real and these show decreased
expression of CD2, CD3, CD4, CD8, CD11 and MHC class I (Stevenson et al.,
1987; Scheppler et al., 1989).
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4.3.3 Phenotypic expression on fresh AM from MVV-infected and control
sheep
The results shown in this study are similar to those in previous reports,
especially the increased expression of MHC class I and II on AM, and the decrease
in CD4 : CD8 lymphocyte ratios in lungs from MVV-infected sheep (Cordier et al.,
1992-, Nash et al., 1992 ; Lujan et al., 1993). The increased amount of MHC class II
on the AM surface in MVV-infected sheep may reflect local specific immune
responses in the lung or just a local inflammatory reaction. Most studies report that
MHC class II expression on monocytes and AM from HIV infected patients with
AIDS is decreased compared to normal individuals, but unaltered in HIV infected
patients with ARC (Heagy et al., 1984; Sei et al., 1986; Roy et al., 1987; Bray et
al., 1993). This suggests that the decrease in the CD4 T cell population in AIDS
patients may indirectly influence MHC class II expression on
monocyte/macrophages perhaps through the action of EFN-y. IFN-y is found in the
serum of HIV-infected patients which may help maintain or upregulate the MHC
class II expression on circulating monocytes/AM from ARC patients (Roy et al.,
1987). However, IFN-y production in HIV-infected patients with AIDS is impaired
(Murray et al., 1984), which may allow the downregulation of MHC class II
expression on circulating monocytes of AIDS patients. A similar decrease in LFA-1
expression in monocytes is also seen in ARC and AIDS patients (Roy et al., 1987).
In addition, increasing FcyRI expression on monocytes parallels elevated serum
IFN-y concentrations in HIV seropositive patients (Capsoni et al., 1992).
Although monocyte/macrophages are the predominant target cells of MVV
the in vivo infection is not usually lytic but is persistent. In situ hybridization for
viral RNA indicates that a large number of AM from MVV-infected sheep were
infected (15% of AM, 2 weeks post infection) (Gendelman et al., 1985), but that
viral replication in AM is strictly restricted, with only a small amount of virus being
produced (Gendelman et al., 1985; Haase et al., 1986). This has been confirmed on
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freshly prepared cytosmears of BAL cells from naturally MVV-infected sheep in
which 1-3 cells in 200- 300 cells were positive for gag p 15 (data not shown).
Therefore, the great increase in MHC class II molecule expression on AM may not
be caused by virus infection in these cells. LV-IFN, known to be produced when
lymphocytes are cultured with MVV-infected macrophages (Kennedy et al., 1985;
Lairmore et al, Zink et al., 1989) may mediate the increase in AM class II
expression as it has biological activities similar to IFN-y (Narayan et al., 1985). In
addition, it has been reported that there is a marked increase in the number of
lymphocytes and neutrophils in interalveolar tissue and BAL in maedi (Cordier et
al., 1992; Watt et al., 1992b; Lujan et al., 1993). These express more MHC class
II (Cordier et al., 1992), but not CD5 antigen (Watt et al., 1992b) which suggests
that these alveolar lymphocytes are activated. Therefore, the activated lymphocytes
may release more cytokines as well as LV-IFN, which can enhance MHC class II
expression on AM. A similar phenomenon is also seen on macrophages in MVV-
induced arthritis (Kennedy-Stoskopf et al., 1989b; Harkiss et al., 1991).
Another important phenomenon noted in BAL cells from MVV-infected
sheep with pulmonary lesions is a decrease in the CD4 : CD8 lymphocyte ratio.
This is similar to the effect found in HIV infected patients with AIDS (Giorgi et al.,
1989: Davidson et al., 1988). However, in HIV infected patients with ARC and
AIDS, the change in CD4 : CD8 lymphocyte ratio is attributed to the depletion of
the CD4+ subpopulation. In contrast, the decrease in CD4 : CDS lymphocyte ratio
in BAL cells from MVV-infected sheep does not result from a decrease in the CD4+
cell subpopulation, as CD4+ lymphocytes are not a target cell for MVV and most
groups do not see a decreased CD4+ T cell population in the blood of MVV infected
sheep. Cordier et al (1992) also reported a relative increase in the numbers of CD8+
lymphocytes in BAL fluid in naturally infected sheep, but not in experimentally
infected sheep. Moreover, they found more CD4+ lymphocytes than CD8+ cells in
lymphoid nodules in lungs of MVV-infected sheep (Cordier et al., 1992). Therefore
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the decrease in CD4 : CD8 ratio may not only arise from an accumulation of the
CD8+ lymphocyte subset, but may also be partially attributed to a redistribution of
CD4+ lymphocytes between alveoli and nodules (Cordier et al., 1992). A decrease
in the CD4 : CD8 lymphocyte ratio has also been reported in synovial fluid from
joints with MVV induced arthritis (Kennedy-Stoskopf et al., 1989b; Harkiss, et al.,
1991), but not in asymptomatic sheep (Lairmore et al., 1988) and in the CSF of
MVV infected sheep (Torsteinsdottir et al., 1992). The increase in the CD8+
subpopulation in the lung may reflect an increase in cytotoxic activity of specific
cells which eliminate MVV-infected AM. However, whether persistently infected
AM can act as target cells for CTL's is still uncertain.
Increasing neutrophil chemotactic activity (NCA) and fibronectin release
from AM has been reported in MVV-infected sheep (Cordier et al., 1990) which
implies that some functional changes occur in AM of MVV-infected sheep. In this
study the majority of experimentally infected sheep did not show gross lesions in
their lungs. This may be due to their young age and short infective course when
compared to naturally infected sheep. Moreover, the change in MHC class II
expression on AM, CD4 : CD8 lymphocyte ratio or cell numbers in BAL coincides
closely with pulmonary lesions. This suggests that the accumulation of CD4 and
CD8 lymphocytes and neutrophils in BAL is initiated by a chemotactic activity
released by MVV-infected AM (Cordier et al., 1990). Afterward, these activated
lymphocytes may secret IL-2 and IFN-y or LV-IFN to activate AM and so increase
MHC class II, class I and LFA-1 expression. This cycle may be repeated and
gradually amplified many times during the long time course of the disease. A great
number of activated macrophages and their products, in particular IL-1, TNF-a, and
fibronectin (Cordier et al., 1990) accumulating in the lung may lead to interstitial
pneumonia which interferes with normal pulmonary physiological functions.
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4.4 Summary
Cultured sheep monocytes from blood induced the expression of some cell
markers, such as CD4, CD8, and FcyRIII (VPM32 antigen) which are not expressed
on fresh monocytes. These differentiated MDM also showed a greatly decreased
MHC class II molecule expression after 3-5 days in culture. However, MHC class
II could be re-expressed at the cell surface after treatment with Con A activated
lymphocyte supernatant.
In vitro, early after MVV infection (first 3 days), most surface molecules
including CD4, CD8, MHC class I and class II showed slightly enhanced
expression, which may be similar to that seen on HIV persistently infected
macrophages. Up to 5 days post infection MVV made no statistical difference to
MDM surface antigen expression. But by 7 days post infection degenerative
changes occurring due to the lytic nature of the infection caused generalized loss of
surface antigen expression.
MHC class I, class II and LFA-1 expression on AM from MVV-infected
sheep, especially those with maedi, were greatly enhanced compared to uninfected
control sheep. Furthermore, the CD4 : CD8 lymphocyte ratio in BAL from MVV-
infected sheep was greatly decreased.
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CHAPTER 5
PART A: IN VITRO STUDIES ON THE PHAGOCYTIC ACTIVITY
OF CULTURED MONOCYTE-DERIVED-MACROPHAGES
INFECTED WITH MAEDI VISNA VIRUS
PART B: STUDIES ON THE PHAGOCYTIC ACTIVITY OF
MONOCYTES AND ALVEOLAR MACROPHAGES FROM MAEDI
VISNA VIRUS INFECTED SHEEP
115
5.1 Introduction
Macrophages are programmed with a wide range of biological functions,
predominantly to regulate the immune response of lymphoid cells (Harding et al.,
1988; Weaver and Unanue, 1990; Unanue, 1992) and the nonspecific effector
capacity of the body against invading microorganisms (Nathan, 1986).
Macrophages exist throughout the body, but their functions are somewhat
heterogeneous, depending on the microenvironment in which they are found (Brain,
1992). Chemotactic, phagocytic and microbicidal activities are basic functions of
monocyte/macrophages migrating into inflammatory areas against invading
microorganisms. Both Fey and C3b receptors on the cell surface of monocytes,
macrophages and neutrophils mediate their phagocytic activity (Hed and Stendahl,
1982; Jungi et al., 1990; Sarmay, 1992). Therefore, analysis of Fc receptors and
phagocytosis is commonly used to study the effector function of macrophages and
their contribution to the pathogenesis of disease.
HIV induces the depletion of T lymphocytes which is a central feature of
immunosuppression (Bowen et al., 1986; Fauci 1988; Lifson and Engleman, 1989;
Geelen and Goudsmit, 1991). Monocytes expressing CD4 molecules also act as
target cells for HIV infection and become a reservoir of viral persistence after
infection (Lifson et al., 1989; Collman et al., 1990; Schmidmayerova et al., 1992)
which may contribute to the immunosuppression seen during HIV infection.
Defects in chemotaxis, phagocytosis and the bactericidal capacity of monocytes
have been reported in HIV-infected patients with AIDS-related complex (ARC) or
AIDS (Smith et al., 1984; Bowen et al., 1986; Wahl et al., 1989) although they vary
from study to study. Loss of macrophage function may contribute to infection of
AIDS patients suffering by opportunistic pathogens. However, functional defects in
monocytes are usually not found in HIV-infected asymptomatic patients. Most
functional defects in monocytes are attributed to the depletion of CD4+ T cells in
AIDS patients (Bowen et al., 1986) rather than a direct defect at the monocyte level.
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Clinically, immunosuppression in MVV-infected sheep is not a common
feature (Georgsson et al., 1990) which suggests that macrophage function may not
be defective during MVV infection. This may be because only a small proportion
of macrophages are infected (Gendelman et al., 1985) or the fact that there is no
depletion of CD4+ cells in MVV infection and so no loss of T cell help for
macrophage function. However, in field studies, concurrent bacterial infections are
often found in MVV-infected sheep with interstitial pneumonia. (Cutlip et al., 1977;
Markson et al., 1983; Myer et al., 1988). In vivo, a decrease in the delayed type
hypersensitivity response to PPD has been reported in MVV-infected sheep which is
also thought to be a defect at monocyte level. (Dr. P. Bird, personal communication;
Myer et al., 1988). However, the functional capabilities of monocytes and
macrophages during MVV infections in vivo or in vitro are poorly documented.
Alveolar macrophages (AM) contribute to primary non-specific defense
mechanisms against invading microorganisms in the lung. Many viral infections of
the respiratory tract result in changes in the phagocytic and bactericidal activity of
AM which may lead to concurrent bacterial infection (Fuentes, 1986; Boschert et
al., 1988). Some functional activities of AM including fibronectin release and
neutrophil chemotactic factor activity are activated during MVV infection (Cordier
et al., 1990). LV-IFN has similar biological activities to IFN-y (Narayan et al.,
1985; Zink et al., 1987) and may be the cause of the above activation and enhanced
MHC class II expression on AM (Kennedy et al., 1985; Cordier et al., 1990). This
evidence suggests that the functional activity of AM in MVV-infected sheep may be
enhanced. However superinfection with Pasteurella spp in maedi suggests the
opposite, a defect in pulmonary defence mechanisms occurring in some MVV-
infected sheep.
Results in the previous chapters have shown that cultured MDM infected
with MVV do not show significant changes in surface molecule expression (chapter
4). This does not mean that effector functions are unaltered in these macrophages.
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Therefore, the phagocytic function of monocyte/macrophages during MVV
infection in vitro and in vivo was studied. The results clearly show that the
phagocytic capacity of MVV-infected MDM, in vitro, was markedly decreased after
5 days postinfection, whilst the Fc receptor expression on MVV-infected MDM
assayed by erythrocyte rosetting was not significantly changed. In contrast, the
phagocytic activity of AM from MVV-infected sheep without lung lesions for
opsonized bacteria is greatly enhanced, but that this activity may gradually become
defective in MVV-infected sheep as pulmonary lesions develop.
5.2 Results
PART A: In vitro Phagocytic Capacity of MVV-infected MDM
5.2.1 Kinetics of phagocytosis of particles by MDM
Using FITC-labelled particles as subtracts for phagocytosis, it was possible
to use flow cytometry to analyze phagocytic activity. The time of incubation and
the concentration of FITC-labelled particles used in phagocytic assays were titrated
in preliminary experiments. Most yeast and opsonized bacteria were bound and
ingested by the MDM within 30 minutes at 37°C with only a slight increase with
longer incubation times. Therefore a one hour assay was used. Phagocytosis of
P. hemolytica by MDM was greatly affected by the bacterial concentration which
was fed to the cultures (figure 5.4.A). High bacterial concentrations were toxic to
the MDM which became granular and gradually detached from growing surfaces.
Furthermore, opsonization was very important for phagocytosis of P. hemolytica
and RBC. Different concentrations of antiserum also affected how well the
opsonized particles were phagocytized (data not shown). In contrast, it was not
necessary to opsonize yeast used in the phagocytic assay.
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Figure 5.1 Phagocytosis of sheep RBC by cultured MDM
A. Sheep RBC were washed in PBS, opsonized with rabbit anti-SRBC
antiserum (1 : 40) and then resuspended to 1% in RPMI/2%FCS medium as
described in section 2.8.3 . Cultured MDM (day 12) were fed with 50 |il of 1%
opsonized SRBC in a final volume of 250(0.1 RPMI/2%FCS medium for 1 hour at
37°C. Non-absorbed RBC were removed and external RBC were hypotonically
lysed with distilled water for 30 seconds and then cells were immediately saturated
by 2x PBS. Cells were fixed in methanol and then stained with Giemsa's solution
and observed by a light microscopy.
Magnification: x500
B. As (A), except the RBC were pre-labelled with FITC in PBS (section 2.8.2)





The fluorescence intensity of MDM was related to the number of FITC-particles
which were bound to the cell surface or ingested by the cells. The phagocytic
capacity of MDM was also directly examined by light or UV microscopy to
compare with the fluorescence intensity detected by flow cytometry and actual
particle ingestion. This showed that MDM could ingest up to 50 RBC per cell
(figure 5.1 A & B) although the median of phagocytic activity was 16-25 RBC per
cell.
5.2.2 Phagocytic activity of MVV-infected MDM for RBC
In order to study functional alterations in MDM after MVV infection, MDM
were cultured in 24-well plates and the erythrocyte rosetting and phagocytosis of
opsonized RBC were assayed by flow cytometry (figure 5.2). In the early phase of
viral infection (before 5 days post infection), both MVV-infected and uninfected
cells showed very high phagocytic activity, with nearly 90-95% of cultured MDM
having erythrocyte rosetting and phagocytic activity (figure 5.2 and table 5.1).
However, the phagocytic capacity of MVV-infected MDM by 5 and 7 days
postinfection was dramatically decreased to 67% and 47% or less positive cells,
respectively (figure 5.2 & table 5.1). There was a statistically significant difference
between MVV-infected and mock-infected MDM at these time points (p < 0.05)
(table 5.1). Experiments which analyzed FcR expressed on the surface of MDM in
productive infection using erythrocyte rosetting did not show any difference
between mock and MVV-infected MDM (figure 5.2).
5.2.3 Phagocytosis of yeast (Candida utilis)
Compared to RBC and P. hemolytica, yeast was directly and quickly
ingested by MDM within 30 minutes. In a similar manner to RBC, a defect in
phagocytosis of yeast by MVV-infected MDM was seen, in particular, after 5 days
of virus infection (table 5.1). Although only 2 experiments were carried out and so
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statistics cannot be applied, we believe that this difference is real. At 7 days post
infection, incubation with yeast for 15 minutes gave the lowest percentage of cells
with phagocytosed particles (figure 5.3). The number of cells positive for yeast
then increased up to a 30 minute incubation but was unchanged after this. Therefore
the defect in phagocytosis was not overcome by longer incubation times.
5.2.4 Phagocytosis of P. hemolytica
Phagocytosis of FITC-labelled and opsonized bacteria by MDM was
examined to compare with phagocytosis of RBC and yeast. There was no
impairment of phagocytosis of opsonized bacteria by MDM infected with MVV
after 5 and 7 days postinfection (table 5.1 and figure 5.4.B). However, the
fluorescence levels indicated may not be completely due to internalized bacteria as
many externally bound bacteria were detected by UV microscopy (data not shown).
Unlike RBC these externally bound particles could not be lysed by water. Attempts
to quench external fluorescence by treatment with crystal violet failed as this also
decreased the internal fluorescence intensity and so made the assay less sensitive
(data not shown). It is therefore likely that any fall in phagocytic activity for
opsonized bacteria may be masked by the steady FcR levels already shown by
erythrocyte rosetting.
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Figure 5.2 Comparison of phagocytosis and erythrocyte rosetting of opsonized
RBC by MVV- or mock-infected MDM
Phagocytosis: MDM were cultured and infected with MVV, 1 TCID50 per
cell, in 24-well plates on day 5, 7 and 9 respectively. Fifty p.1 of 1% FITC-labelled
and opsonized RBC in RPMI/2%FCS were fed to the culture for 1 hour. After
washing, external RBC were lysed with distilled water and then saturated with 2x
PBS. MDM were harvested and transferred to Rhesus tubes. After centrifugation
5,000 MDM were analyzed by flow cytometry.
Erythrocyte rosetting: MDM were harvested, washed in PBSA with 0.01%
sodium azide and then pelleted in Rhesus tubes. Fifty (il of 1% opsonized SRBC
were added to each Rhesus tube and cells incubated on ice for 30 minutes. Cells
were resuspended in PBSA and immediately analyzed by flow cytometry.
This is a representative profile of 3 separate experiments comparing the
phagocytic and erythrocyte rosetting activity of MVV-infected and uninfected
MDM. The unshaded areas (□) are negative control MDM without RBC and the
shaded areas (■) are MDM binding or ingesting RBC. Erythrocyte rosetting (upper
panel) was compared to phagocytosis (lower panel). Figures on the top right of




























































Figure 5.3 Phagocytosis of yeast by MDM
MDM were cultured and infected with MVV, 1 TCID50 per cell, in 24-well
plates on day 5, 7 and 9 respectively. Yeast (Candida utili) were cultured and
labelled with FITC as described in section 2.8.2. After 3 washes, the yeast were
resuspended at lxlO^/ml in RPMI/2%FCS. 50|il of FITC-labelled yeast in 250|il
RPMI was added to MDM either infected or mock infected with MVV. After 15,
30, and 60 minutes incubation at 37°C, cells were washed three times with PBS.
Cells were removed from the plates, fixed in 1% paraformaldehyde in PBS for 1
hour, and then analyzed by flow cytometry.
The unshaded area (□) indicates negative control, uninfected MDM which
had not been fed FITC-labelled yeast. The shaded area (■) shows MVV-infected or
uninfected MDM fed with FITC-labelled yeast. Data are expressed as percentage
























































Figure 5.4 Phagocytosis of opsonized P. hemolytica by MDM
MDM were cultured and infected with MVV, 1 TCID50 per cell, on day 7, 9
and 11. P. hemolytica was cultured on blood agar at 37°C overnight. Bacterial
colonies were removed and resuspended in PBS. The bacterial concentration was
adjusted to OD55o=0.5 in PBS (around 3-4 xlO^ CFU/ml), labelled with FITC, and
opsonized by rabbit anti-P. hemolytica antiserum (1:10) as described in section
2.8.2. After two washes, the bacteria were resuspended to the original
concentration in RPMI medium and used in the assay. Phagocytosis was assayed as
previously described in section 2.8.4.
A. Titration of bacterial concentration in the phagocytosis assay. Unshaded
areas (□) indicate cultured MDM fed with 10pl (1), 50pl (2) and lOOpl (3) of the
standard bacterial suspension in 250ul RPMI medium at 37°C for 1 hour. The
shaded area (■) shows the background control.
B. A representative profile from 3 separate experiments of bacterial
phagocytosis by infected MDM. Fifty pi of bacterial suspension in 250pl
RPMI/2%FCS was used in this assay. The shaded area (■) shows the negative
control MDM overlapped by an unshaded area (□) which was MDM fed with
FITC-labelled bacteria. Numbers at the top right of panels show the percentage
































TABLE 5.1 Phagocytic Activity of Cultured Monocyte-derived Macrophages
Infected with Maedi Visna Virus
post infection**
Target particles uninfected 3 days 5 days 7 days
RBC (N=5) 95.7 ±3.0* 95.2 ±3.7 66.9±14.0a 47.4±11.0a
Yeast (N=2) 88.5 ± 1.2 87.1 ±0.3 71.7±7.3 49.0±9.4
P. hemolytica (N=3)+ 89.2±3.0 91.3 ± 1.6 87.8 ±3.0 87.3 ± 3.6
* Data are expressed as percentages of positive cells with phagocytic activity by setting
a 1 % gate on negative controls.
** Cultured MDM on day 5, 7 and 9 were infected with MVV, 1 TCID5Q per cell, and
phagocytic activity (60 minute incubation) was analyzed on day 12 by flow cytometry.
+ Bound and ingested bacteria.
a Indicates a statistically significant difference (P < 0.05) between uninfected and
MVV-infected MDM using a Mann Whitney two tail test.
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Part B: Phagocytic and Erythrocyte Rosetting Activity of Monocytes and AM
from MVV-Infected Sheep
5.2.5 Phagocytosis and erythrocyte rosetting by fresh monocytes from
MVV-infected sheep
The phagocytic capacity of fresh monocytes during MVV infection was
studied using a modified double staining method and flow cytometry. VPM 65 is a
monoclonal antibody specific for CD 14 which is highly expressed on monocytes
(but expressed with low density on DC and neutrophils) and it was used to label
monocytes in total PBMC. The phagocytic and erythrocyte rosetting activity of
lymphocytes stained with SBU-T4, SBU-T8, VPM8, and ST197 were used as
controls to compare with the monocyte activity. The results clearly reveal that large
B and T lymphocytes (gated in monocyte enriched area) had a subpopulation
expressing FcR which bound the opsonized RBC and bacteria, but the cells did not
ingest RBC (figure 5.5). In contrast, a phagocytic activity was clearly found in
fresh monocytes which were labelled with VPM65 (figure 5.5). Compared to
cultured MDM, fresh monocytes did not show a very strong phagocytic capacity for
opsonized RBC and bacteria. The activities greatly varied in individual sheep.
Nine experimentally infected sheep (2-3 years old) without clinical
symptoms, five naturally infected sheep from the field, and eight non infected
control sheep (2-3 years old) were used to investigate any changes in the phagocytic
function of fresh monocytes. There was no difference in the erythrocyte rosetting
activity of monocytes from uninfected or MVV infected sheep (figure 5.6). There
was also no difference in the phagocytic activity of monocytes from these sheep for
RBC or P. hemolytica (figure 5.6). All groups were analyzed using a Mann
Whitney non-parametric test.
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Figure 5.5 Phagocytic and erythrocyte rosetting activity of PBMC
FITC-labelled and opsonized RBC and P. hemolytica were prepared as
described in the materials and methods (section 2.8.2 & 2.8.3). One x 10^ PBMC
were pelleted in Rhesus tubes and then fed with 50|il FITC-targets. The cell
mixture was incubated at 37°C for 1 hour. External RBC were removed by
hypotonical lysis by distilled water for 30 seconds which was then neutralized with
2x PBS followed by 3 washes with PBSA. The cells were stained with monoclonal
antibodies followed by anti-mouse IgG-phycoerythrin conjugate (section 2.7.2).
After 3 washes with PBSA, cells were fixed in 1% paraformaldehyde and 10,000
cells gated in the monocyte enriched area were analyzed by flow cytometry. For
the erythrocyte rosetting assay, PBMC were first stained with the monoclonal
antibodies followed by the phycoerythrin conjugate and then mixed with opsonized
RBC on ice for 30 minutes. PBMC only, PBMC fed with FTTC-labelled particles
and PBMC stained with Monoclonal antibody were used as background controls.
These are representative profiles of B and T cells (sheep 848A) and
monocytes (sheep 1235T) mediating the phagocytic and erythrocyte rosetting
activity in PBMC. Panels (row 1 to 5 ) were PBMC stained with SBU-T4
(anti-CD4), SBU-T8 (anti-CD8), ST-197 (anti-T19), VPM8 (anti-Ig light chain)
and VPM65 (anti-CD 14) respectively, against FITC-labelled P. hemolytica and
































Figure 5.6 Comparison of the phagocytic and erythrocyte rosetting activity of
monocytes from MVV-infected and uninfected control sheep
PBMC from 8 control sheep (□), 9 experimentally infected sheep without
clinical symptoms (■) and 5 naturally infected sheep from the field (t) were used
in this assay. Phagocytosis and erythrocyte rosetting by monocytes were assayed
by the modified double staining method as described in section 2.8.7. Ten thousand
cells were analyzed in the monocyte enriched area by flow cytometry. Data are





















5.2.6 Phagocytosis and erythrocyte rosetting by AM from MVV-infected sheep
Five experimentally and eight naturally MVV-infected sheep were used in
this e-experiment. Eight grossly normal lungs collected from control animals or the
abattoir were used as controls. The control sheep were not age and breed matched
to the MVV-infected sheep. A direct phagocytic assay detected by flow cytometry
was used (see section 2.8.6).
A representative profile of phagocytosis and erythrocyte rosetting by AM is
shown in figure 5.7. There was no significant difference in the erythrocyte rosetting
or phagocytosis activity for RBC in any of the sheep groups (table 5.2). However,
with P. hemolytica the phagocytic activity of AM was enhanced in MVV infected
sheep without lung lesions (MF 46.7 increased to 70.8). This difference was
statistically significant (P=0.0481). There was no difference in phagocytosis of
P. hemolytica between the control group and AM from sheep with MVV induced
lung lesions (table 5.2)
5.2.7 Phagocytic capacity of the monocyte/macrophage lineage.
The phagocytic capacity of fresh monocytes and AM taken from normal
sheep and uninfected MDM (day 12) in the previous studies are summarized and
shown in figure 5.8. Cultured MDM had a very strong phagocytic and erythrocyte
rosetting activity. In contrast, AM also had a strong phagocytic activity, but up to
45% of AM from control sheep did not show erythrocyte rosetting activity as
detected by flow cytometry (table 5.2). Fresh monocytes showed the lowest
phagocytic capacity when compared to AM and MDM. Erythrocyte rosetting by
fresh monocytes gave 35% positive cells in normal control sheep (figure 5.6).
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Figure 5.7 Phagocytosis and erythrocyte rosetting by AM
FITC-labelled and opsonized targets were prepared as described in materials
and methods (section 2.8.2 & 2.8.3). 1 x 10^ AM were pelleted in Rhesus tube and
then mixed with 50|al of FITC-labelled targets. Cells were incubated for 1 hour at
37°C. External RBC were hypotonically lysed with distilled water for 30 seconds
and then saturated with 2x PBS. After 3 washes, cells were fixed in 1 %
paraformaldehyde and analyzed by flow cytometry. In the erythrocyte rosetting
assay, AM were washed with PBSA and then mixed with 50|il FrTC-labelled,
opsonized RBC at 0°C for 30 minutes and immediately analyzed by flow
cytometry.
These are representative profiles of phagocytic and erythrocyte rosetting
assays by AM from a MVV infected sheep. The unshaded area (□) indicates the
negative control cells which were not fed targets and are overlapped by a shaded
area (■) which was AM fed with the FTTC-labelled targets. Mean fluorescence
intensity was used to express the phagocytic activity with P. hemolytica and RBC.
Due to the presence of 2 distinct cell populations, percentage positive cell number
was used for erythrocyte rosetting with a 1% positive region set on negative control
cells.
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Figure 5.8 Comparison of the phagocytic and erythrocyte rosetting activity of
monocytes, AM, and cultured MDM
This figure shows the summarized results from the previous experiments
comparing the phagocytic and erythrocyte rosetting activity by monocytes, AM and
cultured MDM from uninfected control sheep or uninfected MDM (day 12). Data
are expressed as the percentage positive cells from a 1% positive region set on the
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TABLE 5.2 The Comparison of Phagocytic and Erythrocyte Rosetting Activity














46.7 + 12.4* 54.4 ± 13.7 54.5 + 9.8
MVV-infected sheep 70.8 + 20.0a 54.2 + 6.1




MVV-infected sheep 41.8 ± 16.1






* Data are expressed as mean fluorescence intensity (MF) (MF with FITC targets - MF
without FITC targets) or percentage of positive cells by setting a 1 % gate on the
negative control.
** P value between MW-infected and control sheep using a Mann Whitney two-tail test,
(a) indicates a statistically significant difference.
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5.3 Discussion
Different approaches to determining phagocytosis and Fc receptor
expression have been developed. In general, the assay most frequently used to
quantify phagocytosis directly counts the number of cells containing ingested
particles under a microscope (Boschert et al., 1988; Washburn et al., 1985).
However, this procedure is very tedious and time-consuming, and is subject to
operator error due to personal perception and the accuracy of counting large
numbers of cells by eye. More automated assays include measurement of ingested
RBC by a colorimetric assay using haemoglobin as the substrate (Jungi et al., 1990);
the total fluorescence intensity of ingested FITC-labelled particles in lysates of the
phagocytic cells detected by spectrofluorimetry (Oda et al., 1986; Ragsdale et al.,
1989); and radioactive counting of 5Chromium-labelled particles instead of FITC-
labelled panicles are all employed in phagocytic assays (Salmon et al., 1984).
However, these methods have some limitations which include: equivalence of the
phagocytic cell number in parallel wells, harvesting errors and labelling levels with
radiation as well as operator safety.
In initial studies, the different approaches mentioned above were tested and
compared. Flow cytometry (Bjerknes et al., 1989; Buschmann et al., 1989,
Tuijnman et al., 1990) was the best and simplest approach for the phagocytic assays
used in this study. It can not only quantitatively analyze the number of cells with
phagocytic activity, but can also qualitatively analyze the number of ingested RBC
in each phagocyte by fluorescence intensity. Moreover, it can count more than
5,000 cells within specific parameters in a couple of minutes. Therefore, it is a
good and convenient method to approach the phagocytic assay.
Compared to yeast and bacteria, RBC were the best targets in phagocytic
assays, as external RBC can easily be lysed with distilled water. The assay then
only measures those cells which have internalized RBC. Bacteria and yeast cannot
be removed from the surface by this method and so there are still some labelled
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panicles binding to the cell surface. Therefore results with yeast and bacteria are
the sum of surface binding and internalization. When crystal violet was used to
quench external fluorescence (Hed et al., 1982), it was found that all fluorescence
was interfered with and so this method could not be used in flow cytometry. A
method for stripping the external particles from the cell surface is therefore
necessary (eg protein digestion) before surface binding and internalization of yeast
and bacteria can be separated. However, treatment with trypsin to remove
externally bound P. hemolytica was not successful in this study (data not shown).
Monocytes and macrophages have several distinct lectin-like receptors for
sugar residues which are important in the phagocytosis of bacteria and fungi
(Gordon and Mokoena, 1989). P. hemolytica (Gram negative bacteria) contains an
outer lipid bilayer which may inhibit direct binding to macrophages (Maheswaran et
al., 1980) therefore opsonization was used. The mannosyl fucosyl receptors (MFR)
and the receptor for [3-glucan on the surface of monocytes and macrophages are
involved in receptor-mediated phagocytosis of yeast and Leishmania (Blackwell et
al., 1985; Czop and Austen. 1985). Hence, it is not necessary to opsonize yeast with
antiserum or complement to mediate phagocytic activity. However, yeast which
have been opsonized with serum show greatly enhanced internalization (Oda et al.,
1986). This means that complement receptors, Fc receptors and MFR of monocytes
and macrophages collaborate in the binding and phagocytosis of yeast and bacteria.
Both Fey and C3b receptors are very important surface molecules which
mediate phagocytosis on macrophages and neutrophils (Sarmay,1992; Jungi et al.,
1990; Anderson, 1989; Hed and Stendahl, 1982). The C3b receptor primarily
promotes attachment so that the particle is bound onto the membrane, whereas the
FcR mediates ingestion (Hed and Stendahl et al., 1982). The ingested
microorganisms in phagosomes may be killed by the peroxidase-hydrogen
peroxidase system (Locksley et al., 1987; Nakagawara et al., 1981). Internalized
particles may also be partially degraded and peptides derived can become associated
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with MHC class II molecules. Antigen breakdown and re-expression on the surface
of macrophages plays a major role in initiating an immune response (Brodsky and
Guagliardi, 1991).
After culture, FcyR expression on MDM and their phagocytic activity are
greatly increased (Jungi et al., 1986) and the experiments shown here agree with
these findings. Modulation of the Fey receptor associated with a functional
phagocytic impairment has been reported (Fleit et al., 1982). Here FcR binding of
opsonized RBC was unimpaired in MDM which had been infected with MVV for
more than 5 days. However there was a decrease in ingestion of these bound RBC
at these times post infection. Therefore, productively MVV infected MDM had a
functional impairment in the macrophage not reflected in the apparently normal
phenotype and surface particle binding at these late times post infection.
When intracellular killing of bacteria was assayed in cultured MDM either
uninfected or MVV infected, the activity was found to be very low (10-30%
bacteria killed if fed to MDM at 1-2 bacteria per MDM) and variable from
experiment to experiment (data not shown). However, ConA supernatant treatment
increased this activity so that greater than 90% of bacteria were killed within 1 hour.
In other systems the intracellular killing activity of MDM is also low if compared to
the bactericidal activity of peritoneal or alveolar macrophages (Maheswaran et al.,
1980; Collins et al., 1983). It is thought that the peritoneal or alveolar macrophage
activity is similar to that found in vivo. In vitro the differentiation of monocytes
into macrophages is accompanied by an apparent reduction in the ability of cultured
MDM to produce H202 and 02~ (Nakagawara et al., 1981). Phagocytosis of an
organism does not always activate the killing mechanism, but killing can be
amplified by the treatment of macrophages with LPS, TNF, GM-CSF and IFN-y
(Murray et al., 1987; Weiser et al., 1987; Bermudez and Young, 1988) suggesting
cytokines present in local inflammatory areas or regional lymph nodes during an
acute immune response in vivo are very important in the upregulation of
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microbicidal activity of macrophages, but that these cytokines are not present in
vitro cultures.
There was no defect in the binding and phagocytic activity of monocytes
from MVV infected sheep for P. hemolytica in this study. This suggests that the
low level of MVV in monocytes from infected sheep does not interfere with their
function. In addition, there may be no build up of infected monocytes in the blood
as circulating monocytes quickly enter into tissues and differentiate into
macrophages (Beelen et al., 1989). A decrease in the phagocytic and bactericidal
capacity of monocytes from HIV-infected patients, especially ARC and AIDS
patients (Bravo-Cuellar et al., 1992; Szkaradkiewicz et al., 1992) and from bovine
immunodeficiency virus (BlV)-infected calves (Onuma et al., 1992) has been
reported. Bender et al (1988) have reported a defect in vivo in the clearance of
particles injected into the blood stream by monocytes from AIDS patients.
However, Eales et al (1987) have also reported that there is no defect in the
microbicidal activity of monocytes for Candida, Aspergillus, Toxaplasma and
Chylamydia in AIDS (Eales et al., 1987; Murry et al., 1987). The differences in
these observations may come from differences in the depletion of CD4 lymphocytes
and the impairment of cytokines released by T lymphocytes in AIDS patients which
may regulate monocyte function in vivo. Also HIV-infected patients receive
different immunological and/or drug therapies which may affect monocyte function.
There is a defect in chemotaxis of monocytes in HIV infected patients with AIDS,
especially in those patients with Kaposi's sarcoma or opportunistic infections
(Martin et al., 1988; Smith et al., 1984; Poli et al., 1985a; Wahl et al., 1989). This
evidence suggests that an impairment in phagocytic activity or intracellular killing
ability by monocytes does not occur in early HIV infection, but is seen in patients in
the late stages of disease (AIDS) and this impairment may contribute to the
secondary infections and neoplasms which develop in late HIV disease.
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It has been reported that alveolar lymphocytes in sites of lesions during
MVV infection are in an activated state (Watt et al., 1992b; Cordier et al., 1992) and
it is assumed that cytokines from activated lymphocytes are released into the blood
stream or local tissues where they may enhance macrophage functions. Here,
binding and phagocytosis of P. hemolytica by AM from MVV infected sheep
without pulmonary lesions was greatly enhanced when compared to that from
control sheep, but phagocytosis of RBC by AM was not. This difference may be
due to external bound P. hemolytica rather than the phagocytized particles. The
difference in particle size (RBC > bacteria) may also contribute. Erythrocyte
rosetting was unaffected in the AM from these animals suggesting that any
difference may be due to the sugar residue receptors of AM. There was no
difference in the phagocytic and erythrocyte rosetting activity of AM from sheep
with lung lesions compared to controls. The groups were not age matched and
limited numbers were used which may have been why significant change were not
seen.
Pasteurella hemolytica is an important opportunistic pathogen of the upper
respiratory tract of sheep. Pasteurellosis is generally associated with various forms
of stress including fatigue or viral infections. The disease is commonly found in
MVV-infected sheep with interstitial pneumonia (Markson et al., 1984; Myer et al.,
1988). However the data presented here suggest that early events in AM interaction
with tissue bacteria (binding and internalization) are not affected in sheep with
MVV induced lung lesions. Therefore later stages in the anti-bacterial function of
AM (eg intracellular killing) or other factors involved in normal pulmonary function
must be reduced in sheep with pasteurellosis. Normal pulmonary immunity also
involves local immunity (CMI, IgG, IgA), pulmonary secretions and physiological
conditions in the lung (Christensen and Mousing, 1992; Burrells, 1985). Perhaps a
major contribution is the alveolar wall thickening seen in lungs affected by maedi
which reduces transduction of plasma components into respiratory system. This
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may lead to a failure in opsonization and allow bacteria entering the lower
respiratory tract to replicate.
5.4 Summary
The phagocytic and erythrocyte rosetting activities of
monocyte/macrophages from different organs were heterogeneous. Cultured MDM
displayed the strongest phagocytic capacity and erythrocyte rosetting activity when
compared to fresh monocytes and AM.
In vitro, the phagocytic capacity of MVV-infected MDM for RBC and yeast
was defective by 5 days postinfection, but not earlier in infection.
There was no significant difference in phagocytic capacity and erythrocyte
rosetting activity by fresh monocytes from MVV-infected and uninfected control
sheep. In contrast, the binding and phagocytosis of P. hemolytica by AM from
MVV-infected sheep without pulmonary lesions was greatly increased compared to
AM from uninfected sheep. No defects were seen in the binding and phagocytosis
of P. hemolytica or RBC by AM from sheep with pulmonary lesions.
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CHAPTER 6
THE EFFECT OF MAEDI VISNA VIRUS INFECTION ON THE
ANTIGEN PRESENTING FUNCTION OF MACROPHAGES
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6.1 Introduction
The immune response involves a complex interaction between
T-lymphocytes and antigen presenting cells (Weave and Unanue, 1990). Initiation
of the immune response is also regulated by a complex cytokine network released
by the activated T lymphocytes and antigen presenting cells (APC) (Weaver et al.,
1988 & 1990). CD4+ T-cells recognize antigen associated with self MHC class II
molecules, whilst CD8+ T-cells see antigen on MHC class I molecules (Unanue,
1992). Although T-lymphocyte activation is at the center of the immune response,
APC play an important role in antigen processing and presentation (Ziegler and
Unanue, 1981).
The dysfunction of the immune response in HIV infection, including the
impairment of proliferative responses to mitogens, recall antigens, T-cell mediated
cytotoxicity and natural killer cell mediated lysis has been well discussed (Bowen et
al., 1986). Immunosuppression in HIV-infected patients with AIDS is believed to
be a result of the depletion of CD4+ lymphocytes and impairment of lymphokine
production (Levy, 1993; Bowen et al., 1986; Fauci, 1988; Lifson and Engleman,
1989). However in late stages of infection dendritic cells, follicular dendritic cells
and Langerhan's cells in the spleen, lymph nodes and skin are also gradually
destroyed (Fox and Cottier-Fox, 1992; Eales et al., 1988; Tschachler et al., 1987;
Cameron et al., 1987; Macatonia et al., 1989; Armstrong and Home, 1984) which
contributes to the immunological abnormalities in HIV infection. Monocytes also
act as target cells for HIV infection and this cell type becomes a reservoir of HIV
infection (Schmidtmayerova et al., 1992; Schuitemaker et al., 1992a; Gendelman et
al., 1985; Ho et al., 1986). Hence, the HIV/macrophage interaction is closely
related to disease progression, especially during the asymptomatic stage of HIV
disease.
It has been reported that the accessory cell function of monocytes in early
HIV infection is not significantly affected (Terpstra et al.. 1989; Clerici et al.,
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1990), but other researchers have presented different results which show a decrease
in antigen presenting and accessory cell functions of monocytes for T-cells in HIV-
infected patients before the appearance of other symptoms of AIDS (Petit et al.,
1988; Ennen et al., 1990; Melendez-Guerrero et al., 1991). The monocyte cell line,
U937, and macrophage hybridomas also reduce their MHC class II expression (Petit
et al., 1987; Sperber et al., 1993) and accessory cell function for anti-CD3
monoclonal antibody induced T-cell lymphoproliferative responses after HIV
infection (Petit et al., 1988). This suggests that HIV infection in macrophages may
contribute to immunopathological features observed in early HIV infection and in
AIDS patients. Addressing antigen presenting function of monocyte/macrophages
in HIV infection in vivo is very complex, because many functional defects of
monocytes and macrophages in HIV infection may be related to the depletion of
CD4 lymphocytes rather than direct virus infection. However, in MVV infection
there is no depletion of lymphocytes and so the effect of lentivirus/macrophage
interaction on antigen presenting function may be studied in this disease.
In MVV infection, macrophages not only act as predominant target cells for
virus, but also present viral antigens to induce immune responses. The development
of humoral and cellular immune responses to MVV (Kajikawa et al., 1990; Larsen
et al., 1982; Shivonen et al., 1981) is very similar to other viral infections, but these
mechanisms do not eliminate virus from the host. When saying MVV does not
affect proliferative responses in sheep most researchers have looked at the
lymphoproliferative response of PBMC from MVV-infected sheep to mitogens or
MVV antigens in vitro (Griffin et al., 1978; Larsen et al., 1982a). A decreased
primary immune response to ovalbumin (measured by immunoglobulin production
in serum) or DTH response to PPD has been found in MVV-infected sheep in vivo
(Dr. P. Bird, personal communication), but this was not reflected in the
lymphoproliferative response in vitro. Therefore there may be an immune response
defect in vivo and it may occur at the monocyte level. In addition, bacterial
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bronchopneumonia in maedi is a common feature in naturally infected sheep with
maedi (Markson et al., 1983; Cultlip et al., 1979), which suggests that partial
immunosuppression may occur in some MVV-infected sheep. This is at odds with
studies on immunity of the respiratory tract in MVV infection which have shown
that alveolar lymphocytes, both CD4 and CD8 positive populations are activated
(increased MHC class II or decreased CD5) (Cordier et al., 1992; Watt et al.,
1992b). Spontaneous release of fibronectin and neutrophil chemotactic factor and
MHC class II expression of AM from maedi lungs are also increased in MVV-
infected sheep (Cordier et al., 1990) which suggests that AM in MVV infection are
more activated than in control sheep.
The reason for the discrepancy in results in MVV infection is not clear. In
vivo, only a very small proportion of monocytes or macrophages are infected and
express viral antigens (Gendelman et al., 1985). Therefore the effect on effector
and antigen presenting functions of monocyte/macrophages due to direct viral
infection may be very limited. In vitro, MVV undergoes productive infection in
cultured MDM and so the effect of virus infection in the majority of macrophages
and so on total antigen presentation may be studied. In this chapter the antigen
presenting function of MVV-infected macrophages, in vitro, was evaluated by using
antigen specific-T cell lines. The results showed a defect in antigen presenting
function of MVV-infected MDM late in virus infection but not early after infection
(before day 3 post infection).
6.2 Results
6.2.1 Generation of antigen specific-T cell lines
Two sheep (1203T & 1275T) were used to generate ovalbumin-specific T
cell lines. In these experiments, two T cell lines (1203T1 and T4) were generated
from sheep 1203T, which were specific for ovalbumin, but not for an irrelevant
antigen (PPD). In contrast, the generation of ovalbumin specific T cell lines from
142
sheep 1275T failed in 3 separate experiments. After 2-3 cycles of antigen
stimulation, phenotypic analysis of the T cells from sheep 1275T showed greatly
decreased numbers of CD4 lymphocytes and these T cells were not sensitive to
ovalbumin. However, a T-cell line (1275T-T4) generated after 2 cycles of antigen
stimulation was used in later experiments. The lymphoproliferative response of
PBMC and ovalbumin-specific T-cell lines (1203T-T1 and 1275T-T4) are shown in
figure 6.1 A & B, respectively.
Ovalbumin-specific T-cell lines were generated from sheep primed with
antigen in complete Freund's adjuvant (CFA) which contains heat inactivated
Mycobacterium tuberculosis. Therefore, the PBMC from these primed sheep not
only responded to ovalbumin, but also to purified protein derivative (PPD) (data not
shown). But after 2 cycles of ovalbumin and IL-2 stimulation, these cell lines
became specific for the original stimulating antigen (ovalbumin), not to antigens in
the adjuvant (figure 6.l.B).
PBMC from sheep 1275T which had been primed with ovalbumin in CFA
and sheep 1216V which had been primed with BCG showed proliferative responses
to PPD. Both sheep were boosted with PPD (50|lg) in PBS and the PBMC used to
generate PPD-specific T-cell lines. After 2 cycles of antigen then rhIL-2
stimulation, two PPD specific T cell lines were generated from both sheep.
However, both PPD-specific T-cell lines showed high backgrounds after 7 days with
IL-2 (figure 6.2.B). The background may have been due to IL-2 receptors of the
lymphocytes not being completely down regulated after 7 days with rhIL-2. To
reduce this background, both lines were submitted to 7 days with antigen and then
the IL-2 cycle was prolonged to 10-12 days. The lines were still specific for PPD
(heat shock protein 65KD of Mycobacterium paratuberculosis, ovalbumin and
MVV antigen did not induce responses) and the background was decreased (figure
6.2.C).
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Figure 6.1 Characteristics of ovalbumin-specific T cell lines
A. Proliferative response of PBMC to ovalbumin
PBMC prepared from antigen-primed sheep (1203T & 1275T) were
cultured with various dilutions of ovalbumin at 1x10^ cells per well in 96-well flat-
bottom microtiter plates for five days at 37°C, 5% CCA. Lymphocyte proliferation
was measured by ^H-thymidine incorporation (l|iCi per well) over the last five
hours as described in section 2.9.3. Data are expressed as CPM + standard
deviation.
B. Proliferative response of ovalbumin-specific T cell lines
Ovalbumin-specific T-cell lines were generated after two (1275T-T4) or
four (1203T-T1) cycles of antigen stimulation and IL-2 expansion as described in
section 2.9.2. Antigen specific T-cells were cultured at 5x10^ cells/well with
irradiated autologous PBMC (2xl(P/well) in the presence of various dilutions of
ovalbumin or irrelevant antigen (PPD) as indicated at a total volume of 200|Jl at
37°C, 5% CCA for 5 days. Proliferation was measured as above.
C. Antigen presenting function of MDM
Autologous MDM (sheep 1203T) were cultured for 12 days in 25cm2 flasks.
MDM were harvested and plated. 1x10^ cells per well, into 96-well flat-bottom
microtiter plates. For comparison, aliquotes of MDM were treated with 50% Con-
A supernatant (v/v) for two days before the proliferation assay to increase MHC
class II expression. 3x10^ ovalbumin-specific T-cells (1203T-T1) and various
dilutions of ovalbumin were added in a total volume of 200pi per well. Cells were
cultured for 5 days and the proliferation was measured as above. The T-cell line
with irradiated PBMC (2xl0^cell/well) and antigen as described in B was set up as
a positive control. MDM or T cells alone, T cells with antigen (all counts under
1.000 CPM) and irradiated PBMC or MDM with T-cells without antigen (counts
were about 2,000 and 5,000, respectively) were set up as background controls. The
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Figure 6.2 Characteristics of PPD-specific T-cell lines
A. Lymphoproliferative response of PBMC from sheep 1216V and 1275T after
boosting with PPD. PBMC were cultured lxlCP cells per well with serial dilutions
of PPD in 96-well flat-bottom microtiter plates for five days at 37°C, 5% CO2.
Lymphocyte proliferation was measured by ^H-thymidine incorporation (1 piCi per
well) over the last five hours as described in section 2.9.3.
Data are expressed as CPM + standard deviation.
B. PPD-specific T cell lines were generated from sheep 1216V and 1275T after
2 cycles of antigen stimulation and IL-2 expansion (7 days). 3x10^ PPD-specific T
cells, 2x10^ irradiated autologous PBMC and various dilutions of antigen, either
PPD or irrelevant (ovalbumin), in a total volume of 200|ll were plated into 96-well
flat-bottom microtiter plate and then cultured at 37°C, 5% CO2 for 5 days.
Lvmphoproliferation was measured as described in section 2.9.3.
Data are expressed as CPM + standard deviation.
C. Antigen presenting function of MDM using PPD-specific T cell lines
The PPD-specific T cell line (1216V-P3) was generated as described in
profile B, except the line was expanded in IL-2 for 12 days during the second cycle.
1x10^ autologous MDM (day 12), 3x10^ PPD-specific T cells and various dilutions
of antigens (as indicated) in a total volume of 200|il were plated into 96-well flat-
bottom plates and cultured for 5 days at 37°C, 5% CCh. Lymphoproliferation was
measured as above. T cells with antigen or T cells with MDM in the absence of
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TABLE 6.1 Phenotype of antigen-specific T cell lines
T cell line* cycle antigen positive cells (%)**
specificity CD4 CD8 Ig T19
1203T-T1 4 OVA 53.8 12.6 13.0 9.6
1275T-T4 2 OVA 32.1 45.2 13.1 2.7
1216V-P3 2 PPD 66.4 11.1 1.5 8.7
1275T-P3 2 PPD 74.5 11.8 1.4 2.0
* Antigen specific T cell lines were generated after antigen stimulation and IL-2 expansion of PBMC.
The T cell phenotype were analyzed by flow cytometry after IL-2 expansion.
** Cells stained with SBU-T4 (anti-CD4), SBU-T8 (anti-CD8), VPM8 (anti-Ig L-chain)
and ST197 (anti-T19).
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The phenotype of these antigen-specific T-cell lines is shown in table 6.1.
The table shows that the majority of antigen specific cells had expanded the CD4+
population.
6.2.2 Antigen presenting function of cultured MDM
Cultured MDM express very low levels of MHC class II molecules on the
cell surface (section 4.2.1) and they were next studied to see if they could present
antigen to trigger a T cell response. The ovalbumin-specific T-cell line (1203T-T1)
was used for the responding cells. Con A-supernatant activated MDM (section
4.2.3) were used as MHC class II positive controls. There was no difference in the
antigen presenting function of MDM either previously activated with Con A-
supernatant or not (figure 6.1.C). A similar result was also found with PPD-specific
T cell lines (data not shown). However, another ovalbumin-specific T cell line
(1203T-T4) from the same sheep did not respond to ovalbumin presented by
cultured MDM but proliferated with antigen and Con A-supernatant activated MDM
(figure 6.5). The lymphoproliferative response of T cell lines was related to the
number of stimulating cell (dose-effect) (data not shown). In this study a ratio of
MDM : responding cell of 1 : 3-5 showed good proliferative responses.
6.2.3 The effect of MVV infection on the antigen presenting function of MDM
In order to study the effect of MVV infection on the antigen presenting
function of MDM, the ovalbumin-specific T cell line (1203T-T1) was used as the
responding cell with MVV or mock infected MDM (autologous). The results
clearly indicated that an impairment in antigen presenting function of MDM
occurred by 5 days postinfection compared to uninfected MDM (figure 6.3.A).
Using the cell line 1275T-T4 cell line both MDM at 3 days and 5 days showed a
reduction in their ability to present antigen (figure 6.3.C). Con A supernatant
treatment of MDM for 2 days before the proliferative assay reduced the difference
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in antigen presenting ability of 5 days infected MDM and mock infected MDM
(figure 6.3.B). Con A-supernatant may interfere with viral replication in the cell
and so these cells may not have reached the same stage in infection as unactivated
MDM.
To reduce backgrounds the PPD-specific T cells underwent an IL-2
expansion cycle which was lengthened to 10 days (1216V-P5 and 1275T-P5) before
being used as responding cells for MVV-infected MDM. The lymphocytes showed
a similar reduction in proliferation to MVV-infected MDM as ovalbumin-specific T
cells, one line showed a decreased response to both 3 and 5 day infected MDM
(figure 6.4.A) whilst one showed a decrease to only 5 days infected MDM (figure
6.4.B). The defects in presentation of PPD were seen at low antigen concentrations
(0.3|Ug/ml), but were overcome by higher concentrations of PPD (9jlg/ml) (figure
6.4).
To address whether the decrease in the antigen presenting capacity of MVV-
infected MDM was related to MHC class II expression on the cell surface, the
phenotype of MVV or mock-infected MDM after Con A-supernatant activation was
investigated. The results show a decrease in MHC class II expression on MVV-
infected MDM as early as 3 days post infection compared to ConA-supernatant
activated uninfected MDM (table 6.2). Table 6.2 also shows that MDM not treated
with ConA-supernatant had little MHC class II expression. This is probably
switched on during the 5 days assay with lymphocytes. Not all the lymphocytes are
in resting phase when added to the cultures (backgrounds can be high) and so are
probably secreting lymphokines which can upregulate MHC class II expression on
the surface of MDM.
6.2,4 Antigen presenting function of alveolar macrophages
Due to arthritis, sheep 1203T was put down and so it was possible to
obtained AM from BAL. The ability of these fresh AM to present ovalbumin to a
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Figure 6.3 Comparison of the antigen presenting function of MDM either
infected or mock-infected with MVV
MDM (autologous) were cultured in 25cm^ flasks and then infected with
MVV at 1 TCID50 per cell on day 7 (—°—) and 9 ( ♦ ) (as indicated). On day 12
cells were harvested and lxlO^ viable MDM were plated into 96-well microtiter
plates. 3x10^ ovalbumin-specific T cells (1203T-T1 for profile A and B; 1275T-
T4 for profile C) and various dilutions of ovalbumin in a total volume of 200fil
were added and then cultured for 5 days. Lymphocyte proliferation was measured
by the incorporation of ^H-thymidine (1 jiiCi per well) over the last five hours as
previously described (section 2.9.3).
Data are expressed as CPM + standard deviation.
A. Proliferation of ovalbumin-specific T cells (1203T-T1) with mock or MVV
infected MDM without Con A-supernatant treatment.
B. As A except the cultured MDM had been pre-treated with 50% Con A-
supematant (v/v) for 2 days before the proliferation assay.
C. Response of ovalbumin-specific T cells (1275T-T4) to mock or MVV










Figure 6.4 Comparison of the antigen presenting function of MVV infected
MDM using PPD-specific cell lines
MDM (autologous) were cultured in 25cm2 flasks and then infected with
MVV at 1 TCID50 per cell on day 7 (—n—) and 9 (—♦—) (as indicated). On day 12
cells were harvested and lxlO4 viable MDM were plated into 96-well microtiter
plates. 3X104 PPD-specific T cells (1216V-P5 and 1275T-P5 which had gone
through 3 cycles of antigen stimulation with a 10 day IL-2 expansion cycle) and
serial diluted antigen in a total volume of 200|il were added and then cultured for 5
days. Lymphocyte proliferation was measured by the incorporation of
^H-thymidine (lpCi per well) over the last five hours and measured as previously
described (section 2.9.3). Data are expressed as CPM + standard deviation.
A. Response of PPD-specific T cells (1216V-P5) to mock or MVV infected
MDM.


















































Figure 6.5 Antigen presenting function of alveolar macrophages
2x10^ AM (sheep 1203T), 3x10^ cells from the ovalbumin-specific T-cell
line (1203T-T4) and various dilutions of ovalbumin were plated into 96-well flat-
bottom microtiter plates in a total volume of 200|il in each well. Controls included
MDM (2x10^ per well) either Con A-supernatant activated or not activated before





medium 3 9 27 81
Ovalbumin concentration (ug/ml)
H
MDM treated with ConA-supernatant
MDM without ConA-supernatant treatment
Alveolar macrophages





MHC class n DQ 5.1 30.4 12.4 5.7 5.9
MHC class II DR 4.9 32.4 12.0 9.3 9.3
MHC class I 45.5 45.2 34.8 30.8 27.9
CD8 17.5 2.7 10.2 9.0 10.2
LFA-1 31.0 38.1 _ 21.7 20.5
* MDM were infected with MVY. 1 TCID50 per cell, on day 5, 7, 9 and 11 and their phenotype was
analyzed on day 12. 50% Con A-supernatant (V/V) was added to cultures 2 days before analysis.
** Data are expressed as mean fluorescence intensity where negative control fluorescence has been
subtracted.
# Control MDM were not treated with Con A-supernatant and were uninfected.
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1203T cell line was tested in comparison to autologous cultured MDM. The results
show that AM could not efficiently stimulate lymphoproliferation of an ovalbumin-
specific T cell line (1203T-T4) compared to activated MDM (figure 6.5). The AM
used in this assay expressed moderate levels of MHC class II DQ (MF=41.2) and
DR (MF=50.3) on their cell surface as detected by flow cytometry (data not shown).
6.4 Discussion
The purpose of this study was to evaluate the antigen presenting capacity of
macrophages for inert antigen after infection with MVV. Factors affecting the
lymphoproliferative response are at three different levels: antigen uptake and
processing, antigen presentation with MHC class II and accessory factors
(cytokines) released by macrophages. PBMC and partially purified lymphocytes
from PBMC may contain dendritic cells, monocytes and B cells which can all act as
antigen presenting cells. Therefore to study the antigen presenting ability of
macrophages alone, generation of antigen-specific T cell lines was used.
It has been reported that activated sheep lymphoblasts respond well to
recombinant human IL-2 (rhIL-2) (Bujdoso et al., 1989). T-cell lines can be
generated by antigen stimulation followed by rhIL-2 expansion for 2 weeks by
which time activated cells have gone back to a resting stage (Bujdoso et al., 1989).
However, in my hands ovalbumin-activated T-cells could not survive in culture with
rhIL-2 for two weeks, especially lymphocytes from sheep 1275T. Most activated
T-cells underwent "programmed cell death" (PCD) (Cohen, 1991) after 2 weeks in
culture with rhIL-2. In contrast, with PPD specific T-cell lines some cells survived
in culture in the presence of rhIL-2 for 10-12 days. However the majority of T cells
eventually underwent apoptosis which led to a loss of cells during late phase of this
cycle. Culturing PPD-specific blasts with IL-2 for 7 days may not allow enough
time for all IL-2 receptors to be down regulated and this may be the cause of high
backgrounds in proliferative assays with PPD cell lines. To reduce backgrounds a
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balance between the length of culture with IL-2 and surviving cells was determined
by microscopic observation.
Two ovalbumin-specific T cell lines were generated from sheep 1203T, but
not from sheep 1275T. The reason for this difference is unclear but may be due to
immune response genes in different sheep. Sheep 1203T PBMC did respond better
to ovalbumin than 1275T. It is unlikely to be the absence of costimulating
molecules in cultures (Weave and Unanue, 1990) as PPD lines could be made from
sheep 1275T. Poor presentation of ovalbumin on the MHC class II molecules of
1275T is probably the cause. This is supported by the fact that the only ovalbumin
specific T cell line to be generated from this sheep was composed mainly of CD8+
lymphocytes and had lost most of its CD4+ lymphocytes (Table 6.1).
Most antigen presentation on MHC class II is thought to occur on newly
synthesized class II molecules (Neefjes et al., 1990). Therefore both unactivated
and Con A supernatant activated MDM need to synthesize MHC class II to stimulate
T cell proliferation. With activated MDM this is likely to occur as the cells are
expressing high levels of class II when they are added to the lymphocytes.
Unactivated MDM express little detectable class II when they are added to
lymphocytes and so MHC class II expression must be switched on by culture with
the lymphocytes but before the T cells have interacted with large amounts of
presented antigen. The T cell line in this case may spontaneously release cytokines,
such as IL-2 and IFN-yinto the cultures (Paulnck, 1992; Katz and Michalek, 1991;
Torres et al., 1982) which would upregulate expression of MHC class II on the
macrophages (Sztein et al., 1984), allowing presentation of the antigen which was
present continuously. One T cell line (1203T-T4) could not use unactivated MDM
as antigen presenting cells. The most probable explanations for this are that this line
was truly resting and therefore not producing sufficient lymphokines to allow MHC
class II expression on macrophages or that this T cell line produced lymphokines
incapable of upregulating MHC class II on macrophages. Activated Thl cells
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produce IL-2 and IFN-y, whilst Th2 cells produce IL-4 (Eastcott et al., 1990;
Finkelman et al., 1990). Th2 cell responses are strictly dependent on accessory cell
expression of IL-1, compared to Thl proliferation (Weaver et al., 1988). The
lymphokine profiles of the T cell lines used here have not been investigated but this
would be of interest to these results.
The antigen presenting function of MVV-infected MDM was found to
decrease by 3 to 5 days postinfection when ovalbumin or PPD T cell lines were used
as responding cells. This result paralleled those from the phagocytic assays (chapter
5). There may therefore be a fault in antigen uptake and processing in productively
infected macrophages. There was also reduced expression of MHC class II even
after Con A supernatant activation in MVV-infected MDM (table 6.2) which could
contribute to the decreased antigen presentation. Whether there is also a decrease in
costimulatory factors released by MVV-infected MDM, compared to uninfected
MDM, in early or productive infection is unknown.
Ennen et al (1990) reported a decrease in IL-1 production from HIV-infected
MDM in response to anti-CD3 monoclonal antibody stimulation compared to
uninfected MDM, but this is not seen on LPS stimulation. However, the decrease in
IL-1 secretion by HIV-infected cells in vitro occurs after 3 weeks post infection
which is longer than the infection times used here for MVV infected MDM. In
addition, the decrease in antigen presenting function of MVV-infected MDM seen
here in vitro may not parallel the situation in vivo where lymphoproliferation is a
hallmark of MVV induced lesions (Cutlip et al., 1979; Olive et al., 1981b).
It has been reported that there is a decrease in MHC class II expression and
accessory cell function in HIV-infected MDM or macrophage hybridomas which is
related to reverse transcriptase activity and p24 levels (day 21-24 post infection) in
the culture (Petit et al., 1988; Ennen et al., 1990; Sperber et al., 1993). A defect in
accessory cell function of monocytes in stimulating lymphocyte proliferation for
recall antigens (Rich et al., 1988), anti-CD3 monoclonal antibody (Melendez-
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Guerrero et al., 1991), or in mixed leukocyte reactions (MLR) (Twigg III et al.,
1991) has been reported in HIV infected patients, especially those patients with
ARC or AIDS. The defect in MLR reactions stimulated by monocytes is paralleled
to the decrease in MHC class II expression on these cells (Heagy et al., 1986; Sei et
al., 1986). This is similar to the results seen here with MVV. Lacroix et al (1993)
reported that a defect in accessory cell function in HIV-infected MDM occurred as
early as 2 days post infection. However, this defect is limited to low MDM : T cell
ratios using anti-CD3 monoclonal antibody stimulation, but is not seen with other
mitogens or recall antigens (Ennen et al., 1990). The MDM : T cell ratio used in the
above study may not be physiological. Here, MVV replication is lytic in MDM
which is not the same as the chronic HIV replication seen in MDM or the U937 cell
line.
Part of the pathogenesis of HIV disease includes a decreasing memory T cell
population which might have resulted from decreased monocyte accessory function
when recall antigens were used (Rich et al., 1988). Results from cultures with HIV
infected PBL and monocytes are complicated by the fact that lymphocytes may be
infected with HIV at the start or become infected with HIV from virus-infected
monocytes during the culture. Lymphocytes may therefore not respond to antigen
stimulation because of HIV infection or interference by gpl20 present in the culture
(Mann et al., 1990b). This phenomenon may be more evident in vitro when MDM
or U937 cells are highly infected and produce more viral particles which may infect
or interfere with lymphocytes. Therefore, the decrease in accessory cell function in
HIV infection may not only be due to monocytes, but also to the infection or
interference of lymphocytes. This is supported by a mump-specific T cell line
which did not indicate an impairment in accessory cell function of monocytes from
HIV-infected patients (Twigg III et al., 1991).
During MVV disease progression there is enhancement of MHC class II
expression on macrophages (Lujan et al., 1993; Harkiss et al., 1991; Cordier et al.,
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1990). This suggests that there may be an increase in accessory cell function of AM
in antigen presentation. However, AM taken from sheep 1203T did not efficiently
stimulate T-cell proliferation when compared to activated MDM. Suppression of
T-cell proliferation caused by AM has been reported (Holt et al., 1985 & 1986; Fu
and Blankenhorn, 1992), but this effect may vary in different species (Holt et al.,
1986). The suppressive effect of AM is mediated by the nitric oxide synthase
pathway (Holt et al., 1993; Mills, 1991; Fu and Blankenhorn, 1992) and this
pathway can be amplified by treatment of AM with IFN-y, TNF-a, IL-1, and
endotoxin (Ding et al., 1988; Nussler et al., 1992; Stuehr and Marietta, 1987).
Therefore, the increased activation state of AM in MVV-infections (Cordier et al.,
1992; Lujan et al., 1993) suggests not only an enhancement of accessory cell
functions of AM but also an increase in the release of more nitric oxide in MVV
infected sheep which may in turn inhibit local pulmonary immunity. However
accessory cell functions and suppressive effects of AM in sheep have not been well
studied. Indeed in HIV and tuberculosis there is increased HLA-DR expression and
IL-1 release by AM (Ina et al., 1991; Buhl et al., 1993; Soliman et al., 1992) but
infections of the lung are not cleared and so measures of AM activation are not
necessarily linked to increases in effective pulmonary immunity.
6.4 Summary
Antigen specific T-cell lines were generated from antigen primed sheep after
2 cycles of antigen then IL-2 stimulation. The period of IL-2 stimulation was varied
for different cell lines. Cultured MDM could efficiently present antigens to antigen
specific T cell lines. The interaction of T-cell lines and MDM played a role in the
activation of MDM function. Productively MVV-infected MDM showed a decrease
in their antigen presenting capacity (3-5 days postinfection). AM did not present
antigen well to a T cell line.
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CHAPTER 7




After viral infection, the host develops a humoral and cell-mediated immune
response. The development of specific antibodies or cytotoxic T lymphocytes
(CTL) is specifically programmed to eliminate free virus and virus-infected cells
(Sissons and Oldstone, 1980; Kohl, 1991). Natural killer (NK) cells,
monocytes/macrophages and neutrophils can directly lyse virus infected cells or
tumor cells in the absence of specific antiserum (Graziano and Fanger, 1987;
Yokoyama,1993). Both virus-specific and non-specific defense mechanisms have
important roles against viral infection. Usually, the development of virus-specific
cytotoxic activity mediates the clearance and so resolution of virus infection.
However in some cases virus specific cytotoxicity may mediate pathological lesions
as in the case of adult mice infected with lymphocytic choriomenigitis virus (Leist
et al., 1988). Lentivirus infections are unusual (Narayan and Clements, 1989) in
that the virus can persist in target cells, even though the host has developed virus-
specific CTL and antibody.
High frequencies of HIV-specific CTLs have been found in HIV patients,
especially at the asymptomatic stage (Walker et al., 1987 & 1988; Riviere et al.,
1989; Nixon et al., 1988; Vanham et al., 1990; Hoffenbach et al., 1989), but in late
phases of HIV infection, especially in the patients with AIDS, CTL activity against
HIV is markedly decreased (Vanham et al., 1990; Carmichael et al., 1993; Clerici et
al., 1991). Class I restricted CTL activity directed against HIV env, pol, gag, nef,
rev and vif products has been seen (Koup et al., 1989; Nixon et al., 1988; Michel et
al., 1992; Lyerlv et al., 1987; Walker et al., 1987; Riviere et al., 1989; Buseyne et
al., 1993; Clerici et al., 1991). Virus-specific, MHC class II restricted, CD4+ T cell
mediated cytotoxic activity has also been documented in HIV infections (Orentas et
al., 1990., Littaua et al., 1992; Curiel et al., 1993) or antigen primed mice (Michel et
al., 1992). Virus-specific CTL can be detected in blood (Hoffenbach et al., 1989:
Koup et al., 1989), bronchoalveolar lavage (BAL) cells (Plata et al., 1989; Autran et
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al., 1991) and CSF (Sethi et al., 1988) in HIV-infected patients suggesting good
cellular immunosurveillance within the infected host. However, HIV genetic
variants which can escape cytotoxic T cell recognition have been reported in a
longitudinal study (Phillips et al., 1991). The mutation of virus therefore, provides
a pathway for escaping immunosurveillance. With SIV, similar results have been
shown with high frequencies of CTL for the nef gene product (Bourgault et al.,
1992).
Non MHC-restricted CD16+ lymphocyte mediated cytotoxicity has been
described (Rivere et al., 1989; Weinhold et al., 1988) that is able to kill gpl20
coated or HIV-infected target cells. Patients with AIDS have been shown to have
defective NK activity (Poli et al., 1985; Rook et al., 1985; Scott-Algara et al.,
1992), but this defect can be modified by adding IL-2 to cell cultures (Rook et al.,
1983 & 1985). These activities are very important in controlling viral replication.
HIV-infected macrophage or monocyte cell lines can be lysed by MHC
restricted virus-specific CTL, non-MHC restricted NK cells or ADCC (Plata et al.,
1987; Vanham et al., 1990; Autran et al., 1991). The interaction of macrophages
and these cytotoxic activities indicates that virus infected macrophages present viral
antigen to initiate the immune response and that these cells are eliminated by
activated virus-specific or non-specific cytotoxic cells. In vivo, HIV persistence in
macrophages can be detected at all stages of infection (Ho et al., 1989).
Macrophages harboring virus but evading host immunosurveillance are therefore
important in the pathogenesis of HIV infection.
Monocyte/macrophages are the predominant infected cells in MVV
infection. No decrease in lymphocyte, dendritic or monocyte cell numbers in MVV
infected sheep have been reported. Virus specific and MHC-restricted CTL activity
can be detected in all MVV infected sheep by stimulating PBMC with MVV-
infected skin fibroblasts. (Blacklaws et al., 1994), but direct cytotoxic activity in
acute or persistent infections is very difficult to detect (Bird et al., 1993; Blacklaws
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et al., 1994). This is different to the direct cytotoxic activity seen in PBMC from
HIV infected patients. There is limited viral antigen expressed on infected
macrophages in vivo (Haase et al., 1976; Gendelman et al., 1985) and so there may
not be sufficient antigen to activate circulating precursors in PBMC to show CTL
activity in vitro. Studies on pulmonary immunity in MVV infection have shown
greatly increased numbers of CD8 lymphocytes and decreased CD4/CD8 ratios in
BAL fluids of maedi lungs (Lujan et al., 1993; section 4.2.7). Most of these
lymphocytes are activated (Cordier et al., 1992; Watt et al., 1992b) which may
indicate lymphocytes with either CTL activity or suppressive effects on pulmonary
immunity in MVV infection.
It has been shown that skin fibroblasts are good target cells in CTL assays
with MVV (Blacklaws et al., 1994). However in vivo the important target cell will
be the infected macrophage. Therefore the ability of CTL to lyse MVV infected
macrophages was studied. In addition, NK or LAK mediated cytotoxic activity is
also very important in controlling tumors or virus-infected cells during early viral
infection. The role of NK or LAK cells in controlling and destroying MVV infected
macrophages was investigated.
7.2 Results
7.2.1 In vitro activated MVV-specific, cytotoxic T lymphocytes
Due to line breeding within breeds of sheep, we were not certain that sheep
from the same flock would express different haplotypes. Therefore skin cells
derived from different sheep were tested their ability to present antigen to PBMC
derived CTLs. Results with CTL from 2 different infected sheep are shown in
Table 7.1. Many experimental sheep which came from the same flock appeared to
share MHC alleles and could present viral antigens to the CTLs. Sheep 1235T
showed the lowest cross reaction with both sheep 1071P and 1091P. Sheep 1238T
also showed low cross reaction with sheep 109IP.
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Using these and similar results to select heterologous sheep from which to
isolated MDM, the ability of CTL to recognize and kill MVV infected macrophages
was analyzed. After stimulation of PBMC from MVV infected sheep (107IP,
1091P, YT40 and 865A), the majority of lymphocytes were CD8+ lymphocytes
(ranged between 78% and 62%). These cell populations from all 4 infected sheep
contained activated CTL. They all showed virus specific activity for autologous
MVV-infected skin fibroblasts, but not heterologous MVV-infected skin fibroblasts
(figure 7.1.A, C, E, G). Similar results were also detected using MVV-infected
MDM (figure 7.1. B, D, F, H) indicating that the cytotoxic activity is MHC
restricted on both fibroblasts and macrophages. However levels of non-specific
cytotoxic activity were often high on uninfected macrophages (10-35%), especially
autologous macrophages. The levels of non-specific activity varied in different
sheep. Sometimes non-specific cytotoxicity was also seen on autologous uninfected
skin fibroblasts rather than heterologous skin fibroblasts (figure 7.1.A, C),
especially in high effector to target ratios.
In the above assays, autologous MDM were derived from the infected sheep.
These macrophages may therefore have expressed low levels of MVV antigen
without infection in vitro due to MVV persistence in monocytes in vivo. Indeed
when MDM from MVV infected sheep were stained for gag antigen (pi5)
occasional cells were gag positive (less than 1%, data not shown). Therefore some
of the background non-specific killing of autologous MDM seen above may in fact
be viral specific. To test this hypothesis MDM were derived from an uninfected
sheep whose skin cells were known to cross react with the effector lymphocytes
(1238T MDM with 107IP CTLs, see table 7.1). The results showed similar levels
of nonspecific lysis with uninfected autologous (1071P) and cross reacting (1238T)
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TABLE 7.1 Cross-Reactivity of Different Target Cells (Skin Fibroblasts)
in CTL Assays
Specific lysis (%)
Target cells 1071P CTL* 1091P CTL
(skin fibroblasts)
T ;: E ratio T:: E ratio
1:25 1:50 1:8 1:25
Mock-infected
107 IP 2.6 6.0 ND ND
109 IP ND** ND 1.1 4.1
1213T 9.9 11.0 ND ND
1220T 12.0 14.0 -1.2 4.5
1231T -4.2 1.5 2.3 3.3
1235T 2.9 5.8 -3.4 -1.2
1238T 8.0 11.1 -2.4 -0.1
1262T 6.1 8.1 3.3 3.0
MVV-infected
107 IP 57.1 59.6 ND ND
1091P ND ND 31.4 36.0
1213T 56.7 69.1 ND ND
1220T 54.3 56.4 12.4 18.0
1231T 72.8 79.5 14.1 26.5
1235T 3.1 4.7 1.2 2.6
1238T 47.1 49.5 3.9 9.0
1262T 61.4 63.7 11.3 19.8
* PBL (107IP) were stimulated on MVV infected skin fibroblasts in the presence of rh-IL-2
for 2 weeks. 1091P CTL (figure7.1C) resuscitated from liquid nitrogen were cultured on
MVV-infected skin fibroblasts for another one week and then used in CTL assays.
Spontaneous release was always less than 31% of the maximal release. Results have been
expressed as specific lysis, that is specific ^Cr release.
** ND: not done
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Figure 7.1 Detection of MVV-specific, MHC restricted cytotoxicity
PBL from MVV-infected sheep (A&B sheep 107IP; C&D: sheep 1091P;
E&F: sheep YT40; G&H: sheep 865A) were cultured on MVV-infected autologous
skin fibroblasts (SK) in the presence of rh-EL2 for 2 weeks as described in materials
and methods (section 2.10.1). Target cells (lxlO4 per well), autologous (auto) and
heterologous (hetero) SK (A, C, E, G) and MDM (B, D ,F ,H), in 96-well flat-
bottom microtiter plates as indicated were infected or mock-infected with MVV,
0.5 TCID50 (SK) or 1 TCID50 (MDM), for 1 (SK) and 2 days (MDM),
respectively. Cells were labeled with 2.5 (A-D) or 1.5 (E-H) jiCi 51Chromium in
the well overnight, washed and used in cytotoxicity assays (16 hours assay) at 3
different target and effector ratios as indicated.
Results have been expressed as % specific 51Cr release. The percentage
spontaneous 51Cr release from targets compared to maximal release was: A: 19-
































































Figure 7.2 Recognition of alveolar macrophage targets
Effector cells (865A PBL) had been stimulated on MVV-infected
autologous skin fibroblasts (SK) in the presence of IL-2 for 3 weeks. Autologous
(865A) and heterologous (1250J) AM were resuscitated from liquid nitrogen,
cultured in 25cm2 flasks and then infected with MVV, 1 TCID50 per cell for 2
days. AM were labeled with ^Chromium, lOOuCi per flask, overnight. After four
washes, 2xl()4 AM were plated into 96-well flat-bottom microtiter plates as target
cells. Effector cells were added at 3 different target : effector ratios as indicated
and the cytotoxic assay was incubated for 6 hours.
Results have been expressed as % specific 51Cr release. The spontaneous








MDM targets (data not shown). Therefore the non-specific cytotoxicity seen in
autologous MDM was not caused by virus infection of the cells in vivo.
Although recognition of MDM had been shown, in vivo the natural target for
CTLs, especially in sheep with maedi, might be expected to be AM. Therefore AM
were used as targets for in vitro stimulated CTLs from blood. MVV-infected
autologous AM were specifically lysed by CTL compared with autologous
uninfected AM and heterologous AM (figure 7.2). AM spontaneously release was
often high and so assay incubations were reduced to 6 hours.
7.2.2 CD8+ lymphocytes mediate the CTL activity
To investigate the phenotype of the CTL, CD4+ or CD8+ lymphocytes were
depleted from cultured cell populations by complement. The results (sheep 107IP)
are shown in table 7.2. CD4+ depleted effectors (CD8+=92.6%; CD4+= 0.2%)
lysed MVV-infected autologous MDM and skin cells. However, there was some
nonspecific lysis of autologous uninfected targets. In contrast, the levels of specific
lysis on MVV-infected autologous MDM and skin fibroblasts mediated by CD8+
depleted CTL (CD8+=0.2%; CD4+=71.1%) were greatly decreased, suggesting that
cytotoxicity was mediated by CD8+ CTL. When MDM targets were compared to
skin cells targets, depletion of CD8+ cells was seen to completely inhibit lysis of
MVV infected skin cells. However, there was still greater lysis of MVV infected
than mock infected MDM with this depleted population suggesting another cell may
also be involved, in a minor fashion, in CTL activity (perhaps CD4+ cells).
Interestingly, the nonspecific lysis of uninfected autologous targets (both MDM and
skin cells) was also dramatically decreased, suggesting that the nonspecific lysis, in
part, was mediated by CD8+ cells. A similar result was also seen in sheep 865A
(data not shown).
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TABLE 7.2 CD8+ Lymphocyte Mediated Cytotoxicity (Sheep 1071P)
Targets
(autologous)
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PBL were stimulated on MVV-infected skin fibroblasts in the presence of rhIL-2 for 2 weeks
as described in materials and methods (section 2.11.1). Activated CTL were incubated with
monoclonal antibody, IgG2a, SBU-T4 (anti-CD4), SBU-T8 (anti-CD8), followed by
complement depletion before use in assays. The spontaneous release was between 20.2 and
25.7%. Results have been expressed as specific lysis, that is specific Cr release.
Cell phenotype was analyzed by flow cytometry.
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7.2.3 Generation of MVV-specific cytotoxic T lymphocytes using autologous
macrophages
To address whether MVV-infected macrophages can stimulate vims-specific
precursors in vitro, autologous MDM (figure 7.3.A: sheep YT40) and AM (figure
7.3.B: sheep 1257J) infected with MVV were used as stimulating cells to activate
CTLs from PBMC. After 2 weeks activation, the CD8+ lymphocyte population was
increased in both cultures to 65% (YT40) and 66% (1257J) respectively. An
apparently MHC restricted CTL activity was detected using autologous, vims-
infected skin fibroblasts (YT40, data not shown) or MDM (figure 7.3.A & B).
Levels of non-specific lysis of autologous uninfected MDM could be high (around
15-30%) as was also seen with lymphocyte effectors cultured on skin cells.
7.2.4 Cytotoxic activity of alveolar lymphocytes from MVV-infected sheep
Only a very low frequency of MVV infected sheep show direct CTL activity
by PBMC (Blacklaws et al., 1994) To investigate whether alveolar lymphocytes
can mediate CTL activity without in vitro stimulation, 3 sheep (YT40, 865A and
111) which had been infected with MVV more than 4 years were used to obtain
bronchoalveolar lavages. None of these sheep showed clinical symptoms and the
lungs had no gross lesions. Alveolar lymphocytes were collected and purified by
removing adherent ceils, twice, onto plastic tissue culture flasks or plates. The AM-
depleted alveolar lymphocytes were 85-90% lymphocytes and were then used as
effector cells. Fresh AM (data not shown), skin fibroblasts and MDM, either
autologous or heterologous, were used as target cells, but there was no vims-specific
MHC restricted cytotoxic activity detected with most sheep (figure 7.4.A, B, C).
Low levels of CTL activity using skin fibroblast targets were seen in sheep YT40
(figure 7.4.B), but the difference between uninfected and infected targets did not
exceed 10%. Using unstimulated PBMC, high effector to target ratio (100:1) are
needed to see specific lysis of MVV infected cells. Here these levels were never
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reached as lymphocytes are a minor population in lung fluids. The lack of CTL
activity here may be for this reason.
Alveolar lymphocytes from the sheep 865A were also stimulated on MVV-
infected skin fibroblasts for 12 days in the same manner as previously described and
then used as effector cells in a cytotoxic assay. Only a low level of cytotoxic
activity was detected on MVV-infected autologous MDM (T:E = 1:10) compared to
heterologous targets (figure 7.4.D) which may be due to the low number of effectors
recovered after culture. Also non-specific cytotoxicity seen with autologous MDM
was relatively high in this assay (difference between uninfected and infected
autologous targets was less than 10%).
7.2.5 Lymphokine activated killer (LAK) cells mediate cytotoxicity
To study the non-specific cytotoxic activity seen with autologous and
heterologous uninfected MDM mediated by LAK cells, PBL were cultured with
rhIL2 (lOU/ml) for 5-13 days and then used as effector cells (LAK). MVV-infected
and uninfected MDM were set up as target cells. These results showed various
levels of non-specific lysis of MVV-infected or mock-infected targets (autologous
and heterologous) in different sheep (figure 7.5 A, B, C). Autologous MVV
infected MDM were more susceptible than other targets with sheep 647R (figure
7.5A). Sheep 647R was MVV infected and is known to have precursor CTL in its
blood which may be causing this result, however sheep 1138W (figure 7.5 B, C) is
uninfected and precursor CTL have never been detected in the blood of uninfected
sheep. All MDM targets were lysed to the same extent with LAK cells from sheep
1138W. Therefore the reactivity shown by IL-2 stimulated PBL for MDM is likely
to be LAK mediated rather than CTL mediated. The susceptibility of macrophages
169
Figure 7.3 Stimulation of CTL by macrophages in vitro
PBL were stimulated on MVV-infected autologous MDM (A: sheep YT40)
or AM (B:1257J) in the presence of IL-2 for 2 weeks as described in section 2.10.1.
Target cells (lxlO4 per well), autologous and heterologous MDM (A & B) as
indicated, in 96-well flat-bottom microtiter plates were infected or mock-infected
with MVV, 1 TCID50 per cell (MDM), for 2 days. Cells were labeled with 1.5p.Ci
51 Chromium in the well overnight before being washed and used in cytotoxic
assays (16 hours) which were performed at 2 or 3 different target: effector ratios as
indicated.
Results have been expressed as % specific 51Cr release. The percentage
spontaneous 51Cr release from targets compared to maximal release was.:



















Figure 7.4 Alveolar lymphocyte effectors from MVV-infected sheep
Alveolar lymphocytes were purified from BAL fluid from 3 MVV-infected
sheep (A: 111; B: YT40; C: 865A) by adherence of AM to plastic plates or tissue
culture flasks twice. The AM-depleted fresh alveolar lymphocytes were used as
effector cells (A, B, C). Alveolar lymphocytes from sheep 865A, were also
stimulated on autologous MVV-infected skin fibroblasts (SK) for 12 days as
described in section 2.10.1 and then used as effector cells (D). Target cells (lxlO4
per well), autologous and heterologous SK or MDM (as indicated), in 96-well flat-
bottom microtiter plates were infected or mock-infected with MVV, 0.5 TCID50
(SK) or 1 TCID50 (MDM) per cell, for 1 (SK) and 2 days (MDM), respectively.
Cells were labeled with 1.5ltCi 51Chromium in the well overnight washed and then
used in the cytotoxic assay (16 hours) using different target and effector ratios as
indicated.
Results have been expressed as % specific 51Cr release. The percentage
spontaneous ^lCr release from targets compared to maximal release was: A 22-
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to lysis was maturation dependent; immature MDM (day 5) were more resistant than
mature MDM day (12-14) (data not shown). Skin fibroblasts, especially MVV-
infected cells, were also lysed by LAK cells, but the levels were relatively low
compared to MDM targets (figure 7.5.C).
NK (LAK) cells in humans express CD2 and CD 16 and it is thought these
molecules that cytotoxic activity is triggered through these molecules (Segal and
Snider, 1989). CD 16 is the Fcylll receptor for which there is no specific
monoclonal antibody in sheep. FcR+ cells were separated from others in PBL by
their ability to bind antibody coated RBC. Erythrocyte rosetting (ER) positive
(ER+) and negative (ER") PBL were separated (section 2.10.5), cultured in RPMI
medium with IL-2 for 5 days and then used as effector cells. The results clearly
indicated that ER+ LAK cells mediated cytotoxicity, but infected cells were not
recognized to a much greater extent than uninfected cells (figure 7.6).
7.3 Discussion
Development of viral specific humoral and CMI responses, especially CTL,
is important in controlling viral replication and dissemination. Cell mediated
cytotoxicity is predominantly mediated by CTL and NK cells under MHC-restricted
and non-MHC-restricted conditions respectively (Berke, 1983; Segal and Snider.
1989). They normally recognize altered antigen on target ceil surfaces, for CTL this
is viral peptide in MHC antigen grooves (Brodsky and Guagliardi, 1991) whilst the
altered antigen for NK cells is unknown. The binding of target cells to cytotoxic
cells induces the effector cell to deliver a "lethal hit" to the bound target cell causing
it to die (Segal and Snider, 1989). One model of killing target cells by cytotoxic
cells involves the secretion of granules containing granzymes and perforin.
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Figure 7.5 Cytotoxic activity mediated by lymphokine-activated killer cells
LAK cells were stimulated by culturing 2x10^ PBL (monocyte depleted)
per ml (A MVV infected sheep 647R; B & C uninfected sheep 1138W) in
RPMI/10%FCS in the presence of rhIL-2 (lOU/ml) for 5 days (A, B) and 13 days
(C), respectively. Target cells (lxlO4 per well), autologous and heterologous
MDM (A, B, C) and autologous skin fibroblasts (SK) (C) in 96-well flat-bottom
microtiter plates were infected or mock-infected with MVV, 0.5 TCrD50 (SK) or
1 TCID5q (MDM), for 1 (SK) and 2 days (MDM) per cell, respectively. Cells were
labelled with 1.5 jiCi 5 Chromium in the well overnight, washed and then used in
cytotoxic assays (16 hours) with different target: effector ratios as indicated.
Results have been expressed as % specific 51Cr release. The percentage
spontaneous ^lQ- release from targets compared to maximal release was: A: 27-
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Figure 7.6 Erythrocyte rosetting positive LAK cell mediated cytotoxicity
Erythrocyte rosetting positive (ER+) and negative (ER~) PBL (MVV-
infected sheep 1091P) were separated as described in section 2.10.5 and then
cultured in the presence of rh-IL2 (lOU/mi) for 5 days before use as effector cells.
Target cells (lxlO4 per well) were autologous skin fibroblasts (SK) infected or
mock-infected with MVV, 0.5 TCID50 per cell for 1 day. Cells were labeled with
1.5 pCi 51Chromium overnight, washed and then used in cytotoxic assays (16
hours) with different target: effector ratios as indicated.
Results have been expressed as percentage specific 51Cr release. The
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perforins polymerize to form polyperforins, insert into the membrane to create
transmembrane channels and then trigger target cell death, apoptosis (Cohen, 1991).
CTL activity in lymphocytes not given in vitro stimulation is rare in PBMC
from MVV-infected sheep (Blacklaws et al., 1994), even in lymphocytes draining
acutely infected lymph nodes (Bird et al., 1993). Additional stimulation of
precursor cells in vitro is necessary to see CTL activity in most MVV infected
sheep. This was also found with CAEV, the most closely related lentivirus to
MVV; goat PBL had to be stimulated with viral antigen in vitro to see CTL activity
(Lichtensteiger et al., 1993). However in 1/7 sheep CTL were demonstrated in
uninfected PBMC. In HIV, 15-85% patients may show killing without secondary in
vitro stimulation (Nixon et al., 1992) and CTL activity without in vitro stimulation
has also been reported in PBMC with SIV (Vowels et al., 1989). Both HIV and SIV
replicate in PBMC and it was therefore thought that if lymphocytes from a major
site of MVV replication were studied, sufficient antigen may be presented in vivo at
these sites to stimulate CTL activity which could then be seen directly in vitro in a
higher proportion of cases. None of the sheep analyzed showed clear CTL activity
in alveolar lymphocytes (Figure7.4). However, none of the lungs obtained showed
gross lesions and therefore may not have been the best samples to use: clinical
scoring of sheep for maedi is difficult and inaccurate and advanced maedi cases
usually do not develop due to management and control of experimental sheep.
There is no significant increase in the number of CD8+ lymphocytes in the BAL
fluid of sheep without lung lesions and the number of lymphocytes recovered from
these lungs was also low and so effector to target ratios were low.
In contrast, direct CTL have been reported in alveolar lymphocytes without
stimulation in HIV-infected patients with interstitial pneumonia at low E: T ratios
(Plata et al., 1987). HIV-infected patients with interstitial pneumonia display an
abnormally high infiltration of CD8+ D44+ T lymphocytes (Plata et al., 1987)
which suggests these cells are a subset of CTL. These patients also showed high
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levels of AM (12-58%) expressing viral antigen (Plata et al., 1987). It is these viral
antigen expressing AM which may be stimulating alveolar lymphocytes to become
active CTL. However, a high frequency of AM expressing viral antigen is not seen
in MVV infected sheep without lung lesions (Watt et al., 1992b; personal
observation). In a similar manner to the results shown here, direct CTL activity
mediated by alveolar lymphocytes cannot be detected in HIV seropositive patients
without interstitial lung lesions (Autran et al., 1991). It has been reported that the
number of CD8+ lymphocytes in MVV-infected sheep with pulmonary lesions is
increased and that most alveolar lymphocytes are also activated (Cordier et al.,
1992; Watt et al., 1992b). Hence, the results shown here cannot be extrapolated to
show lack of CTL activity in lungs in MVV-infected sheep with pulmonary lesions.
A subpopulation of HIV-infected patients with AIDS develop suppressor T
lymphocytes (CD8+, CD57+) in BAL fluid which suppress CTL activity (Joly et al.,
1989; Autran et al., 1991). The decrease of cytotoxic activity in HIV-infected
patients with AIDS is also related to the gradual depletion of CD4+ lymphocytes
and the impairment of cytokine production by CD4+ lymphocytes (Murray et al.,
1984). Whether there is a development of suppressor T lymphocytes which
suppress CTL activity in MVV infection is still not clear.
Precursor CTLs in the blood of MVV infected sheep were stimulated
consistently by autologous MVV infected AM and MDM. Previous studies have
used skin fibroblasts (Blacklaws et al., 1994; Lichtensteiger et al., 1993) and also
MDM (Kennedv-Stoskopf, 1989) to present antigen. Therefore the in vivo infected
cell type can stimulate precursor CTLs into active CTLs. Similarly, both AM and
MDM can act as targets for MHC restricted lysis by MVV specific CTL. AM have
also been used successfully as targets with HIV specific CTL (Plata et al., 1987:
Autran et al., 1991). Using skin cells, the CTL population has been shown to be
CD8+. Skin fibroblasts do not express MHC class II molecules by FACS analysis
and therefore use of the MHC class I/CD8+ interaction is not surprising. However,
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AM and MDM express MHC class II especially when cultured with lymphocytes
and so may be useful targets in determining the role of class II restricted CD4+ CTL
in MVV. CD4+ CTL have been reported in HIV infected and in antigen primed
situations (Orentas et al., 1990; Littaua et al., 1992; Curiel et al., 1993).
Skin fibroblasts gave lower backgrounds and variation and better viral
infections than AM and MDM and so results were much clearer with fibroblasts.
Here there was often recognition of uninfected autologous macrophages which
confused results. Depletion of CD8+ cells caused a decrease in recognition of MVV
infected autologous MDM but did not reduce the 51q- release to background levels.
The same CD8+ depletion using MVV infected skin fibroblast targets reduced
cytotoxicity to background levels. Therefore the major effector population with
MDM targets was CD8+ but other effectors may also have been present (CD4+).
However depletion of CD4+ lymphocytes did not reduce the levels of lysis seen,
perhaps because sufficient CD8+ lymphocytes remained to give maximal lysis over
16 hours.
Inflammatory lesions may induce the activation of macrophages which are
then, if infected, not only targets for MVV specific CTL but also for NK or LAK
cells. IL-2 has been reported to induce functionally activated LAK cells against
tumor or virus-infected cells (Taylor and Cohen, 1992). IL-2 generated LAK cells
also show nonspecific cytotoxic activity against macrophages, especially autologous
macrophages, whether they are infected with virus or not (Djeu and Blanchard,
1988; Streck et al., 1990). Human NK cells are CD2+ and CD16+ (Perussia et al.,
1984; Tilden et al., 1987; Segal and Sinder, 1989) and some NK cells also express
low levels of the CD8 marker (Tilden et al., 1987; Perussia et al., 1984). Hence
CD8+ depletion of effector cells may not only have depleted CD8+ CTL but also
LAK cells which may be why this depletion also greatly decreased the background
on non-infected MDM (table 7.2). Using erythrocyte resetting to separate FcR~ and
FcR+ cells it was found that non-specific lytic activity restricted in the FcR+
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fraction of PBMC (figure 7.6). This would again suggest that poor background
using macrophage targets were caused by FcR+ LAK cells.
In vivo, IL-2 administration has been found to enhance NK cell function
(Djien et al., 1988; Taylor and Cohen, 1992). The lymphokine activated killers
(LAK) lyse normal autologous macrophages. This phenomenon is thought to be a
feedback regulatory mechanism for controlling cytokine production from activated
monocyte/macrophages (Djeu and Blanchard, 1988), because over production of
TNF-a or IL-1 from activated macrophages may be indirectly involved in
autoimmune disease. Therefore, LAK activity may play a role in reducing the
number of activated macrophages after infection.
LAK cytotoxic activity seen also varies with the kinetic activation of PBL
and the maturation state of MDM as well as individual variation (Djeu and
Blanchard, 1988). The frequency of LAK cells in PBL culture stimulated by MVV-
infected skin fibroblasts with IL-2 may be different from PBL cultures with IL-2 for
2 weeks only. Hence it is difficult to evaluate the levels of non-specific activity
involved in CTL assays here. An ADCC assay in HIV infection using U937
(monocytic cell line) as target cells showed around 35% non-specific lysis with
un-infected MDM (Goudsmit et al., 1988), but the reason has not been discussed.
Non-specific backgrounds have also been reported with macrophages lysed by IL-2
activated effector cells (Langlade-Demoyen et al., 1988) and with autologous non-
pulsed (hsp) monocytes during a CD4+ mediated CTL assay (Ottenhoff et al.,
1988). These reports support the view that the results obtained here with MDM
targets were within normal ranges.
It has been reported that two distinct effectors mediate SIV env-specific
target cell lysis (Yamamoto et al., 1990). One is CD16+, MHC class I-unrestricted
which is similar to LAK cells. Weinhold et al (1988) also showed that CD4+
lymphocytes coated with HIV gpl20 were lysed by a population of non-T cell
effectors. This cytotoxicity was enhanced after activation of effector cells with
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IL-2, but greatly decreased after the depletion of CD16+ cells. Riviere et al. (1989)
using a monoclonal antibody for CD3+ incubated with effector cells to block
reactions, inhibited gag-specific cytotoxic activity, but not env-specific cytotoxicity.
Furthermore, the depletion of CD8+ cells had no effect on cytotoxic activity against
autologous target cells infected with vaccinia virus expressing env protein. This
suggests that two distinct types of effector cells mediate killing of targets expressing
gag and env protein. NK or LAK cells play a significant role in controlling env
protein expressing cells whilst classical CTL kill gag expressing cells. Here, the
cell lysis seen with virus-infected autologous MDM mediated by LAK from MVV
infected sheep is higher than mock-infected controls which may be due to an env
specific effect as seen with HIV and SIV, although some CTL activity cannot be
ruled out.
Cultured MDM from MVV-infected sheep, especially long-term or naturally
infected sheep with pulmonary lesions, showed some differences from uninfected
sheep (section 3.2.2). More cells in these cultures underwent "programmed cell
death" (PCD) (Cohen, 1991; Mangan and Wahl, 1991; Ohno et al., 1993) due to
expression of some early signals for death. It has been thought that PCD in
monocytes may be regulated by a complex network of cytokine-mediated
intercellular communication (Mangan and Wahl, 1991). This may have contributed
to the higher spontaneous 51Cr release seen with of MDM compared to skin
fibroblasts.
7.4 Summary
MVV-specific CTL precursors were detected in PBL of all MVV-infected
sheep. MVV infected MDM and AM were targets for CTLs and could also
stimulate CTL activity in vitro. The major effector cell population using MVV
infected macrophage targets was CD8+ although another population may also have
been involved.
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There was no direct or precursor CTL activity found in alveolar lymphocytes
from MVV infected sheep without lung lesions.






All the lentiviruses cause persistent infections which are typified by slow
disease progression. Although the depletion of CD4+ lymphocytes is a central
feature of immunosuppression in HIV, SIV and FIV infection (Narayan and
Clements, 1989; Pedersen et al., 1989; McEntee et al., 1991), macrophages are
thought to be the site of viral persistence. In MVV and CAEV macrophages are
also the site of viral persistence as they are the major target cells for infection.
Therefore a better understanding of the interaction between MVV and macrophages
may lead to more insight into the interaction of HIV and macrophages unclouded by
interference by the CD4+ infection.
The research undertaken here looked at the interaction of MVV and
macrophages with 3 main aspects: MVV replication in the macrophages; the effect
of MVV infection on the phenotype and functional capacities (phagocytic and
antigen presenting function) of macrophages, and the ability of MVV infected
macrophages to act as targets for effector mechanisms involved in clearing virus
infected cells eg CTL.
8.2 Interaction of Macrophages and Lentiviruses
Mammalian animals normally have both non-specific (NK cells, neutrophils
and macrophages) and specific (CMI and humoral immunity) defences against
invading pathogens. During the early phase of primary infection viruses rapidly
replicate in target cells and cause lesions with a lot of progeny being produced and
spread. It is at this firsr stage that non-specific immune mechanisms are important
in limiting the amount of virus produced. Once sufficient inflammation and antigen
have been produced the host develops specific immunity which is important in
eliminating these pathogens and allowing recovery from infection. However for
patients with defects in immunity, infection may result in death. This basic model is
normally seen in most viral infections (Sissons and Oldstone, 1980). HIV, SIV and
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FIV have a similar pattern in early viral infection, even though these events progress
slowly compared to other viruses. There is a rapid rise in viral production in PBMC
and plasma virus titer prior to the development of viral antibodies. After the
development of viral specific antibodies and cytotoxic cells, most virus and virus
infected cells are eliminated. However, a reservoir of viral replication is established
in macrophages throughout the asymptomatic period of infection. Another peak of
viral production is seen in the late phase of HIV infection when immunodeficiency
becomes marked (Miedema et al., 1990; Dear et al., 1991; Clark et al., 1991).
Surprisingly, there is only a low level of virus generated in acute MVV infected
lymph nodes (Dr.P. Bird, personal communication) and few virus associated cells
are released in efferent lymph (11 in 10^ efferent cells). However both humoral and
cell mediated immune responses are induced as is seen in other lentivirus infections
(Bird et al., 1993).
In MVV infection there is a low level of viral infection (Gendelman et al.,
1985), which persists together with a large amount of pathology accumulating in
lung, brain, joints and mammary glands (Cutlip et al., 1979; Oliver, et al., 1983).
The virus is known to persist in macrophages. Macrophages have a short life span
and may die after activation and virus infection. Here it has been shown that MVV-
infected macrophages can be killed by CTL and LAK cells (section 7.2) once
productive infection is switched on. This is one mechanism by which productively
infected cells may be cleared. Therefore the maintenance of infection in the
macrophage pool requires continual recruitment of newly infected cells or latently
infected cells into target tissues. There are several ways in which this may occur.
Promonocytes containing proviral DNA are found in the bone marrow and may
transfer infection into target organs as monocytes seed into tissues (Gendelman et
al., 1985). Virions accumulating in vesicles (section 3.2.3 & 3.2.4) may be released
when macrophages die or are killed by immune effector mechanisms and may be
immediately taken up by neighboring macrophages. In addition, virions or viral
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DNA may be passaged to new daughter cells if macrophage division occurs as seen
in the joints of CAEV infected goats (Jutila and Banks, 1988). This allows the
equilibrium to be maintained between clearance and infection such that infection
continues at low levels in target tissues.
The tissue macrophages from lesions appear activated (by surface antigen
expression, libronectin and neutrophil chemotactic production; Cordier et al., 1990)
during MVV infection. The interaction of virus infected macrophages and
lymphocytes at these sites may induce the secretion of cytokines, eg LV-IFN
(Narayan et al.,1985; Zink et al., 1987; Lairmore et al., 1988) which amplify surface
molecule changes and functions of macrophages (Cordier et al., 1990; Lujan et al.,
1993). Cytokines produced from lymphocytes interacting with these activated
macrophages (TNF-a and IL-1) may also enhance expression from the viral LTR
and increase viral antigen production eg env gpllO (Clements et al., 1979). If this
occurs, free viral antigen may interfere with uninfected cell functions. Gag p25
antigen has been seen in efferent lymph plasma (Bird et al., 1993) and so free viral
antigens may be present in the body fluids of MVV infected sheep. In HIV, env
gpl20 secreted from infected cells is known to interfere with the activity of
uninfected cells (Habeshaw et al., 1990; Wagner et al., 1992). The env protein
production in MVV-infected AM in vitro appears normal (section 3.2.8) and
although there are no reports of MVV env adversely affecting immune functions,
this may be through a lack of research as no recombinant env gpllO is available.
Free virus antigen may also add to the general immune activation, if macrophages
take it up and present it to lymphocytes.
Whether the persistently infected macrophages at sites of MVV induced
lesions (lung, synovium) are actually activated is not clear. Studies on phagocytosis
and antigen presenting function in productively infected macrophages in vitro
(section 5.2 and section 6.2) have shown functional defects. But in vivo there are
only a low percentage of productively infected macrophages. This may be one of
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the reasons why functional defects of macrophages cannot be seen in vivo, although
a suggestion of a decrease in phagocytosis and erythrocyte rosetting may be seen in
AM from lungs with lesions (section 5.2.6).
8.3 Immunosurveillance problems
Another problem with lentivirus infections is that virus is not cleared by host
immunosurveillance. Factors contributing to control of viral replication in vivo may
include: virus-specific CTL and antibodies, non-specific NK (LAK) cells, IFN-y,
and macrophages themselves. Factors allowing persistence of the virus include the
restriction of viral replication, antigenic drift (Narayan and Clement, 1989) or
perhaps the induction of the wrong types of effector mechanisms.
Restriction of viral replication and persistence in target cells are
characteristics of lentiviral infection. Only a few cells are infected in vivo and these
contain relatively low copy numbers of viral RNA (50-150 copies per cell). In
contrast, in vitro, there are thousands of copies of the viral genome and more than
50-100 progeny virions are produced per cell (Haase et al., 1982). Viral persistence
has been found in lung, brain, spleen and lymph nodes, but there is no evidence
showing MVV persistence in Kupffer's cells (Gendelman et al., 1985; Kennedy et
al., 1985), the resident liver macrophage. Hence, it is possible that within the liver
microenvironment, a host regulatory factor within Kupffer's cells is regulating
monocyte differentiation and is aborting viral infection in Kupffer's cells. The study
of the interaction between MVV and Kupffer's cells, whether virus can enter the cell
and if so, how this infection is aborted by the Kupffer's cell, may be helpful in
finding a way to breakdown viral persistence in macrophages. The block in
infection of Kupffer's cells has been overcome by EIAV (Salinovich et al., 1986),
another lentivirus where Kupffer's cells are the major target cells. However, in vitro
observations may not reflect what happens in a much more complex in vivo situation
in which the immune system is involved.
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Recently, using PCR with in situ hybridization, a high frequency of target
cells harboring viral DNA have been shown in the lung (Staskus et al., 1991; Haase
et al., 1990). These epithelial cells did not have viral RNA and so may have been
truly latent. Latent cells do not express viral antigen and so cannot be removed by
immune effector mechanisms allowing virus to persist in the host.
Antigenic mutation may allow MVV to persist in sheep. Escape mutants are
known to arise in MVV to neutralizing antibody and in HIV, CTL escape mutants
have also been documented (Narayan et al., 1978; Phillips et al., 1991). Again this
would allow the persistence of virus in the host. Early work on immune responses
to MVV show transient proliferative responses to MVV antigen (Larsen et al., 1982;
Shivonen et al., 1981) which would also allow periodic replication of the virus in
the host. However recently, it has been reported that proliferation to MVV antigen
(Reyburn et al., 1992b) and CTL activity (Blacklaws et al., 1994) can be
consistently detected in PBMC from MVV-infected sheep. Additionally, antibody
is always present; as no viremia is seen in MVV, neutralizing antibody may be
functioning all the time. We have shown that macrophages can act as targets for
CTL and can induce CTL activity (section 7.2). All these suggest that good
immunosurveillance is in operation. This may be why little antigen and few
infected cells are seen at lesions. Virus would therefore need to persist by other
mechanisms eg latency.
It is not known which MVV antigens are recognized by CMI responses
(except p25 in the proliferation response; Reyburn et al., 1992b). In HIV and SIV
nearly all viral antigens are recognized (Michel et al., 1992; Letvin et al., 1992).
Lentivirus replication has an early stage in which non-structural proteins involved in
control of virus replication are expressed (rev and tat). Later productive stages of
virus replication probably have expression of all viral genes including the structural
genes (gag, pol, and env). Good immunity should involve responses to early
antigens ie rev and tat which would allow viral replication to be stopped before
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progeny are produced. It will be interesting to see if in MVV, there are good
immune responses (CTL) to rev or tat, as this may be one of the most important
factors in keeping the numbers of infected cells low in vivo. MVV has a restricted
replication state in monocytes (Gendelman et al., 1986), but it is not known if rev
and tat are expressed in these infected cells, and so whether these can be targets for
immune surveillance. If it was shown that there was a specific lack of immunity to
early viral antigen it would be very interesting to see if immunization could
overcome this defect and if this helped to decrease the numbers of infected cells
seen in vivo ever further.
CD8 proliferation is a common feature in many viral infections (McMichael
et al., 1983) and lentiviruses are not exceptions. A great increase in CD8+
lymphoblasts was seen in efferent lymph after MVV infection, but the CTL activity
detected in 1 out 5 sheep during this period was when cell-associated virus exited
the lymph node (Bird et al., 1993). A similar phenomenon, activated CD8+
lymphocytes, was seen in lymph nodes of monkeys after SIV infection (Reimann et
al., 1991). These CD8+ lymphocytes are activated, but do not express IL-2 receptor
(CD25) and so are thought to be in a defective maturation state (Bird et al., 1993;
Reimann et al., 1991; Salazar-Gonzalez et al., 1985). An increase in CD8+
lymphocytes is also seen in bronchoalveolar lavage, CSF or synovial fluid from
MVV infected sheep, particularly in those sheep which have developed lesions
(Harkiss et al., 1991; Torsteinsdottir et al., 1992; Lujan et al., 1993; section 4.2.7).
Though virus-specific CD8+ CTL are important in the lysis of virus-infected cells
during acute infection, the activated CD8+ lymphocytes in lentiviral infection may
mainly function to regulate viral replication. The increase in CD8+ lymphocytes
does not parallel CTL activity in SIV and MVV (Reimann et al., 1991; Bird et al.,
1993), but activated CD8+ lymphocytes can suppress HIV and SIV replication in
CD4+ lymphocytes in a non-MHC restricted manner (Kannagi et al., 1988; Walker
et al., 1988). This point has not been studied in MVV infection.
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Evidence shows that there is only an IgGj response to MVV antigen after
viral infection (Reyburn, 1992a), but IgG2 responses can be induced by immunizing
with gag p25 antigen (Dr. P. Bird, personal communication). The presence of Thl
or Th2 lymphocytes and which cytokines mediate the production of IgGj or IgG2
has not been shown in sheep, but there may be a predominant antibody isotope
produced due to the induction of a specific helper cell subset (Th2). IgG! antibody
in MVV infected sheep may not mediate ADCC activity (Reyburn, 1992a). This
may be an important defect in control of viral replication. If the other
subpopulation (Thl lymphocytes) was induced would a different and more effective
antibody be produced? The induction of incorrect immune effector mechanisms eg
IgG2 and CD8+ cells discussed above may fail to efficiently eliminate virus infected
cells and allow lentivirus persistence.
Most previous studies on MVV infection used PBMC and serum because of
ease of sampling. There is no significant alteration in lymphocyte phenotypes in
PBMC and good antibody and CMI responses appear to be present in infected
sheep. However, there are significant changes in CD4:CD8 lymphocyte ratios and
lymphocyte and macrophage phenotypes in lung, synovium and CSF (Cordier et al.,
1992; Lujan et al., 1993; Torsteinsdottir et al., 1992), suggesting that the situation in
blood may not really reflect the situation in organs targeted by MVV infection. For
example we cannot prove CTL activity in BAF fluid (section 7.2.4) whilst it was
clearly seen in PBMC. This may be due to the wrong specimens (samples from
lungs with no lesions) or low effector : target ratios being used, but this could also
indicate a specific lack of immunity in sites where virus is found.
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8.4 Respiratory Tract Immunity
Concurrent infection with pasteurellosis is a common feature in maedi,
especially in field cases (Cutlip et al., 1977; Markson et al., 1983; Myer et al.,
1988), but it is not seen in MVV infected sheep without lung lesions, suggesting that
the immunological defence of the respiratory tract may be impaired in some sheep
which have developed pulmonary lesions. Pulmonary defence against infection is
very complex and consists of local humoral (IgA and IgG) and cellular immunity,
complement, ciliary activity, mucus production and phagocytosis (Burrells, 1985;
Christoensen and Mousing, 1992). The major immunoglobulin generated in the
respiratory tract particularly in the upper respiratory tract is secretory IgA which can
efficiently agglutinate invading bacteria; this may enhance mucociliary clearance of
pathogens and inhibit bacterial colonization of the mucosa. However significant
amounts of IgG and complement components are also found in the lower respiratory
tract (Burrells, 1985). These plasma components enter the respiratory system by
transduction, although some may be produced locally (Kaltreider, 1976). IgG and
complement components are an important source of opsonin for phagocytes. The
phagocytic and microbicidal effect of AM and the opsonins in the pulmonary
environment therefore act together in destroying invading pathogens (Kaltreider,
1976). In maedi affected lungs, the alveolar walls are greatly thickened which may
decrease the transduction of plasma factors into the lung. This would reduce the
amount of opsonin in the respiratory system available for action with AM, allowing
the replication of gram negative bacteria (which require opsonization for
phagocytosis) entering alveolar areas. The impairment of CD4+ lymphocyte
function and production of cytokines (IFN-y) which decrease AM function
contribute to opportunistic pathogen infections seen in AIDS patients. There is no
evidence of mycotic and protozoal infections (phagocytosed without opsonization)
in MVV infected sheep (Markson et al., 1983), but these are often seen in AIDS
patients (Marchevsky et al., 1985). This may indicate that the basic phagocytosis of
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fungi and protozoa by AM from MVV-infected sheep is intact. Indeed the absence
of a significant difference in the phagocytic activity of AM from MVV infected
sheep with pulmonary lesions compared to controls supports this view (section
5.2.6). In addition, increases in the number of activated lymphocytes in MVV have
been reported (Watt et al., 1992b; Cordier et al., 1992). The cytokines secreted
from activated lymphocytes may activate macrophage functions (phagocytic and
intracellular killing activity) which are important in eliminating pathogens.
Therefore the physiological impairment of the lung (thickness of alveolar walls)
may be more important in allowing gram negative bacterial superinfection in maedi
affected lungs than alterations in AM function.
Recently, research has focused on the suppressive effect of AM, via nitric
oxide, on pulmonary immunity (Mills,1991; Holt, 1986). Nitric oxide is functional
against microorganisms and tumor cells (Liew and Cox, 1991), but also suppresses
pulmonary DC function and lymphocyte responses (Holt et al., 1986 & 1993). One
hypothesis suggests that the suppressive effect of AM is necessary for the control of
the non-specific activity of AM. AM frequently come into contact with foreign
antigens from air or the upper respiratory tract which may non-specifically trigger
AM to release accessory cell factors leading to immunopathological lesions. The
major physiological function of AM is thought to be the release of chemotactic
factors, ingestion and degradation of antigen and microbicidal activity (Brain. 1992)
rather than an antigen presenting function for lymphocytes. Therefore, the increase
in the number of lymphocytes and AM and their activation in MVV infection is not
only responsible for the induction of the active chronic inflammation seen, but also
may cause a suppressive state in local immunity. This may contribute to the
concurrent infections seen in some maedi affected lungs.
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8.5 Immune Mechanisms of Pathology
Pathology accumulated during MVV infection is mediated by immune
responses (Nathanson et al, 1976). It is not known however, if this is through MVV
antigens or responses to autoimmune antigens. It has been shown that CSF
lymphocytes proliferate to MVV antigen (Torsteinsdottir et al., 1992). The levels of
proliferation correlated to the severity of lesions, suggesting that anti-MVV
immunity mediates pathology. This could be through persistent, small amounts of
viral antigen being produced in target organs which continuously stimulate immune
responses and cytokine production (low levels) leading to chronic inflammation.
It has been shown that stressed macrophages, either virally infected or
cytokine activated, may induce heat shock protein (hsp) expression which can be
recognized by y5 T cells (Aquino et al., 1992) or NK and LAK cells (section 7.2.5).
Hsp is expressed on HIV-infected lymphocytes which are lysed by hsp-specific
antibody (ADCC) (Cesare et al., 1992), cytotoxic CD4+ lymphocytes (Munk et al.,
1989; Ottenhoff et al., 1988) and NK cells (Cesare et al., 1992; Djeu and Blanchard,
1988). Hence, it is possible that MVV-infected macrophages may also express hsp
antigen (Dr G. Harkiss, personal communication) and initiate autoimmune responses
leading to chronic inflammation.
8.6 Summary
My work has looked at the in vitro infection of macrophages with MVV. In
this system, most macrophages become productively infected. This is different to
the situation in vivo where low frequencies of productive virus infection are seen.
MVV infection does appear to decrease antigen presenting and phagocytic functions
of macrophages in vitro which you would expect to lead to immunosuppression.
However, immunosuppression is not usually seen in vivo, due to the low levels of
infection and the presence of other cell types which can take over these functions.
Infected macrophages are targets for immunosurveillance (CTL and NK/LAK cells)
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and the low levels of infected cells and antigen seen in vivo may be, in part, due to
clearance from the host and so mechanisms for evasion of the immune response
must exist. These may include latency or restricted replication in immature
macrophages.
In vivo a complex interaction with lymphocytes and macrophages causes a
chronic inflammatory state which was not replicated here by the in vitro infected
macrophages. Future work should therefore perhaps focus on the production of
sheep promonocyte/monocyte cell lines or the definition of in vitro culture
conditions which would allow the establishment of persistent MVV infections in
vitro and their effect on macrophage function to be studied. From results shown
here, functional assays with in vivo material (AM, synovial macrophages) should be
continued as the changes in phenotype documented do not necessarily correlate to
changes in macrophage function.
192
REFERENCES
Anderson, C. L. 1987. Structural and functional polymorphism of human Fc
receptors for IgG.
Chemical Immunology 47:1-20
Andreesen, R., Brugger,W., Scheibenbogen,C., Kreutz, M., Leser, H.G., Rehm, A.
and Lohr, G.W. 1990. Surface phenotype analysis of human monocyte to
macrophage maturation.
Journal of Leukocyte Biology 47:490-497.
Armstrong, J.A. and Home, R. 1984. Folicullar dendritic cells and vims-like
particles in AIDS related lymphadenopathy.
Lancet 11:370-372.
Aquino, D.A. and Brosnan, C.F. 1992. Heat-shock proteins and immunopathology.
Chemical Immunology 53:1-16.
Audoly, G., Sauze, N., Harkiss, G., Vitu, C., Russo, P., Querat, G., Suzan, M. and
Vigne, R. 1992. Identification and subcellular localization of the Q gene product of
visna vims.
Virology 189:734-739.
Autran, B., Sadat-Sowti, B., Hadida, F., Parrot, A., Guillon, J., Plata, F., Mayaud,
C. and Debre, P. 1991. HIV-specific cytotoxic T lymphocytes against alveolar
macrophages: specificities and downregulation.
Research in Virology 142:113-118.
Baldwin, G. C., Fleischmann, J., Chung, Y., Koyanagi, Y., Chen, I.S.Y. and Golde,
D.W. 1990. Human immunodeficiency vims causes mononuclear phagocyte
dysfunction.
Proceedings of National Academy of Sciences of the USA 87:3933-3937.
Banapour, B., Marthas, M., Munn, R. J. and Luciw, P.A. 1991. In vitro
macrophage tropism of pathogenic and nonpathogenic molecular clones of simian
immunodeficiency vims (SIVmac).
Virology 183:12-19.
Bandyopadhyay, S., Ziegner, U., Campbell, D.E., Miller, D.S., Hoxie, J.A. and
Starr, S.E. 1990. Natural killer cell-mediated lysis of T cell lines chronically
infected with HIV-1.
Clinical and Experimental Immunology 79:430-435.
Barban, V., Querat, G., Sauze, N., Filippi, P., Vinge, R., Pierre, R. and Vitu, C.
1984. Lentiviruses are naturally resident in a latent form in long-term ovine
fibroblast cultures.
Journal of Virology 52:680-682.
193
Becker, S., Warren, M.K. and Haskill, S. 1987. Colony-stimulating factor-induced
monocyte survival and differentiation into macrophages in serum-free cultures.
Journal of Immunology 139:3703-3709.
Beelen, R.H.L., Bos, H.J., Kamperdijk, E.W.A. and Hoefsmit, E.C.M. 1989.
Ultrastructure of monocytes and macrophages pp7-16. In Human monocytes. Eds:
Zembala, M. and Asherson, G.L. Academic Press Ltd, London.
Belsito, D.V., Sanchez, M.R., Baer, R.L., Valentine, F. and Thorbecke, G.J. 1984.
Reduced Langhan's cell la antigen and ATPase activity in patients with the acquired
immunodeficiency syndrome.
The New England Journal of Medicine 310:1279-1282.
Bender, B.S., Davidson, B.L., Kline, R., Brown, C. and Quinn, T.C. 1988. Role of
the mononuclear phagocyte system in the immunopathogenesis of human
immunodeficiency virus infection and the acquired immunodeficiency syndrome.
Reviews of Infectious Diseases 10:1142-1154.
Berke, G. 1983. Cytotoxic T-lymphocytes. How do they function?.
Immunological Review 72:5-37.
Bermudez, L.E.M. and Young, L.S. 1988. Tumor necrosis factor, alone or in
combination with IL-2, but not IFN-y, is associated with macrophage killing of
Mycobacterium avium complex.
Journal of Immunology 140:3006-1013.
Bemhard, W. 1960. The detection and study of tumor viruses with the electron
microscope.
Cancer Research 20:712-727.
Bevilacqua, M.P. 1993. Endothelial-leukocyte adhesion molecules.
Annual Review of Immunology 11:767-804.
Bird, P., Blacklaws, B., Reyburn, H.T., Allen, D., Hopkins, J., Sargan, D. and
McConnell, I. 1993. Early events in immune evasion by the lentivirus maedi-visna
occuring within infected lymphoid tissue.
Journal of Virology 67:5187-5197.
Bjerknes, R., Bassoe, C-F., Sjursen, H., Laerum, O.D. and Solberg, C.O. 1989.
Flow cytometry for the study of phagocyte functions.
Reviews of Infectious Diseases 11:16-33.
Blacklaws, B.A., Bird, P., Allen, D. and McConnell, I. 1994. Circulating cytotoxic
T lymphocyte precursors in maedi-visna virus infected sheep.
Journal of General Virology, submitted.
194
Blackwell, J.M., Ezekowitz, R.A.B., Roberts, M.R., Channon, J.Y., Sim, R.B. and
Gordon, S. 1985. Macrophage complement and lectin-like receptors bind
Leishmania in the absence of serum.
Journal of Experimental Medicine 162:324-331.
Blumberg, R.S., Paradis, T., Hartshorn, K.L., Vogt, M., Ho, D.D., Hirsch, M. S.,
Leban, J., Sato, V. L. and Schooley, R. T. 1987. Antibody-dependent cell-mediated
cytotoxicity against cells infected with the human immunodeficiency virus.
Journal of Infectious Diseases 156:878-884.
Boschert, K.R., Schoeb, T.R., Chandler, D.B. and Dillehay, D.L. 1988. Inhibition
of phagocytosis and interleukin-1 production in pulmonary macrophages from rats
with sialodacryoadenitis virus infection.
Journal of Leukocyte Biololgy 44:87-92.
Bourgault, I., Vent, A. and Levy, J.P. 1992. Three epitopic peptides of the simian
immunodeficiency virus nef protein recognized by macaque cytolytic
T- lymphocytes.
Journal of Virology 66:750-756.
Bowen, D.L., Lane, H.C. and Fauci, A.S.
acquired immunodeficiency syndrome.
Progress in Allergy 37:207-223.
1986. Immunologic abnormalities in the
Brahic, M., Filippi, P., Vinger, R. and Haase, A.T. 1977. Visna virus RNA
synthesis.
Journal of Virology 24:74-81.
Brain, T.D. 1992 Mechanisms, measurement, and significance of lung macrophage
function.
Environmental Health Perspectives 97:5-10.
Bravo-Cuellar, A., Nowacki, W., Vuillier, F., de Saint-Martin, J. and Orbach-
Arbouys, S. 1992. The bactericidal capacity of peripheral blood monocytes from
HIV positive patients may collapse very soon after the infection.
Immunology Letters 31:297-299.
Bray, D.H., Squire, B., Kawana, A., Johnson, M.A., Poulter, L.W. 1993.
Antiretroviral treatment reverses HIV-induced reduction in the expression of surface
antigens on alveolar macrophages in AIDS patients.
Clinical and Experimental Immunology 91:13-17.
Breen, E.C., Rezai, A.R., Nakajima, K., Beall, G,N., Mitsuyasu, R.T., Hirano, T.,
Kishimoto, T. and Martinez-Maza, O. 1990. Infection with HIV is associated with
elevated IL-6 levels and production.
Journal of Immunology 144:480-484.
195
Brinchmann, J.E., Gaudernack, G. and Vartdal, F. 1990. CD8+ T cells inhibit HIV
replication in naturally infected CD4+ T cells: Evidence for a soluble inhibitor.
Journal of Immunology 144:2961-2966.
Brodsky, F.M., Guagliardi, L.E. 1991. The cell biology of antigen processing and
presentation.
Annual Review Immunology 9:707-744.
Bruggen, I.V., Price, P., Robertson, T.A. and Paradimitriou, J.M. 1989.
Morphological and functional changes during cytomegalovirus replication in murine
macrophages.
Journal of Leukocyte Biology 46:508-520.
Buhl, R., Jaffe, H.A., Holroyd, K.J., Borok, Z., Roum, J.H., Mastrangeli, A., Wells,
F.B., Kirby, M., Saltini, C. and Crystal, R.G. 1993. Activation of alveoar
macrophages in asymptomatic HIV-infected individuals.
Journal of Immunology 150:1019-1028.
Bujdoso, R., Young, P., Harkiss, G. D. and McConnell, I. 1989. Antigen-
presentation in the sheep: generation of antigen-specific T cell lines.
Immunology 66:559-564.
Burrells, C. 1985. Cellular and humoral elements of the lower respiratory tract of
sheep.
Veterinary Immunology and Immunopathology 10: 225-243.
Buschmann, H. and Winter, M. 1989. Assessment of phagocytic activity of
granulocytes using laser flow cytometry.
Journal of Immunological Methods 124:231-234.
Buseyne, F., McChesney, M., Porrot, F., Kovarik, S., Guy, B. and Riviere, Y.
1993. Gag-specific cytotoxic T lymphocytes from human immunodeficiency virus
type 1-infected individuals: gag epitopes are clustered in three regions of the p24
gag protein.
Journal of Virology 67:694-702.
Cameron, P. U., Dawkins, R.L., Armstrong, J.A. and Bonifacio, E. 1987. Western
blot profiles, lymph node ultrastructure and viral expression in HIV-infected
patients: a correlative study.
Clinical and Experimental Immunology 68:465-478.
Cameron, P.U., Freudenthal, P.S., Barker, J.M., Gezelter, S., Inaba, K. and
Steinman, R.M. 1992. Dendritic cells exposed to human immunodeficiency virus
type-1 transmit a vigorous cytopathic infection to CD4+ T cells.
Science 257:383-387.
196
Capsoni, F., Minonzio, F., Ongari, A.M., Rizzardi, G.P., Lazzarin, A. and Zanussi,
C. 1992. Monocyte-derived macrophage function in HIV-infected subjects: in vitro
modulation by rIFN-y and rGM-CSF.
Clinical Immunology and Immunopathology 62: 176-182.
Capsoni, F., Minonzio, F., Ongari, A.M., Colombo, G., Rizzardi, G.P., Bonara, P.,
D'Arminio-Monforte, A. and Zanussi, C. 1992. Increased expression of IgG Fc
receptor type I on neutrophils and monocytes from HIV-infected subjects.
Clinical and Experimental Immunology 90:175-180.
Carmichael, A., Jin, X., Sissons, P. and Borysiewicz, L. 1993. Quantitative analysis
of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T
lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL
responses to HIV-1 and Epstein-Barr virus in late disease.
Journal of Experimental Medicine 177:249-256.
Cesare, S.D., Poccia, F., Mastino, A. and Colizzi, V. 1992. Surface expressed
heat-shock proteins by stressed or human immunodeficiency virus (HlV)-infected
lymphoid cells represent the target for antibody-dependent cellular cytotoxicity.
Immunology 341-343.
Chen, B.D.M., Clark, C.R. and Chou, T. 1988. Granulocyte/macrophage colony-
stimulating factor stimulates monocyte and tissue macrophage proliferation and
enhances their responsiveness to macrophage colony-stimulating factor.
Blood 71: 997-1002.
Cheng-Mayer, C., Quiroga, M., Tung, J.W., Dina, D. and Levy, J.A. 1990. Viral
determinants of human immunodeficiency virus type 1 T-cell or macrophage
tropism, cytopathogenecity, and CD4 antigen modulation.
Journal of Virology 64:4390-4398.
Christensen, G. and Mousing, J. 1992. Respiratory System pp 138-162. In Disease
of Swine, 7th Edn. Eds: Leman, A.D., Atraw, B.F., Mengeling, W.C., D'Allaire, S.
and Taylor, D.J., Wolfe Publishing LTD, Iowa.
Clements , J.E., Narayan, O., Griffin, D.E. and Johnson, R.T. 1979. The synthesis
and structure of visna virus DNA.
Virology 93:377-386.
Clements , J.E., Pedersen, F.S., Narayan, O. and Haseltine, W.A. 1980. Genomic
changes associated with antigenic variation of visna virus during persistent
infection.
Proceedings of National Academy of Sciences of the USA 77:4454-4458.
Clerici, M., Lucey, D.R., Zajac, R.A., Boswell, R.N., Gebel, H.M., Takahashi, H.,
Berzofsky, J.A. and Shearer, G.M. 1991. Detection of cytotoxic T lymphocytes
specific for synthetic peptides of gpl60 in HIV-seropositive individuals.
Journal of Immunology 146:2214-2219.
197
Clerici, M., Stocks, N.I., Zajac, R.A., Boswell, R.N. and Shearer, G.M. 1990.
Accessory cell function in asymptomatic human immunodeficiency virus-infected
patients.
Clinical Immunology and Immunolopathology 54:168-173.
Clouse, K.A., Powell, D., Washinton, I., Poli, G., Strebel, K., Farrar, W., Barstand,
P., Kovacs, J., Fauci, A.S. and Folks, T.M. 1989. Monokine regulation of human
immunodeficiency virus-type 1 expression in a chronically infected human T cell
clone.
Journal of Immunology 142:431-438.
Coffin, J.M. 1990. Retroviridae and their replication. In Virology, 2nd Edn, Eds:
B.N. Fields & D.M. Knipe, Raven Press Ltd., New York.
Cohen, J.J. 1991. Programmed cell death in the immune system.
Advances in Immunology 50:55-85.
Collins, F.M., Niederbuhl, C.J. and Campbell, S.G. 1983. Bactericidal activity of
alveolar and peritoneal macrophages exposed in vitro to three strains of Pasteurella
multocida.
Infection and Immunity 39:779-784.
Collman, R., Godfrey, B., Cutilli, J., Rhodes, A., Hassan, N.F., Sweet, R., Douglas,
S.D., Friedman, H., Nathanson, N. and Gonazales-Fcarano, F. 1990. Macrophage -
tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor.
Journal of Virology 64:4468-4476.
Collman, R., Hassan, N.F., Walker, R., Godfrey, B., Cutilli, J., Hastings, J.C.,
Friedman, H., Douglas, S.D. and Nathanson, N. 1989. Infection of monocyte-
derived macrophages with human immunodeficiency virus type 1 (HIV-1):
Monocyte- tropic and lymphocyte-tropic strain of HIV-1 show distinctive patterns
of replication in a panel of cell types.
Journal of Experimental Medicine 170:1149-1163.
Cordier, G., Cozon, G., Greenland, T., Rocher, F., Guiguen, F., Guerret, S., Brune,
J. and Mornex, J. F. 1990. In vivo activation of alveolar macrophages in ovine
lentivirus infection.
Clinical Immunology and Immunopathology. 55:355-367.
Cordier, G., Guiguen, F., Cadore, J.L., Cozon, G., Jacquier, M.F. and Momex, J.F.
1992. Characterization of the lymphocytic alveolitis in visna maedi virus-induced
interstitial lung disease of sheep.
Clinical and Experimental Immunology 90:18-24.
Coward, J.E., Harter, D.H. and Morgan, C.
of visna virus-infected cell cultures.
Virology 40:1030-1038.
1970. Electron microscopic observation
198
Coward, J.E., Marter, D.H., Hsu, K.C. and Morgan, C. 1972. Ferritin-conjugated
antibody labeling of visna virus.
Virology 50:925-930.
Crane, S.E., Buzy, J. and Clements, J.E. 1991a. Identification of cell membrane
proteins that bind visna virus.
Journal of Virology 65: 6137-6143.
Crane, S.E., Kanda, P. and Clements, J.C. 1991b. Identification of the fusion
domain in the visna virus transmembrane protein.
Virology 185:488-492.
Crane, S.E., Clements , J.E. and Narayan, O. 1988. Separate epitopes in the
envelope of visna virus are responsible for fusion and neutralization: biological
implications for anti-fusion antibodies in limiting virus replication.
Journal of Virology 62:2680-2685.
Crowe, S.M., Mills, J., Elbeik, T., Lifson, J.D., Kosex, J., Marshall, J.A., Engleman,
E.G. and McGrath, M.S. 1992. Human immunodeficiency virus-infected monocyte-
derived macrophages express surface gpl20 and fuse with CD4 lymphoid cells in
vitro: a possible mechanism of T lymphocyte depletion in vivo.
Clinical Immunology and Immunopathology 65:143-151.
Crowe, S., Mills, J. and McGrath, M.S. 1987. Quantitative
immunocytofluorographic analysis of CD4 surface antigen expression and HIV
infection of human peripheral blood monocyte/macrophages.
AIDS Research and Human Retroviruses 3:135-145.
Cullen, B.R. 1992. Mechanism of action of regulatory proteins encoded by complex
retroviruses.
Microbiological Reviews 56:375-394.
Cullen, B.R. and Greene, W.C. 1989. Regulation pathways governing HIV-1
replication.
Cell 58:423-426.
Curiel, T.J., Wong, J.T., Gorczyca. P.F., Schooley, R.T. and Walker, B.D. 1993.
CD4+ human immunodeficiency virus type 1 (HIV-1) envelope-specific cytotoxic T
lymphocytes derived from the peripheral blood cells of an HIV-1-infected
individual.
AIDS Research and Human Retroviruses 9:61-68.
Cutlip, R.C., Lehmkuhl, H.D., Schmerr, M.J. and Brogden K 1988. Ovine
progressive pneumonia (media-visna) in sheep.
Veterinary Microbiology 17:237-250.
199
Cutlip, R.C., Lehmkuhl, H.D., Brogden, K.A. and Sacks, J.M. 1986. Breed
susceptibility to ovine progressive pneumonia (maedi/visna) virus.
Veterinary Microbiology 12:283-288.
Cutlip, R.C., Lehmkuhl, H.D., Wood, R.L. and Brogden, K.A. 1985. Arthritis
associated with ovine progressive pneumonia.
American Journal of Veterinary Research 46:65-68.
Cutlip, R.C., Jackson, T.A. and Lehmkuhl, H.D. 1979. Lesions of ovine
progressive pneumonia: interstitial pneumonitis and encephalitis.
Americian Journal of Veterinary Research 40:1370-1374.
Czop, J.K. and Austen, K.F. 1985. A fi-glucan inhibitable receptor on human
monocytes: its identity with the phagocytic receptor for particulate activators of the
alternative complement pathway.
Journal of Immunology 134:2588-2593.
Dahlberg, J.E. 1988. An overview of retrovirus replication and classification.
Advance in Veterinary Science and Comparative Medicine 32:1-35.
Dahlberg, J.E., Gaskin, J.M. and Perk, K. 1981. Morphological and immunological
comparison of caprine arthritis encephalitis and ovine progressive pneumonia virus.
Journal of Virology 39:914-919.
Dalziel, R.G., Hopkins, J., Watt, N.J., Dutia, B.M., Clarke, H.A.K. and McConnell,
I. 1991. Identification of a putative cellular receptor for the lentivirus visna virus.
Journal of General Virology 72:1905-1911.
Davidson, B.L., Kilne, J.R. and Quinn, T.C. 1988. Surface makers of monocyte
function and activation in AIDS.
Journal of Infectious Diseases 158:483-486.
Dinarello, C.A. 1991. Inflammatory cytokines: interleukin-1 and tumor necrosis
factor as effector molecules in autoimmune disease.
Current Opinion in Immunology 3:941-948.
Ding, A.H., Nathan, C.F. and Stuehr, D.J. 1988. Release of reactive nitrogen
intermediates and reactive oxygen intermediates from mouse peritoneal
macrophages.
Journal of Immunology 141:2407-2412.
Djeu, J.Y. and Blanchard, D.K. 1988. Lysis of human monocytes by lymphokine-
activated killer cells.
Cellular Immunology 111:55-65.
Dubois-Dalco, M., Narayan, O. and Griffin, D.E. 1979. Cell surface changes
associated with mutation of visna virus in antibody-treated cell cultures.
Virology 92:353-366.
200
Dubois-Dalco, M., Reese, T.S. and Narayan, O. 1976. Membrane changes
associated with assembley of visna virus.
Virology 74:520-530.
Dutia, B.M., Hopkins, J., Allington, M.P., Bujdoso, R. and McConnell, I. 1990.
Characterization of monoclonal antibodies specific for a- and (3-chains of sheep
MHC class II.
Immunology 70:27-32.
Eales, L.J., Farrant, J., Helbert, M. and Pinching, A.J. 1988. Peripheral blood
dendritic cells in persons with AIDS and AIDS related complex: loss of high
intensity class II antigen expression and function.
Clinical and Experimental Immunology 71:423-427.
Eastcott, J.W., Yamashita, K., Taubman, M.A. and Smith, D.J. 1990.
Characterization of rat T-cell clones with bacterial specificity.
Immunology 71:120-126.
Earl, P.L., Doms, R.W. and Moss, B. 1992. Multimeric CD4 binding exhibited by
human and simian immunodeficiency vims envelope protein dimers
Journal of Virology 66:5610-5614.
Eischen, A., Vincent, E., Bergerat, J.P., Louis, B., Faradji, A., Bohbot, A. and
Oberling, F. 1991. Long term cultures of human monocytes in vitro impact of GM-
CSF on survival and differentiation.
Journal of Immunological Methods 143:209-221.
Elliott, M.J., Vadas, M.A., Eglinton, J.M., Park, L.S., To, L.B., Cleland, L.G.,
Clark, S.C. and Lopez, A.F. 1989. Recombinant human interleukin-3 and
granulocyte-macrophage colony-stimulating factor show common biological effects
and binding characteristics on human monocytes.
Blood 74: 2349-2359.
Ellis, J.A. and Demartini, J.C. 1985a. Evidence of decreased concanavalin A
induced suppressor cell activity in the peripheral blood and pulmonary lymph nodes
of sheep with ovine progressive pneumonia.
Veterinary Immunology and Immunopathology 8:93-106.
Ellis, J.A. and Demartini, J.C. 1985b. Ovine interleukin-2: partial purification and
assay in normal sheep and sheep with ovine progressive pneumonia.
Veterinary Immunology and Immunopathology 8:15-25.
Ellis, J.A. and DeMartini, J.C. 1985c. Immunomorphologic and morphometric
changes in pulmonary lymph nodes of sheep with progressive pneumonia.
Veterinary Pathology 22:32-41.
201
Ellis, J.A., Lairmore, M.D., O'Toole, D.T. and Campos, M. 1991. Differential
induction of tumor necrosis factor alpha in ovine pulmonary alveolar macrophages
following infection with Corynebacterium pseudotuberculosis, Pasteurella
haemolytic, or lentiviruses.
Infection and Immunity 59:3254-3260.
Ennen, J., Seipp, I., Norley, S.G. and Kurth, R. 1990. Decreased accessory cell
function of macrophages after infection with human immunodeficiency virus type 1
in vitro.
European Journal of Immunology 20:2451-2456.
Evans, L.A., McHugh, T.M., Stites, D.P. and Levy, J.A. 1987. Differential ability
of human immunodeficiency virus isolates to productively infect human cells.
Journal of Immunlogy 138:3415-3418.
Fanger, M.W., Graziano, R.F., Shen, L. and Guyre, P.M. 1989. FcyR in
cytotoxicity exerted by mononuclear cells.
Chemical Immunology 47:214-253.
Fauci, A.S. 1988. The human immunodeficiency virus: infectivity and mechanisms
of pathogenesis.
Science 239:617-622.
Feinberg, M.B., Jarrett, R.F., Aldovini, A., Gallo, R.C. and Wong-Stall, F. 1986.
HTLV-III expression and production involve complex regulation at the levels of
splicing and translation of viral RNA.
Cell 46:807-817.
Filippi, P., Vigne, R., Querat, G., Jouanny, C. and Sauze, N. 1982. Intracellular
ribonucleoprotein complexes of visna virus are infectious.
Journal of Virology 42:1057-1066.
Fine, D. and Schochetman, G. 1978. Type D primate retroviruses: a review.
Cancer Reserach 38:3123-3139.
Fleit, H.B., Wright, S.D. and Unkeless, J.C. 1982. Human neutrophil Fc gamma
receptor distribution and structure.
Proceedings of National Academy of Science of USA 79:3275-3284.
Foley, P., Kazazi, F., Biti, R., Sorrell, T.C. and Cunningham, A.L. 1992. HIV
infection of monocytes inhibits the T-lymphocyte proliferative response to recall
antigens, via production of eicosanoids.
Immnology 75: 391-397.
202
Folks, T.M., Justement, J., Kinter, A., Dinarello, C.A. and Fauci, A.S. 1987.
Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell
line.
Science 238:800-802.
Fox, C.H. and Cottier-Fox, M. 1992. The pathobiology of HIV infection.
Immunology Today 13:353-355.
Fu, Y. and Blankenhorn, E.P. 1992. Nitric oxide-induced anti-mitogenic effects in
high and low responder rat strains.
Journal of Immunology 148:2217-2222.
Fuentes, M. and Pijoan, C. 1986. Phagocytosis and intracellular killing of
Pasteurella multocida by porcine alveolar macrophages after infection with
pseudorabies virus.
Veterinary Immunology and Immunopathology 13:165-172.
Geelen, J.L.M.C. and Goudsmit, J. 1991. Virus-host interactions in human
immunodeficiency virus infection.
Progress in Medical Virology 38:27-41.
Geissler, K., Harrington, M., Srivastava, C., Leemhuis, T., Tricot, G. and
Broxmeyer, H.E. 1989. Effects of recombinant human colony stimulating factors
(CSF)(granulocyte-macrophage CSF, granulocyte CSF, and CSF-1) on human
monocyte/macrophage differentiation.
Journal of Immunology 143:140-146.
Gendelman, H.E., Baca, L.M., Kubrak, C.A., Genis, P., Burrous, S., Friedman, R.
M., Jacobs, D. and Meltzer, M.S. 1992. Induction of IFN-a in peripheral blood
mononuclear cells by HIV-infected monocytes.
Journal of Immunology 148:422-428.
Gendelman, H.E., Baca, L.M., Turpin, J., Kalter, D.C., Hansen, B., Orenstein, J.M.,
Dieffenbach, C.W., Friedman, R.M. and Meltzer, M.S. 1990. Regulation of HIV
replication in infected monocytes by IFN-a: mechanisms of viral restriction.
Journal of Immunology 145:2669-2676.
Gendelman, H.E., Orenstein, J.M., Baca, L.M., Weiser, B., Burger, H., Kalter, D.C.
and Meltzer, M.S. 1989. The macrophage in the persistence and pathogenesis of
HIV infection.
AIDS 3:475-495.
Gendelman, H.E., Orenstein, J.M., Martin, M.A., Ferrua, C., Mitra, R., Phipps, T.,
Wahi, L.A., Lane, H.C., Fauci, A., Burke, D. S., Skillman, D. and Meltzer, M.S.
1988. Efficient isolation and propagation of human immunodeficiency virus on
recombinant colony-stimulating factor 1-treated monocytes.
Journal of Experimental Medicine 167:1428-1441.
203
Gendelman, H.E., Narayan, O., Kennedy-Stoskopf, S., Kennedy, P.G.E., Ghotbi, Z.,
Clements, J.E., Stanley, J. and Pezeshkpour, G. 1986. Tropism of sheep lentiviruses
for monocytes: susceptibility to infection and virus gene expression increase during
maturation of monocytes to macrophages.
Journal of Virology 58:67-74.
Gendelman, H.E., Narayan, O., Molineaux, S., Clements, J.E. and Ghotbi, Z. 1985.
Slow, persistent replication of lentiviruses: role of tissue macrophages and
macrophage precusors in bone marrow.
Proceedings of National Academy of Sciences of the USA 82:7080-7090.
Gendelman, H.E., Narayan, O., Kennedy-Stoskopf, S., Clements, J.E. and
Pezeshkpour, G.H. 1984. Slow virus-macrophage interactions: characterization of a
transformed cell line of sheep alveolar macrophages that express a marker for
susceptibility to ovine-caprine lentivirus infections.
Laboratory Investigation 51:547-555.
Georgsson, G., Houwers, D.J., Palsson, P.A. and Petursson, G. 1989. Expression of
viral antigens in the central nervous system of visna-infected sheep: an
immunohistochemical study on experimental visna induced by virus strains of
increased neurovirulence.
Acta Neuropathologica 77:299-306.
Georgsson, G., Palsson, P.. A. and Petursson, G. 1990. Some comparative aspects
of visna and AIDS. p82-98. In Modem Pathology of AIDS and Other Retroviral
Infections. Eds: Racz, P., Haase, A.T., Gluckman, J.C., Basel Kargel.
Giorgi, J.V. and Detels, R. 1989. T-cell subset alterations in HIV-infected
homosexual men: NIAID multicenter AIDS cohort study.
Clinical Immunology and Immunopathology 52:10-18.
Gonda, M.A., Charman, H.P., Walker, J.L. and Coggins, L. 1978. Scanning and
transmission electron microscopic study of equine infectious anemia virus.
American Journal of Veterinary Research 39:731-740.
Gonda, M.A., Wong-staal, F., Gallo, R C., Clements, J.E., Narayan, O. and Gilden,
R. V. 1985. Sequence homology and morphologic similarity of HTLV-IH and visna
vims, a pathogenic lentivirus.
Science 227:173-177.
Gonwa, T.A., Frost, J.P. and Karr, R.W. 1986. All human monocytes have the
capacity of expressing HLA-DQ and HLA-DP molecules upon stimulation with
interferon-y.
Journal of Immunology 137:519-524.
Gonzalez, C.M. 1988. Characterization of sheep macrophage differentiation
antigens by monoclonal antibodies. M. Phil Thesis, University of Edinburgh.
204
Gordon, S. and Mokoena, T. 1989. Receptors for mannosyl structures on
mononuclear phagocytes pp 141-150. Eds: Zembala, M. and Asherson, G.L.
Academic Press Limited, London.
Gorrell, M.D., Brandon, M.R., Sheffer, D., Adams, R.J. and Narayan,0. 1992.
Ovine lentivirus is macrophage tropic and does not replicate productively in T
lymphocytes.
Journal of Virology 66:2679-2688.
Goudsmit, J., Ljunggren, K., Smit, L., Jonda, M. and Fenyo, E. 1988. Biological
significance of the antibody response to HIV antigens expressed on the cell surface.
Archive Virology 103:189-206.
Graziano, R.F. and Fanger, M.W. 1987. FcyRI and FcyRII on monocytes and
granulocytes are cytotoxic trigger molecules for tumor cells.
Journal of Immunology 139:3536-3541.
Griffin, D.E., Narayan, O. and Adams, R.J. 1978. Early immune responses in visna,
a slow viral disease of sheep.
Journal of Infectious Diseases 138:340-349.
Gudnadottir, M. and Kristinsdottir, K. 1967. Complement-fixing antibodies in sera
of sheep affected with visna and maedi.
Journal of Immunology 98:663-667.
Gupta, V., Hopkins, J. and McConnell, I. Unpublished data.
Guy, B., Riviere, Y., Dott, K., Regnault, A. and Kieny, M.P. 1990. Mutational
analysis of the HIV nef protein.
Virology 176:413:425.
Haase, A.T., Retzel, E.F. and Staskus, K.A. 1990. Amplication and detection of
lentiviral DNA inside cells.
Proceedings of National Academy of Sciences of the USA 87:4971-4975.
Haase, A.T. and Baringer, J.R. 1974. The structural polypeptides of RNA slow
viruses.
Virology 57:238-250.
Haase, A.T., Stowring, L., Harris, J.D., Traynor, B., Ventura, P., Peluso, R. and
Brahic, M. 1982. Visna DNA synthesis and the tempo of infection in vitro.
Virology 119:339-410.
Haase, A.T., Strowring, L., Narayan, O., Griffin, D. and Price, D. 1976. Slow
persistent infection caused by visna virus: role of host restriction.
Science 195:175-177.
205
Habeshaw, J.A., Dalgleish, A.G., Bountiff. L., Newell, A.L., Wilks, D., Walker,
L.C. and Manca, F. 1990. AIDS pathogenesis: HIV envelope and its interaction
with cell proteins.
Immunology Today 11:418-424.
Haig, D.M., Brown, D. and MacKellar, A. 1990. Ovine haemopoiesis: the
development of bone marrow-derived colony-forming cells in vitro in the presence
of factors derived from lymphoid cells and helper T-cells.
Veterinary Immunology and Immunopathology 25:125-137.
Harding, C.V., Leyva-Cobian, F. and Unanue, E.R. 1988. Mechanism of antigen
processing.
Immunological Review 166:77-92.
Harkiss, G.D., Watt, N.J., King, T.J., Williams, J. and Hopkins, J. 1991. Retroviral
arthritis: phenotypic analysis of cells in the synovial fluid of sheep with
inflammatory synovitis associated with visna virus infection.
Clinical Immunology and Immunopathology 60: 106-117.
Harper, M.E., Marselle, L.M., Gallo, R.C. and Wong-Stall, F. 1986. Detection of
lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and
peripheral blood from infected individuals by in situ hybridization.
Proceedings of National Academy of Sciences of the USA 83:772-776.
Harris, J.D., Blum, H., Scott, J., Traynor, B., Ventura, P. and Haase, A. 1984. Slow
vims visna: reproduction in vitro of vims from extrachromosomal DNA.
Proceedings of National Academy of Sciences of the USA 81:7212-7215.
Heagy, W., Kelly, V.E., Strom, T.B., Mayer, K., Shapiro, H.M., Mandel, R. and
Finberg, R. 1984. Decreased expression of human class II antigens on monocytes
from patients with acquired immune deficiency syndrome.
Journal of Clinical Investigation 74:2089-2096.
Hed, J. and Stendahl, O. 1982. Differences in the ingestion mechanisms of IgG and
C3b particles in phagocytosis by neutrophils.
Immunology 45:727-736.
Herr, J.C. and Spell, D.R. 1985. Type-A retrovirus particles in heterohybridomas:
precaution for human monoclonal antibody purification.
Journal of Ultrastructure Research 92:80-85.
Hess, J.L., Clements, J.E. and Narayan, O. 1985. Cis- and rra/w-acting
transcriptional regulation of visna vims.
Science 229:482-485.
206
Hess, J.L., Pyper, J.M. and Clements, J.E. 1986. Nucleotide sequence and
transcriptional activity of the caprine arthritis-encephalitis virus long terminal
repeat.
Journal of Virology 60:385-393.
Hess, J.L., Small, J.A. and Clements, J.E. 1989. Sequences in the visna virus LTR
that control transcriptional activity and respond to viral trans activation:
involvement of AP-1 sites in basal activity and trans-activation.
Journal of Virology 63:3001-3015.
Ho, D.D., Moudgil, T. and Alam, M. 1989. Quantitation of human
immunodeficiency vims type 1 in the blood of infected persons.
New England of Journal Medicine 321:1621-1625.
Ho, D.D., Rota, T.R. and Hirsch, M.S. 1986. Infection of monocyte/macrophages
by human T lymphotropic vims type III.
Journal of Clinical Investigation 77:1712-1715.
Ho, D.D., Sarngadharan, M.G., Hirsch, M.S., Schooley, R.T., Rota, T.R., Kennedy,
R.C., Chanh, T.C. and Sato, V.L. 1987. Human immunodeficiency vims
neutralizing antibodies recognize several conserved domains on the envelope
glycoproteins.
Journal of Virology 61:2024-2028.
Hoffenbach, A., Langlade-Demoyen, P., Dadagilo, G., Vilmer, E., Michel, F.,
Mayaud, C., Autran, B. and Plata, F. 1989. Unusually high frequencies of HIV-
specific cytotoxic T lymphocytes in humans.
Journal of Immunology 142:452-462.
Hogg, N. 1989. Surface molecules and receptors pp37-47. In Human monocytes.
Eds: Zembala, M. and Asherson, G.L. Academic Press Ltd, London.
Holt, P.G. 1986. Down-regulation of immune responses in the lower respiratory
tract: the role of alveolar macrophages.
Clinical and Experimental Immunology 63:261-270.
Holt, P.G., Degebrodt, A., O'leary, C., Krska, K. and Plozza, T. 1985. T cell
activation by antigen-presenting cells from lung tissue digests: suppression by
endogenous macrophages.
Clinical and Experimental Immunology 62:586-593.
Holt, P.G., Oliver, J., Bilyk, N., McMenamin, C., Mcmenamin, P.G., Kraal, G. and
Thepen, T. 1993. Downregulation of the antigen presenting cell function(s) of
pulmonary dendritic cells in vivo by resident alveolar macrophages.
Journal of Experimental Medicine 177:397-407.
207
Hopkins, J. and Dutia, B.M. 1990. Monoclonal antibodies to sheep analogues of
human CD45 (leukocyte common antigen), MHC class I and CD5. differential
expression after lymphocyte activation in vivo.
Veterinary Immunology and Immunopathology 24:331-346.
Horii, Y., Muraguchi, A., Suematsu, S., Matsuda, T., Yoshizaki, K., Hirano, T. and
Kishimoto, T. 1988. Regulation of BSF-2/EL-6 production by human mononuclear
cells: macrophage-dependent synthesis of BSF-2/IL-6 by T cells.
Journal of Immunology 141:1529-1535.
Houwers, D.J. and Schaake, J. Jr. 1987. An improved ELISA for the detection of
antibodies to ovine and caprine lentiviruses, employing monoclonal antibodies in a
one-step assay.
Journal of Immunological Methods 98:151-154.
Houwers, D.J. and Nauta, I.M. 1989. Immunoblot analysis of the antibody response
to ovine lentivirus infections.
Veterinary Microbiology 19:127-139.
Houwers, D.J., Konig,C.D.W., De Boer, G.F. and Schaake, J. Jr. 1983. Maedi-
visna control in sheep. I: Artificial rearing of colosrum deprived lambs.
Veterinary Microbiology 8:179-185.
Hudson, L. and Hay, F.C. Non-specific esterase staining pp28-29. In Practical
Immunology, 3rd edition, Blackwell Scientific Publications. Oxford.
Ina, Y., Takada, K., Yamamoto, M., Morishita, M., Yosh, M. 1991. Antigen-
presenting capacity of alveolar macrophages and monocytes in pulmonary
tuberculosis.
European Respiratory Journal 4:88-93.
Jolly, P.E., Huso, D.L., Sheffer, D.,and Narayan, O. 1989. Modulation of lentivirus
replication by antibodies: Fc portion of immunoglobulin molecule is essential for
enhancement of binding, internalization, and neutralization of visna virus in
macrophages.
Journal of Virology 63:1811-1813.
Joly, P., Guillon, J., Mayaud, C., Plata, F., Theodorou, I., Denis M, Debre P. and
Autran, B. 1989. Cell-mediated suppression of HIV-specific cytotoxic T
lymphocytes.
Journal of Immunology 143:2193-2201.
Jones, B.M., Nicholson, J.K.A, Holman, R.C. and Hubbard, M. 1989. Comparison
of monocyte separation methods using flow cytometric analysis.
Journal of Immunological Methods 125:41-47.
208
Jones, N.L. 1986. Cytoskeletal distruption during human cytomegalovirus infection
of human lung fibroblasts.
European Journal of Cell Biology 41:304-312.
Joshi, V.V. and Oleske, J.M. 1986. Pulmonary lesions in children with the acquired
immunodeficiency syndrome: a reappraisal based on data in additional cases and
follow-up study of previously reported cases.
Human Pathology 17:641-642.
Jungi, T.W., Brcic, M., Kuhnert, P., Spycher, M. O., Li, F. and Nydegger, U.E.
1990. Effect of IgG for intravenous use on Fc receptor-mediated phagocytosis by
human monocytes.
Clinical and Experimental Immunology 82:163-169.
Jungi, T.W. and Hafner, S. 1986. Quantitative assessment of Fc receptor expression
and function during in vitro differention of human monocytes to macrophages.
Immunology 58:131-137.
Jutila, M.A. and Banks, K.L. 1988. Increased macrophage division in the synovial
fluid of goats infected with caprine arthritis encephalitis virus.
Journal of Infectious Diseases 157:1193-1202.
Kajikawa, O., Lairmore, M.D. and Demartini, J.C. 1990. Analysis of antibody
responses to phenotypically district lentivirus.
Journal of Clinically Microbiology 28:764-770.
Kalter, D.C., Nakamura, M., Turpin, J.A., Baca, L.M., Hoover, D.L., Diffenbach,
C., Ralph, P., Gendelman, H. E. and Meltzer, M. S. 1991. Enhanced HIV
replication in macrophage colony-stimulating factor-treated monocytes.
Journal of Immunology 146:298-236.
Kaltreider, H.B. 1976 Expression of immune mechanisms in the lung.
American Review of Respiratory Disease 113: 347-379.
Kannagi, M., Kiyotaki, M., King, N.W., Lord, C.I. and Letvin, N.L. 1987. Simian
immunodeficiency virus induces expression of class II major histocompatibility
complex structures on infected target cells in vitro.
Journal of Virology 61:1421-1426.
Kannagi, M„ Chalifoux, L.V., Lord, C.I. and Letvin, N.L. 1988. Suppression of
simian immunodeficiency virus replication in vitro by CD8+ lymphocytes
Journal of Immunology 140:2237-2242.
Kang, Y.S., Lee, C., Mouroy, R.L., Dwived, R.S., Odeyale, C. and Newball, H.H.
1992. Uptake, distribution and fate of bacterial lipopolysaccharides in monocytes
and macrophages: an ultrastructural and functional correlation.
Electron Microscopy Reviews 5:381-419.
209
Katz, J and Michalek, S.M. 1991. A method for generating antigen-specific rat T
helper cell clones.
Journal of Immunological Methods 138:77-86.
Katzman, M. and Lederman, M.M. 1986. Defective postbinding lysis underlies the
impaired natural killer activity in factor Vlll-treated, human T lymphotropic virus
type III seropositive hemophilius.
Journal of Clinical Investigation 77:1057-1062.
Kazazi, F., Mathijs, J., Foley, P. and Cunningham, A.L. 1989. Varation in CD4
expression by human monocytes and macrophages and their relationship to infection
with human immunodeficiency virus.
Journal of Virology 70:2661-2672.
Keizer, G.D., Tel Velde, A.A., Visser,W. and Figdor, G.G. 1987. The role of the
LFA-1, CR3, pi50,95 glycoprotein family in monocyte adhesion associated
functions, defined by subunit specific monoclonal antibodies.
Advances in the Biosciences 66:477-484.
Kennedy, P.G.E., Narayan, O. Ghotbi, Z., Hopkins, J., Gendelman, H.E. and
Clements, J.E 1985. Persistent expression of la antigen and viral genome in visna-
maedi virus-induced inflammatory cells.
Journal of Experimental Medicine 162:1970-1982.
Kennedy- Stoskopf, S. 1989a. Pathogenesis of lentivirus-induced arthritis.
Rheumatology International: Clinical and Eperimental Investigation 9:129-136.
Kennedy-Stoskopf S., Zink, C. and Narayan, O. 1989b. Pathogenesis of ovine
lentivirus-induced arthritis: phenotypic evaluation of T lymphocytes in synovial
fluid, synovium, and peripheral circulation.
Clinical Immunology and Immunopathology 52:323-330.
Kennedy-Stoskopf, S. and Narayan, O. 1986. Neutralizing antibodies to visna
lentivirus: mechanism of action and possible role in virus persistence.
Journal of Virology 59:37-44.
Klatzmann, D., Champagne, E., Chamaret, S., Gruest, J., Guetard, D., Hercend, T.,
Gluckman, J and Montabnier, C. 1984. T-lymphocyte T4 molecular behaves as the
receptor for human retrovirus LAV.
Nature 312: 767-768.
Klein, J.R., Martin, J., Griffing, S. and Nathanson, N, 1985. Precipitating
antibodies in experimental visna and natural progressive pneumonia of sheep.
Research in Veterinary Science 38:129-133.
210
Klimkait, T., Strebel, K„ Hoggan, M.D., Martin, M.A. and Orenstein, J. M. 1990.
The human immunodeficiency virus type 1-specific protein vpu is required for
efficient virus maturation and release.
Journal of Virology 64:621-629.
Kohl, S. 1991. Role of antibody-dependent cellular cytotoxicity in defense against
herpes simplex virus infections.
Reviews of Infectious Diseases 13:108-114.
Koup, R.A., Sullivan, J.L., Levin, P.H., Brettler, D., Mahr, A., Mazzara, G.,
Mckenzie, S. and Panicali, D. 1989. Detection of major histocompatibility complex
class I-restricted, HIV-specific cytotoxic T lymphocytes in the blood infected
hemophilius.
Blood 73:1909-1914.
Kreutz, M., Krause, S.W., Hennemann, B., Rehm. A. and Andreesen, R. 1992.
Macrophage heterogeneity and differentiation: defined serum-free culture conditions
induce different types of macrophages in vitro.
Research in Immunology 143:107-115.
Lacroix, F., Zhao, D.Y., Izaguirre, C.A. and Filion, L.G. 1993. Suppression by
HIV of IL-1 and IL-6 secretion in accessory cells: AC function defect partially
corrected with exogenous IL-1 and IL-6.
Clinical Immunology and Immunopathology 67:109-116.
Lairmore, M.D., Akita, G.Y., Russell, H.I. and DeMartine, J.C. 1987. Replication
and cytopathic effects of ovine lentivirus strains in alveolar macrophages correlate
with in vivo pathogenicity.
Journal of Virology 61:4038-4042.
Lairmore, M.D., Butera, S.T., Callahan, G,N. and DeMartini, J.C. 1988a.
Spontaneous interferon production by pulmonary leukocytes is associated with
lentivirus-induced lymphoid interstitial pneumonia.
Journal of Immunology 140:779-785.
Lairmore, M.D., Poulson, J.M., Adducci, T.A. and DeMartini, J.C. 1988b.
Lentivirus-induced lymphoproliferative disease: comparative pathogenicity of
phenotypically district ovine lentivirus strain.
American Journal of Pathology 130:80-91.
Langlade Demoycn, P., Michel, F., Hoffenbach, A., Vilmer, E., Dadaglio, G.,
Garicia-Pons, F., Mayaud, C., Autran, B., Wain-Hobson, S. and Plata, F. 1988.
Immune recognition of AIDS virus antigens by human and murine cytotoxic T
lymphocytes.
Journal of Immunology 141:1949-1957.
211
Larsen, H.J., Hyllseth, B. and Krogsrud, J. 1982a. Experimental maedi virus
infection in sheep: early cellular and humoral immune response following parenteral
inoculation.
American Journal of Veterinary Research 43:379-383.
Larsen, H.J., Hyllseth, B. and Krogsrud, J. 1982b. Experimental maedi virus
infection in sheep: cellular and humoral immune response during three years
following intranasal inoculation.
American Journal of Veterinary Research 43:384-389.
Laurent, A.G., Krust, B., Rey, M., Montagnier, L. and Hovanessian, A.G. 1989.
Cell surface expression of several species of human immunodeficiency virus type 1
major core protein.
Journal of Virology 63:4074-4078.
Leist, T.S., Buedi, E. and Zinkernagel, R.M. 1988. Virus-triggered immune
suppression in mice caused by virus-specific cytotoxic T cells.
Journal of Experimental Medicine 167:1749-1754.
Lenardo, M. and Baltimore, D. 1989. NF-kB: a pleiotropic mediator of inducible
and tissue-specific gene control.
Cell 58:227-229.
Letvin, N.L. 1990. Animal models for AIDS.
Immunology Today 11:322-326
Levy, J.A. 1993. Pathogenesis of human immunodeficiency virus infection.
Microbiological Reviews 57:183-289.
Lichtensteiger, C.A., Cheevers, W.P. and Davis, W.C. 1993. CD8+ cytotoxic T
lymphocytes against antigenic variants of caprine arthritis encephalitis virus.
Journal of General Virology 74:2111-2116.
Lifson, J.D. and Engleman, E.G. 1989. Role of CD4 in normal immunity and HIV
infection.
Immunological Reviews 109:93-119
Lifson, J.D., Feinberg, M.B., Reyer, G.R., Rabin, L., Banapour, B., Chakrabart, S.,
Moss, B., Wong-staal, F., Steimer, K.S. and Engleman, E.G. 1986. Induction of
CD4 dependent cell fusion by HTLV III/LAV envelope glycoprotein.
Nature 323:725-728.
Lin, F.H. and Thormar, H. 1979. Precipitation of visna viral proteins by immune
sera of rabbits and sheep.
Journal of Virology 29:536-539.
212
Littaua, R.A., Oldstone, Takeda, A. and Ennis, F.A. 1992. A CD4+
cytotoxic T-lymphocyte clone to a conserved epitope on human immunodeficiency
virus type 1 p24: cytotoxic activity and secretion of interleukin-2 and interleukin-6.
Journal of Virology 66:608-611.
Ljunggren, K., Karlson, A., Fenyo, E.M. and Jondal, M. 1989. Natural and
antibody-dependent cytotoxicity in different clinical stages of human
immunodeficiency virus type 1 infection.
Clinical and Experimental Immunology 75:184-189.
Locksley, R.M., Nelson, C., Fankhauser, J.E. and Klebanoff, S.J. 1987. Loss of
granule myeloperoxidase during in vitro culture of human monocytes correlates with
decay in antiprotozoa activity.
American Journal of Tropical Medicine and Hygien 36:541-548.
Lujan, L., Begara, I., Collie, D.D. and Watt, N.J. 1993. Phenotypic analysis of cells
in bronchoalveolar lavage fluid and peripheral blood of maedi visna-infected sheep.
Clinical and Experimental Immunology 91:272-276.
Lujan, L., Garcia Marin. J.F., Fernandez de Luco D, Vargas, A. and Badiola, J.J.
1991. Pathological changes in the lungs and mammary glands of sheep and their
relationship with maedi-visna infection.
Veterinary Record 129:51-54.
Lutley, R., Petursson, G., Palsson, P.A., Georgsson, G., Klein, J. and Nathanson, N.
1983. Antigenic drift in visna: virus varation during long-term infection of Icelandic
sheep.
Journal of General Virology 64:1433-1440.
Lyerly, H.K., Matthews, J., Langlois, A.J., Bolognesi, D.P. and Weinhold, K. J.
1987. Human T-cell lymphotropic virus IIIB glycoprotein (gpl20) bound to CD4
determinants on normal lymphocytes and expressed by infected cells serves as target
for immune attack.
Proceedings of National Academy of Sciences of the USA 84:4601-4605.
Macatonia, S.E., Gompels, M., Pinching, A.J., Patterson, S. and Knight, S. C.
1992. Antigen presentation by macrophages but not by dendritic cells in human
immunodeficiency vims (HIV) infection.
Immunology 75:576-581.
Macatonia, S.E., Lau, R., Patterson, S., Pinching, A. J. and Knight, S. C. 1990.
Dendritic cell infection, depletion and dysfunction in HIV-infected individuals.
Immunology 71:38-45.
Macatonia, S.E., Patterson, S. and Knight, S.C. 1989. Suppression of immune
responses by dendritic cells infected with HIV.
Immuology 67:285-289.
213
Macintyre, E.H., Wintersgill, C.J. and Vatter, A.E. 1973. Visna virus infection of
sheep and human cells in vitro - an ultrastructural study.
Journal of cell Science 13:173-191.
Mackay, C.R., Beya, M-F. and Matzinger, P. 1989. y/5 T cells express a unique
surface molecule appearing late during thymic development.
European Journal of Immunology 19: 1477-1483.
Mackay, C.R., Marston, W.L. and Dudler,L. 1990. Naive and memory T cells
show distinct pathways of lymphocyte replication.
Journal of Experimental Medicine 171:801-817.
Mackay, C.R. 1988. Sheep leukocyte molecules: a review of their distribution,
structure and possible function.
Veterinary Immunology and Immunopathology 19:1-20.
Mackay, C.R. and Imhof, B.A. 1993. Cell adhesion in the immune system.
Immunology Today 14:99-102.
Maddox, J.F., Mackay, C.R. and Brandon, M.R. 1985. Surface antigens, SBU-T4
and SBU-T8, of sheep T lymphocyte subsets defind by monoclonal antibodies.
Immunology 55:739-748.
Maheswaran, S.K., Berggren, K.A., Simonson, R. R., Ward, G. E. and Muscoplat,
C. C. 1980. Kinetics of interaction and fate of Pasteurella hemolytica in bovine
alveolar macrophages.
Infection and Immunity 30:254-262.
Malim, M.H., Bohnlein, S., Hauber, J. and Cullen, B.R. 1989. Functional dissection
of the HIV-1 rev transactivator-derivation of a trans dominant repressor of Rev
function.
Cell 58:205-214.
Manca, F, Habeshaw, J.A. and Dalgleish, A.G. 1990. HIV envelope glycoprotein,
antigen specific T-cell responses, and soluble CD4.
Lancet 335:811-815.
Mangan, D.F. and Wahl, S.M. 1991. Differential regulation of human monocyte
programmed cell death (apoptosis) by chemotactic factors and pro-inflammatory
cytokines.
Journal of Immunology 147:3408-3412.
Mann, D.L., Gartner, S.. LeSane, F., Blattner, W.A. and Popovic, M. 1990a. Cell
surface antigens and function of monocytes and a monocyte-like cell line before and
after infection with HIV.
Clinical Immunology and Immunolopathology 54:174-183.
214
Mann, D.L., Gartner, S., Sane, F.L., Buchow, H. and Popovic, M. 1990b. HIV-1
transmission and function of virus-infected monocytes/macrophages.
Journal of Immunology 144: 2152-2158.
Marchevsky, A., Rosen, M.J., Chrystal, G. and Kleinerman, J. 1985. Pulmonary
complications of the acquired immuodeficiency syndrome: A clinicopathologic
study of 70 cases.
Human Pathology 16:659-670.
Markson, L.M., Spence, J.B. and Dawson, M. 1983. Investigation of a flock heavily
infected with maedi-visna virus.
Veterinary Record 112:267-271.
Martin, L.S., Spira, T.J., Orloff, S.L. and Holman, R.C. 1988. Comparsion of
methods for assessing chemotaxis of monocytes and polymorphonuclear leukocytes
isolated from patients with AIDS or AIDS-related conditions.
Journal of Leukocyte Biology 44:361-366.
Matsuyama, T., Hamamoto, Y., Soma, G., Mizuno, D., Yamamoto, N. and
Kobayashi, N. 1989. Cytocidal effect of tumor necrosis factor on cells chronically
infected with human immunodeficiency virus (HIV): enhancement of HIV
replication.
Journal of Virology 63:2504-2509.
Matthews, T., Langlois, A.J., Robey, W.G., Chang, N.T., Gallo, R.C., Fischinger, P.
J. and Bolognesi, D.P. 1986. Restricted neutralization of divergent human T-
lymphotropic virus type III isolates by antibodies to the major envelope
glycoprotein.
Proceedings of National Academic Science of the USA 83:9709-9713.
McCune, J. M. 1991. HIV-1: The infective process in vivo.
Cell 64:351-363.
McEntee, M.F., Sharma, D.P., Zink, M.C., Adam, R.T., Flexner, R. Clements, J.E.
and Narayan, O. 1991. Rhesus monkey macrophages infected with simian
immunodeficiency vims cause rapid lysis of CD4-bearing lymphocytes.
Journal of General Virology 72:317-324.
McMichael, A.T., Gotch, F.M., Nobel, G.R. and Beare, P.A.S. 1983. Cytotoxic T
cell immunity to influenza vims.
New England Journal of Medicine 309:13-17.
Melendez-Guerrero, L.M., Nicholson, J.K.A. and McDougal, S. 1991. Infection of
human monocytes with HIV-lga_L effect on accessory cell function for T-cell
proliferation in vitro.
AIDS Research and Human Retroviruses 7: 465-474
215
Meltzer, M.S., Skillman, D.R., Gomatos, P.T., Kalter, D.C. and Gendelman, H. E.
1990b. Role of mononuclear phagocytes in the pathogenesis of human
immunodeficiency virus infection.
Annual Review of Immunology 8: 169-194.
Meltzer, M.S., Skillman, D.R., Hoover, D.L., Hanson, B.D., Turpin, J. A., Kalter,
D. C. and Gendelman, H. E. 1990b. Macrophages and the human
immunodeficiency virus.
Immunology Today 11:217-223.
Merigan, T.C. and Katzenstein, D.A. 1991. Relation of the pathogenesis of human
immunodeficiency virus infection to various strategies of its control.
Reviews of Infectious Diseases 13:292-302.
Meyaard, L., Schuitemaker, H. and Miedema, F. 1993. T-cell dysfunction in HIV
infection: anergy due to defective antigen-presenting cell function?
Immunology Today 14:161-164.
Michel, F., Hoffenbach, A., Froussard, P., Langlade-Demoyen, P., Kaczorek, M.,
Kiney, M. P. and Plata, F. 1992. HIV-1 env, nef, and gag-specific T cell immunity
in mice: conserved epitopes in nef p27 and gag p25 proteins
AIDS Research and Human Retroviruses 8: 469-478.
Miedema, F., Tersmette, M. and van Lier, R.A.W. 1990. AIDS pathogenesis: a
dynamic interaction between HIV and the immune system.
Immunology Today 11:293-296.
Minna, J.D., Lueders, K.K. and Kuff, E.L. 1974. Expression of genes for
intracisternal A particle antigen in somatic cell hybrides.
Journal of National Cancer Institute 52:1211-1217.
Mills, C.D. 1991. Molecular basis of "suppressor" macrophages: arginine
metabolism via nitric oxide synthetase pathway.
Journal of Immunology 146:2719-2723.
Moebius, U. 1989. T8 cluster reports: CD8. In Leukocyte Typing IV, pp342-343.
Eds: Knapp, W., Dorken, B., Gilks, W.R., Rieber, E.P., Schmidit, R.E., Stein, H.
and von dem Borne, A.E.G. Oxford University Press, New York.
Muller, F., Rollag, H., Gaudernack, G. and Froland, S.S. 1990. Impaired in vitro
survival of monocytes from patients with HIV infection.
Clinical and Experimental Immunology 81:25-30.
Munk, M.E., Schoel, B., Modrow, S., Karr, R.W., Young, R.A. and Kaufmann, S.
H. E. 1989. T lymphocytes from healthy individuals with specificty to self epitopes
shared by the mycobactrial and human 65-kilodalton heat shock protein.
Journal of Immunology 143:2844-2849.
216
Munn, R.J., Marx, P.A., Yamamoto, J.K. and Gardner, M.B. 1985. Ultrastructural
comparison of the retroviruses associated with human and simian acquired
immunodeficiency syndromes.
Laboratory Investigation 53:194-199.
Murray, H.W., Jacobs, J.L. and Bovbjerg, D.H. 1987a. Accessory cell function of
AIDS monocytes.
Journal of Infectious Disease 156:696.
Murray, H.W., Scavuzzo, D., Jacobs, J.L., Kaplan, M.H., Libby, D., Schindler, J.
and Roberts, R. 1987b. In vitro and in vivo activation of human mononuclear
phagocytes by interferon-y.
Journal of Immunology 138:2457-2462.
Murray, H.W., Rubin, B.Y., Masur, H. and Robert, R.B. 1984. Impaired
production of lymphokines and immune EFN-y in the acquired immunodeficiency
syndrome.
New England Journal of Medicine 310: 883-889.
Mustafa, A.S. and Godal, T. 1987. BCG induced CD4+ cytotoxic T cells from
BCG vaccinated healthy subjects: relation between cytotoxicity and suppression in
vitro.
Clinical and Experimental Immunology 69:255-262.
Myer, M.S., Huchzermeyer, H.F.A.K., York, D.F., Hunter, P., Werwoerd, D.W. and
Garnett, H.M. 1988. The possible involvement of immunosuppression caused by a
lentivirus in the aetiology of jaagsiekte and pasteurellosis in sheep.
Onderstepoort Journal of Veterinary Research 55:127-133.
Myones, B.L., Dalzell, J.G., Hogg, N. and Ross, G.D. 1988. Neutrophil and
monocyte cell surface pi50,95 has iC3b-receptor (CR4) activity resembling CR3
Journal of Clinical Investigation 82:640-651.
Nakagawara, A., Nathan, C.F. and Cohn, Z.A. 1981. Hydrogen peroxide
metabolism in human monocytes during differentiation in vitro.
Journal of Clinical Investigation 68:1243-1252.
Narayan, O. and Clements, J.E. 1990. Lentiviruses. In Virology 2nd Edn, Eds: B.N.
Fields and D. M. Knipe. Raven Press Ltd., New York.
Narayan, O. and Clements, J.E 1989. Biology and pathogenesis of lentiviruses.
Journal of General Virology 70:1617-1639.
Narayan, O. and Zink, M.C. 1988. Role of macrophages in lentivirus infections.
Advances in Veterinary Science and Comparative Medicine 32:129-148.
217
Narayan, O., Sheffer, D., Clements, J.E. and Tennekoon, G. 1985. Restricted
replication of lentiviruses: Visna viruses induce a unique interferon during
interaction between lymphocytes and infected macrophages.
Journal of Experimental Medicine 162:1954-1969.
Narayan, O., Wolinsky, J.S., Clements, J.E., Strandberg, J.D., Griffin D.E. and
Cork, L.C. 1982. Slow virus replication: the role of macrophages in the persistence
and expression of visna viruses of sheep and goats.
Journal of General Virology 59:345-356.
Narayan, O., Clements, J.E., Strandberg, J.D., Cork, L.C. and Griffin, D. 1980.
Biological characterization of the virus causing leukoencephalitis and arthritis in
goats.
Journal of General Virology 50:69-79.
Narayan, O., Griffin, D.E. and Clements, J.E 1978. Virus mutation during slow
infection: temporal development and characterization of mutants of visna virus
recovered from sheep.
Journal of General Virology 41:343-352.
Narayan, O., Kennedy-Stoskopf, S., Sheffer, D., Griffin, D.E. and Clements, J.E.
1983. Activation of caprine arthritis encephalitis virus expression during maturation
of monocytes to macrophages.
Infection and Immunity 41:67-73.
Nash, A.D., Barcham, G.J., Andrews, A.E. and Brandon, M.R. 1992.
Characterisation of ovine alveolar macrophages regulation of surface antigen
expression and cytokine production.
Veterinary Immunology and Immunolopathology 31:77-94.
Nathan, C.F. 1986. Secretory products of macrophages.
Journal of Clinical Investigation 79:319-325.
Nathanson, N., Panitch, H., Palsson, P.A., Petursson, G. and Georgsson, G. 1976.
Pathology of visna: II. effect of immunosuppression upon early central nervous
system lesion.
Laboratory Investigation 35:444-451.
Neefjies, J.J., Stollorz, V., Peters, P.J., Geuze, H.J. and Ploegh, H.L. 1990. The
biosynthetic pathway of MHC class II but not class I molecules intersects the
endocytic route.
Cell 61: 171-183.
Nixon, D.F., Towsend, A.R.M., Elvin, J.G., Rizza, C.R., Gallwey, J. and
McMichael, A.J. 1988. HIV-1 gag-specific cytotoxic T lymphocytes defined with
recombinant vaccinia virus and synthetic peptides.
Nature 336:484-487.
218
Nussler, N.K., Silvio, M.D., Billiar, T.R., Hoffman, R.A., Geller, D.A., Selby, R.,
Madariaga, J. and Simmons, R.L. 1992. Stimulation of the nitric oxide synthase
pathway in human hepatocytes by cytokines and endotoxin.
Journal of Experimental Medicine 176:261-264.
Oda, T. and Maeda, H. 1986. A new simple fluorometric assay for phagocytosis.
Journal of Immunological Methods 88:175-183.
Oliver, R.E., Gorham, J.R., Perryman, L.E. and Spencer, G.R. 1981. Ovine
progressive pneumonia: Experimental intrathoracic, intracerebral, and intra-articular
infections.
Americian Journal of Veterinary Research 42:1560-1564.
Oliver, R.E., Gorham, J.R., Parish, S.F., Hadlow, W.J. and Narayan, O. 1981.
Ovine progressive pneumonia: pathologic and virologic studies on the naturally
occurring disease.
Americian Journal of Veterinary Research 42:1554-1559.
Onuma, M., Koomoto, E., Furuyama, H., Yasutomi, Y., Taniyama, H., Iwai, H. and
Kawakami, Y. 1992. Infection and dysfunction of monocytes induced by
experimental inoculation of calves with bovine immunodeficiency-like virus.
Journal of Acquired Immune Deficiency Syndromes 5:1009-1015.
Orenstein, J. M., Meltzer, M. S., Phipps, T. and Gendelman, H. E. 1988.
Cytoplasmic assembly and accumlation of human immunodeficiency virus type 1
and 2 in recombination human colony-stimulating factor-1-treated human
monocytes: an ultrastructure study.
Journal of Virology 62:2578-2586.
Orentas, R.J., Hildreth, J.E.K., Obah, E., Polydefkis, M., Smith, G.E., Clements,
M.L. and Siliciano, R.F. 1990. Induction of CD4+ human cytolytic T cells specific
for HIV-infected cells by a gpl60 subunit vaccine.
Science 248:1234-1237.
Ottenhoff, T.H.M., Ab, B.K., Van Embden, J.D.A., Thole, J.E.R. and Kiessling, R.
1988. The recombinant 65-kd heat shock protein of Mycobacterium bovis Bacillus
Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T
lymphocytes that lysis human monocytes.
Journal of Experimental Medicine 168: 1947-1952.
Owen, C.A., Campbell, E.J. and Stockley, R.A. 1992. Monocyte adherence to
fibronectin: role of CD11/CD18 integrins and relationship to other monocyte
function.
Journal of Leukocyte Biology 51:400-408.
Palmer, E., Sporborg, C., Harrison, A., Martin, M.L. and Feorino, P. 1985.
Morphology and immunoelectron microscopy of AIDS virus.
Archives of Virology 85:189-196.
219
Pattersson, B.M., Segal, S. and Lueders, K.K., 1978. RNA associated with murine
intracisternal type A particles codes for the main particle protein.
Journal of Virology 27:118-126.
Paulnock, D. M. 1992. Macrophage activation by T cells.
Current Opionion in Immunology 4:344:349.
Pearson, L.D., Poss, M.L. and Demartini, J.C. 1989. Animal lentivirus vaccines:
problems and prospects.
Veterinary Immunology and Immunopathology 20:183-212.
Pedersen, N.C., Yamamoto, J.K., Ishida, T. and Hansen, H. 1989. Feline
immunodeficiency virus infection.
Veterinary Immunology and Immunopathology 21:111-129.
Peluso, R., Haase, A., Stowring, L., Edwards, M. and Ventura, P. 1985. A Trojan
horse mechanism for the spread of visna virus in monocytes.
Virology 147:231-236.
Peng, C., Ho, B.K., Chang, T.W. and Chang, N.T. 1989. Role of human
immunodeficiency virus type 1-specific protease in core protein maturation and
viral infectivity.
Journal of Virology 63:2550-2556.
Perno, C.F., Yarchoan, R., Cooney, D.A., Hartman, N.R., Webb, D.S.A., Hao, Z.,
Mitsuya, H., Johns, D. G. and Broder, S. 1989. Replication of human
immunodeficiency virus in monocytes.
Journal of Experimental Medicine 169:933-951.
Perussia, B., Trinchieri, G., Jackson, A., Warner, N.L., Faust, J., Rumpold, H.,
Kraft, D. and Lanier, L.L. 1984. The Fc receptor for IgG on human killer cells:
phenotypic, functional, and comparative studies with monoclonal antibodies.
Journal of Immunology 133:180-189.
Petit, A.J.C., Tersmette, M., Terpstra, F.G., DeGoede, R.E.Y., Van Lier, R.A. and
Miedema, F. 1988. Decreased accessory cell function by human monocytic cells
after infection with HIV.
Journal of Immunology 140:1485-1489.
Petit, A.J.C., Terpstra, F.G. and Miedema, F. 1987. Human immunodeficiency
virus infection down-regulates HLA class II expression and induces differentiation
in promocytic U937 cells.
Journal Clinical Investigation 79:1883-1889.
Petursson, G., Nathanson, N., Georgsson, G., Panitch, H. and Palsson, P.A. 1976.
Pathogenesis of visna: I. sequential virologic, serologic, and pathologic studies.
Laboratory Investigation 35:402-412.
220
Phillips, R.E., Rowland-Jones, S., Nixon, D.F., Gotch, F.M., Edwards, J.P.,
Ogunlesi, A.O., Elvin, J.G., Rothbard, J.A., Bangham, C.R.M., Rizza, C.R. and
McMichael, A.J. 1991. Human immunodeficiency virus genetic varation that can
escape cytotoxic T cell recognition.
Nature 354:453-459.
Pinching, A.J. 1991. Antibody responses in HIV infection.
Clinical and Experimental Immunology 84:181-184.
Plata, F., Autran, B., Martins, L.P., Wain-Hobson, S., Raphae, M., Mayaud, C.,
Denis, M., Guillon, J-M. and Debre, P. 1987. AIDS virus-specific cytotoxic T
lymphocytes in lung disorder.
Nature 328:348-351.
Pluzek, K-J and Ramlan, J. 1988. Alkaline phosphatase labelled reagents. In
Handbook of Immunoblotting of Proteins. Vol I., Technical Descriptions.
ppl77-188. Eds: Bjerium, O.J. and Heegaard, N.H.H.. CRC Press, Florida.
Poli, G., Bottazzi, B., Acero, R., Bersani, L., Rossi, V., Introna, M., Lazzarin, A.,
Galli, M. and Mantovani, A. 1985a. Monocyte function in intravenous drug abusers
with lymphoadenopathy syndrome and in patients with acquired immunodeficiency
syndrome: selective impairment of chemotaxis.
Clinical and Experimental Immunology 62:136-142.
Poli, G., Introna, M., Zanaboni, F., Peri, G., Carbonari, M., Aiuti, F., Lazzarin, A.,
Moroni, M. and Mantovani, A. 1985b. Naturally killer cells in intravenous drug
abusers with lymphoadenopathy syndrome.
Clinical and Experimental Immunology 62:128-135.
Poli, G., Orenstein, J. M., Kinter, A., Folks, T.M. and Fauci, A. S. 1989.
Interferon-a but not AZT suppresses HIV expression in chronically infected cell
lines.
Science 244:575-577.
Potts, B., Maury, W. and Martin, M.A. 1990. Replication of HIV-1 in primary
monocyte cultures.
Virology 175:465-476.
Pritchard, G.C., Spence, J.B., Arthur, M.J. and Dawson, M. 1984. Maedi-visna
virus infection in commercial flocks of indigenous sheep in Britain.
The Veterinary Record 115:427-429.
Pyper, J.M., Clements, J.E., Gonda, M.A. and Narayan, O. 1986. Sequence
homology between cloned caprine arthritis encephalitis virus and visna virus, two
neurotropic lentiviruses.
Journal of Virology 58:665-670.
221
Ragsdale, R.L. and Grasso, R.J. 1989. An improved spectrofluorometric assay for
quantitating yeast phagocytosis in cultures of murine peritoneal macrophages.
Journal of Immunological Methods 123:259-267.
Reddy, M.M., England, A., Brown, D., Buimovici-Klein, E. and Grieco, M. H.
1987. Lymphoproliferative responses to human immunodeficiency virus antigen in
asymptomatic intravenous drug abusers and in patients with lymphoadenopathy or
AIDS.
Journal of Infectious Diseases 156:374-376.
Reed, L.J. and Muench H. 1938. A simple method of estimating fifty percent and
points.
American Journal of Hygine 27: 493-497.
Reimann, K.A., Snyder, G.B., Chalifoux, L.Y., Waite, B.C.D., Miller, M.D.,
Yamamoto, H., Spertini, O. and Letvin, N.L. 1991. An activated CD8+
lymphocyte appears in lymph nodes of Rhesus monkeys early after infection with
simian immunodeficiency virus.
Journal of Clinical Investigation 88: 1113-1120.
Rein, A., McClure, M.R., Rice, N.R., Luftig, R.B. and Schultz, A.M. 1986.
Myristylation site in Pr65<?aS is essential for virus particle formation by Moloney
murine leukaemia virus.
Proceedings of National Academic Science of the USA 83:7246-7250.
Reyburn, H. T. 1992a. Immune response to maedi-visna virus
PhD Thesis. University of Edinburgh
Reyburn, H.T., Roy, D.J., Blacklaws, B.A., Sargan, D.R., Watt, N.J. and
McConnell, I. 1992b. Characteristics of the T cell-mediated immune response to
maedi-visna virus.
Virology 191:1009-1012.
Reyburn, H.T., Roy, D.J., Blacklaws, B.A., Sargan, D.R. and McConnell, I. 1992c.
Expression of maedi-visna virus major core protein, p25: development of a sensitive
p25 antigen detection assay.
Journal of Virological Methods 37:305-320
Rich, E.A., Toossi, Z., Fujiwara, H., Hanigosky, R., Lederman, M.M. and Ellner,
J.J. 1988. Defective accessory function of monocytes in human immunodeficiency
virus-related disease syndromes.
Journal Laboratory and Clinical Medicine 122:174-181.
Riviere, Y., Tanneau-Salvadori, F., Regnault, A., Lopez, O., Sansonetti, P., Guy, B.,
Kieny, M., Fournel, J. and Montagnier, L. 1989. Human immunodeficiency virus-
specific cytotoxic responses of seropositive individuals: distinict types of effector
cells mediate killing of targets expression gag and env proteins.
Journal of Virology 63: 2270-2277.
222
Robinson, W.E.Jr., Montefiori, D.C. and Mitchell, W.M. 1990. Complement-
mediated antibody-dependent enhancement of HIV-1 infection requires CD4 and
complement receptor.
Virology 175:600-604.
Rook, A.H., Hooks, J.J., Quinnan, G.V., Lane, H.C., Manischewitz, J. F., Macher,
A. M„ Masur, H., Fauci, A. S. and Djeu, J. Y. 1985. Interleukin 2 enhances the
natural killer cell activity of acquired immunodeficiency syndrome patients through
a y-interferon-independent mechanism.
Journal of Immunology 134:1503-1507.
Rook, A.H., Lane, H.C., Folks, T., McCoy, S., Alter, H. and Fauci, A.S. 1987. Sera
from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent
cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Journal of Immunology 138:1064-1067.
Rook, A.H., Masur, H., Lane, H.C., Frederick, W., Kasahara, T., Macher, A.M.,
Djeu, T.Y., Manischewitz, J.F., Jackson, L., Fauci, A.S. and Quinnan, G.V. 1983.
Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific
cytotoxic activities of lymphocytes from patients with the acquired immune
deficiency syndrome.
Journal of Clinical Investigation 72:398-403.
Rook, G.A.W. 1989. Intracellular killing of microorganism. In Human monocytes
pp 292-302. Eds: Zembala, M. and Asherson, G.L. Academic Press Limited,
London.
Ross, G.D., Walport, M.J. and Hogg, N. 1989. Receptors for IgG Fc and fixed C3
pp 123-139. In Human monocytes. Eds: Zembala, M. and Asherson, G.L.
Academic Press Ltd, London.
Rouse, B.T. and Babiuk, L.A. 1979. Mechanisms of viral immunopathology.
Advances in Veterinary Science and Comparative Medicine 23:103-135.
Roux-Lombard, P., Modoux, C., Cruchaud, A. and Dayer, J. 1989. Purified blood
monocytes from HIV 1-infected patients produce high levels of TNF-a and IL-1.
Clinical Immunology and Immunolopathology 50:374-384.
Roy, G., Rojo, N. and Leyva-Cobian, F. 1987. Phenotypic changes in monocytes
and alveolar macrophages in patients with acquired immunodeficiency syndrome
(AIDS) and AIDS-related complex (ARC).
Journal of Laboratory Immunology 23:135-141.
Ruscetti, F.W., Mikovits, J.A., Kalyanaraman, V.S., Overton, R., Stevenson, H.,
Stromberg, K., Herberman, R. B., Farrar, W. L. and Ortaldo, J. R. 1986. Analysis
of effector mechanisms against HTLV-I and HTLV-III/LAV-infected lymphoid
cells.
Journal of Immunology 136:3619-3624.
223
Salmon, J.E., Kimberly, R.P., Gibofsky, A. and Fotino, M. 1984. Defective
mononuclear phagocyte function in systemic lupus erythematosus: dissociation of
Fc receptor-ligand binding and internalization.
Journal of Immunology 133:2525-2531.
Sargan, D.R. and Bennet, I.D. 1989. Transcriptional map of visna virus: definition
of the second intron structure suggests a rev-like gene product.
Journal of Virology 70:1995-2006.
Sargan, D.R., Bennet, I.D., Cousens, C., Roy, D.J., Blacklaws, B.A., Dalziel, R. G.,
Watt, N. J. and McConnell, I. 1991. Nucleotide sequence of EV1, a British isolate
of maedi-visna virus.
Journal of General Virology 72:1893-1903.
Sarmay, G. 1992. Functional studies on Fc receptors.
Immunology Today 13:A6-A9
Savill, J., Fadok, V., Henson, P. and Haslett, C. 1993. Phagocyte recognition of
cells undergoing apoptosis.
Immunology Today 14:131-136.
Scheppler, J.A., Mawle, A.C. and McDougal, J.S. 1988. Evaluation of target cells
for HIV-1-specific antibody-dependent cellular cytotoxicity assays.
Journal of Immunological Methods 115:247-253.
Scheppler, J.A., Nicholson, J.K.A., Swan, D.C., Ahmed-Ansari, A. and McDougal,
J.S. 1989. Down-modulation of MHC-I in a CD4+ T cell line, CEM-E5, after
HIV-1 infection.
Journal of Immunology 143:2858-2866.
Schmidtmayerova, H., Bolmont, C., Baghdiguian, S., Hirsch, I. and Chermann, J.
1992. Distinctive pattern of infection and replication of HIV1 strains in blood-
derived macrophages.
Virology 190:124-133.
Schrader, J.W. 1986. The panspecific hemopoietin of activated T lymphocytes
(interleukine-3).
Annual Review of Immunology 4:205-230.
Schuitemaker, H., Kootstra, N.A., Groenink, M., De Goede, R.E., Miedema, F.,
Tersmette, M. 1992a. Differential tropism of clinical HIV-1 isolates for primary
monocytes and promonocytic cell lines.
AIDS Research & Human Retroviruses 8:1679-1682.
Schuitemaker, H., Koot, M., Kootstra, N.A., Dercksen, M.W., De Goede, R. Y.,
Van Steenwijk, R. P., Lange, J. M.A., Schattenkerk, J. K. M. E., Miedema, F. and
Tersmette, M. 1992b. Biological phenotype of human immunodeficiency virus type
224
1 clones at different stages of infection: progression of disease is associated with a
shift from monocytotropic to T-cell-tropic virus populations.
Journal of Virology 66:1354-1360.
Scott, J.V., Stowring, L., Haase, A., Narayan, O. and Vigne, R. 1979. Antigenic
variation in visna virus.
Cell 18:321-327.
Scott-Algara, D., Vuillier, F., Cayota, A. and Dighiero, G. 1992. Natural killer
(NK) cell activity during HIV infection: a decrease in NK activity is observed at the
clonal level and is not restored after in vitro long-term culture of NK cells.
Clinical and Experimental Immunology 90:181-187.
Segal, D.M. and Snider, D.P. 1989. Targeting and activation of cytotoxic
lymphocytes
Chemical Immunology 47:179-213.
Sei, Y., Petrella, R.J., Tsang, P. and Bekesi, J.G. 1986. Monocytes in AIDS.
The New England Journal of Medicine 315:1611-1612.
Sethi, K.K., Naher, H. and Stroehmann, I. 1988. Phenotypic heterogeneity of
cerebrospinal fluid-derived HIV-specific and HLA-restricted cytotoxic T-cell
clones.
Nature 335: 178-181.
Sheffield, J. B. 1974. Membrane alteration which accompany MuMTV maturation:
I. studies by freeze-cleave techniques.
Virology 57:287-290.
Sigurdsson, B. and Palsson, P.A. 1958. Visna of sheep: a slow, demyelinating
infection.
British Journal of Experimental Pathology 39:519-528.
Sigurdsson, B., Palsson, P.A. and Grimsson, H.M. 1957. Visna, a demyelinating
transmissible disease of sheep.
Journal of Neuropathology and Experimental Neurology 16:389-403.
Sigurdsson, B. 1954. Maedi, a slow progressive pneumonia of sheep: an
epizoological and a pathological study.
British Veterinary Journal 110:225-270.
Sigurdsson, B., Grimsson, H.M. and Palsson, P.A. 1952. Maedi, a chronic
progressive infection of sheep's lung.
Journal of Infectious Disease 90:233-241.
Sihvonen, L. 1981. Early immune responses in experimental maedi.
Research in Veterinary Science 30:217-212.
225
Sissons, J.G.P. and Oldstone, M.B.A. 1980. Antibody-mediated destruction of
virus-infected cells.
Advances in Immunology 29:209-255.
Small, J.A., Bieberich, C.,Ghotbi, Z., Hess, J., Scangos, G.A. and Clements, J. E.
1989. The visna virus long terminal repeat directs expression of a reporter gene in
activated macrophages, lymphocytes and the central nervous systems of transgenic
mice.
Journal of Virology 63:1891 -1896.
Smith, P.D., Ohura, K., Masur, H., Lane, H.C., Fauci, A.S. and Wahl, S.M. 1984.
Monocyte function in the acquired immunne deficiency syndrome: defective
chemotaxis.
Journal of Clinical Investigation 74:2121-2128.
Sokol, R.J., Hudson, G., Wales, J. and James, N.T. 1991. Ultrastructural
morphometry of human leukocytes in health and disease.
Electron Microscopy Review 4:179-195.
Soliman, D.M. 1992. Role of cytokines in alveolar macrophage accessory cell
function in HIV-infected individuals.
Journal of Immunology 149:1462-1469.
Somasundaran, M. and Robinson H.L. 1988. Unexpectedly high levels of HIV-1
RNA and protein synthesis in a cytocidal infection.
Science 242:1554-1557.
Sondel, P.M., Hank, J.A., Kohler, P.C., Chen, B.P., Minkoff, D.Z. and Molenda, J.
A. 1986. Destruction of autologous human lymphocytes by interleukin 2-activated
cytotoxic cells.
Journal of Immunology 137:502-511.
Sonigo, P., Alizon, M., Staskus, K., Klatzmann, D., Cole, S., Danos, O. Retzel, E„
Tiollais, P., Haase, A. and Wain-Hobson, S. 1985. Nucleotide sequence of the visna
lentivirus: relationship to the AIDS virus.
Cell 42:369-382.
Sperber, K., Hamrang, G., Louie, M.J., Kalb, T., Banerjee, R., Choi, H.H.,
Paronetto, F. and Mayer, L. 1993. Progressive impairment of monocytic function
in HIV-l-infected human macrophage hybridomas.
AIDS Research and Human Retroviruses 9: 657-667.
Stanley, J., Bhaduri, L.M., Narayan, O. and Clements, J.E. 1987. Topographical
rearrangements of visna virus envelope glycoprotein during antigenic drift.
Journal of Virology 61:1019-1028.
226
Staskus, K.A., Couch, L., Bitterman, P., Retzel, E.F., Zupancic, M., List, J. and
Haase, A.T. 1991. In situ amplication of visna virus DNA in tissue sections reveals
a reservoir of latently infected cells.
Microbial Pathogenesis 11:67-76.
Steff, K. and Wong-Staal, F. 1991. Genetic regulation of human immunodeficiency
virus.
Microbiological Reviews 55:193-205.
Steffen, M., Reinecker, H.C., Petersen, J., Doehn, C., Peluger, I., Voss, A. and
Raedler, A. 1993. Differences in cytokine secretion by intestinal mononuclear cells,
peripheral blood monocytes and alveolar macrophages from HIV-infected patients.
Clinical and Experimental Immunology 91:30-36.
Stevenson, M., Zhang, X. and Volsky, D.J. 1987. Downregulation of cell surface
molecules during noncytopathic infection of T cells with human immunodeficiency
virus.
Journal of Virology 61:3741-3748.
Streck, R.J., Helinski, E.H., Ovak, G.M. and Pauly, J.L. 1990. Lysis of autologous
human macrophages by lymphokine-activated killer cells: interaction of effector cell
and target cell conjugateds analyzed by scanning electron microscopy.
Journal of Leukocyte Biology 48:237-246.
Stuehr, D.J. and Marietta, M.A. 1987. Induction of nitrite/nitrate synthesis in
murine macrophages by BCG infection, lymphokines, or interferon-y.
Journal of Immunology 139:518-525.
Szkaradkiewicz, A. 1992. Phagocytosis and microbicidal capacity of human
monocytes in the course of HIV infection.
Immunology Letters 33:145-150.
Sztein, M.B., Steeg, P.S., Johnson, H.M. and Oppenheim, J. J. 1984. Regulation of
human peripheral blood monocyte DR antigen expression in vitro by lymphokines
and recombinant interferons.
Journal of Clinical Investigation 73:556-565.
Takeda, A., Tuazon, C.U. and Ennis, F.A.
HIV-1 via Fc receptor-mediated entry.
Science 242:580-583.
1988. Antibody-enhanced infection by
Takemoto, K.K., Mattern, C.F.T., Stone, L.B. and Lavella, G. 1971. Antigenic and
morphological similarities of progressive pneumonia virus, a recently isolated "slow
vims" of sheep, to visna and maedi viruses.
Journal of Virlogy 7:301-308.
227
Taylor, M.K. and Cohen, J.J. 1992. Cell-mediated cytotoxicity.
Current Opionion in Immunology 4:338-343.
Temin, H. M. 1981. Structure, variation and synthesis of retrovirus long terminal
repeat.
Cell 27:1-3.
Terpstra, F. G., Al, B. M., Roos, M. T. L., Wolf, F. D., Goudsmit, J., Schellekens,
P. T. A. and Miedema, F. 1989. Longitudinal study of leukocyte functions in
homosexual men seroconverted for HIV: rapid and persistent loss of B cell function
after HIV infection.
European Journal of Immunology 19:667-673.
Thormar, H. 1961. An electron microscopy study of tissue cultures infected with
visna virus.
Virology 14:463-475.
Thormar, H. 1963. The growth cycle of visna virus in monolayer cultures of sheep
cells.
Virology 19:273-278.
Tilden, A.B., Itoh, K. and Balch, C.M. 1987. Human lymphokines activated killer
(LAK) cells: identification of two types of effector cells.
Journal of Immunology 138:1068-1073.
Tiley, L. and Cullen, B.R. 1992. Structural and functional analysis of the visna
virus rev-response element.
Journal of Virology 66:3609-3615.
Torres, B.A., Farrar, W.L. and Johnson, H,M. 1982. Interleukin 2 regulates
immune interferon (EFN-y) production by normal and suppressor cell cultures.
Journal of Immunology 128:2217-2219.
Torsteinsdottir, S., Georgsson, G., Gisladottir, E., Rafnar, B., Palsson, P.A. and
Petursson, G. 1992. Pathogenesis of central nervous system lesions in visna: cell-
mediated immunity and lymphocyte subsets in blood, brain and cerebrospinal fluid.
Journal of Neuroimmunology 41:149-158.
Tuijnman, W.B., Van de Winkel, J.G.J. Capel, P.J.A. 1990. A flow cytometric
rosetting assay for the analysis of IgG-Fc receptor interactions.
Journal of Immunological Methods 127:207-214.
Twigg III, H.L., Weissler, J.C., Yoffe, B., Ball,E.J. and Lipscomb, M.F. 1991.
Monocyte accessory cell function in patients infected with the human
immunodeficiency virus.
Clinical Immunology and Immunopathology 59:436-448.
228
Twigg III, H.L., Iwamoto, G.K. and Soliman, D.M. 1992. Role of cytokines in
alveolar macrophage accessory cell function in HIV-infected individuals.
Journal of Immunology 149: 1462-1469.
Unanue, E.R. 1992. Cellular studies on antigen presentation by class II MHC
molecules.
Current Opinion in Immunology 4:63-69.
Unanue, E.R. and Cerottini, J-C. 1991. Antigen recognition.
Current Opinion in Immunology 3:1-2.
Vanham, G., Kestens, L., Gigase, P., Colebunders, R., Vandenbruaene, M. Brijs, L.
and Ceuppens, J. L. 1990. Evidence for circulating activated cytotoxic T cells in
HIV-infected subjects before the onset of opportunisitc infections.
Clinical and Experimental Immunology 82:3-9.
Varmus, H.E. 1982. Form and function of retroviral proviruses.
Science 216:812-820.
Vigne, R., Filippi, P., Querat, G., Sauze, N., Vitu, C., Russo, P. and Delori, P.
1982. Precursor polypeptide to structural proteins of visna virus.
Journal of Virology 42:1046-1056.
Wagner, R.P., Levitz, S.M., Tabuni, A. and Kornfeld, H. 1992. HIV-1 envelop
protein (gp 120) inhibits the activity of human bronchoalveolar macrophages against
Cryptocccus neoformans.
American Review of Respiratory Disease 146:1434-1438.
Wahl, S.M., Allen, J.B., Gartner, S., Orenstein, J.M., Popovic, ML, Chenoweth, D.
E., Arthur, L. O., Farrrar, W. L. and Wahl, L. M. 1989. HIV-1 and its envelope
glycoprotein down-regulate chemotactic ligand receptors and chemotactic function
of peripheral blood monocytes.
Journal of Immunology 142:3553-3559.
Walker, B.D., Chakrabarti, S., Moss, B., Paradis, T.J., Flynn, T., Durno, A.G.,
Blumberg, R. S., Kaplan, J.C., Hirsch, M. S. and Schooley, R.T. 1987. HIV-
specific cytotoxic T lymphocytes in seropositive individuals.
Nature 328:345-348.
Walker, B.D., Flexner, C., Birch-Limberger, K., Fisher, L., Paradis, T.J., Aldovini,
A., Young, R., Moss, B. and Schooley, R.T. 1989. Long-term culture and fine
specificity of human cytotoxic T-lymphocyte clones reactive with human
immunodeficiency virus type 1.
Proceedings of National Academy of Sciences of the USA 86:9514-9581.
Washburn, R.G., Tuazon, C.U., Bennett, J.E. 1985. Phagocytic and fungicidal
activity of monocytes from patients with acquired immunodeficiency syndrome.
Journal of infectious disease 151:565.
229
Watanabe, Y. and Jacob, C. 0. 1991. Regulation of MHC class II antigen
expression: opposing effects of tumor necrosis factor-a on fFN-y-induced HLA-DR
and la expression depends on the maturation and differentiation stage of the cell.
Journal of Immunology 146:899-905.
Watt, N.J., King, T.J., Collie, D., Mclntyre, N„ Sargan, D. and McConnell, I.
1992a. Clinicopathological investigation of primary, uncomplicated maedi-visna
virus infection.
Veterinary Record 14:455-461.
Watt, N.J., Maclntyre, N., Collie, D„ Sargan, D. and McConnell, I. 1992b.
Phenotypic analysis of lymphocyte populations in the lungs and regional lymphoid
tissue of sheep naturally infected with maedi visna virus.
Clinical and Experimental Immunology 90:204-208.
Weaver, C.T. and Unanue, E.R. 1990. The costimulatory function of antigen-
presenting cells.
Immunology Today 11:49-55.
Weaver, C.T., Hawrylowicz, C.M. and Unanue, E.R. 1988. T helper cells subsets
require the expression of distinct costimulatory signals by antigen presenting cells.
Proceedings of National Academy of Sciences of the USA 85:8181-8185.
Weiland, F. and Bruns, M. 1980. Ultrastructural studies on maedi-visna virus.
Archieves of Virology 64:277-285.
Weiland, F., Matheka, H.D., Coggins, L. and Hartner, D. 1977. Electron
microscopic studies on equine infectious anemia virus (ELAV).
Archives of Virology 55:335-340.
Weinhold, K.J., Lyerly, H.K., Matthews, T., Tyler, D.S., Ahearne, P.M., Stine,
K.C., Langlois, A.J., Durack, D.T. and Bolognesi, D.P. 1988. Cellular anti-gpl20
cytolytic reactivities in HIV-1 seropositive individuals.
The Lancet 902-905.
Weiser, W.Y., Niel, A.V., Clark, S.C., David, J.R. and Remold, H. G. 1987.
Recombinant human granulocyte/macrophage colony-stimulating factor activites:
intracellular killing of Leishmania donovani by human monocyte-derived
macrophages.
Journal of Experimental Medicine 166:1436-1446.
Wigdahl, B. and Kunsch, C. 1990. Human immunodeficiency virus infection and
neurological dysfunction.
Progress in Medical Virology 37:1-46.
230
Wong-Staal, F., Reitz, M.S., Trainor, C.D. and Gallo, R.C. 1975. Murine
intracisternal type A particles: a biochemical characterization.
Journal of Virology 16:887-896.
Yamatoto, H., Miller, M.D., Watkins, D.I., Snyder, G. B., Chase, N.E., Mazzara,
G.P., Gritz, L., Panicali, D.L. and Letvin, N.L. 1990. Two distinict lymphocyte
populations mediate simian immunodeficiency virus envelope-specific target cell
lysis.
Journal of Immunology 145: 3740-3746.
Yokoyama, W.M. 1993. Recognition structures on natural killer cells.
Current Opionion in Immunology 5:67-73.
Ziegler, K., Unanue, E.R. 1981. Identification of a macrophage antigen-processing
event required for I-region-restricted antigen presentation to T-lymphocytes.
Journal of Immunology 127:1869-1875.
Ziegler-Heitbrock, H.W.L. and Ulevitch, R.J. 1993. CD14: Cell surface receptor
and differentiation maker.
Immunology Today 14:121-125.
Ziegler-Heitbrock, H.W.L., Strobel, M., Kieper, D., Fingerle, G., Schlunck, T.,
Petersmann, I., Ellwart, J., Blumenstein, M. and Haas, J.G. 1992. Differential
expression of cytokines in human blood monocyte subpopulations.
Blood 79:503-511.
Zink, M.C and Narayan, O. 1989. Lentivirus-induced interferon inhibits maturation
and proliferation of monocytes and restricts the replication of caprine arthritis
encephalitis virus.
Journal of Virology 63:2578-2584.
Zink, M.C., Narayan, O., Kennedy, P.G.E. and Clements, J.E. 1987. Pathogenesis
of visna/maedi and caprine arthritis encephalitis: New leads on the mechanism of
restricted virus replication and persistent inflammation.
Veterinary Immunology and Immunopathology 15:167-180.
231
